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EFFECTS OF ULTRAVIOLET RADIATION ON THE SKIN 
 
The optical radiation spectrum of the sun can be divided into three major parts: ultraviolet 
radiation (100 – 400 nm), visible light (400 – 760 nm) and, at the other end of the spectrum, 
infrared (760 nm and more). The most biological harmful radiation is ultraviolet radiation (UV), 
which can be subdivided in UV-A (315 – 400 nm), UV-B (280 – 315 nm) and UV-C (200 – 280 
nm). Earth’s atmosphere, specifically the oxygen and ozone in the stratosphere, blocks most of 
the short-wave UV radiation, but UV-A and partly UV-B radiation can still reach the earth 
surface (Webb, 1997). UV-B radiation makes up only about 0.2% of the radiant energy of the 
sun at ground level but it is the most photochemicallly active wavelength band. UV radiation, 
especially UV-B, can cause photochemical smog and degradation of plastics and other 
compounds. It can also be absorbed by organic molecules such as proteins and DNA (de 
Gruijl, 1997; Jung and Bohnert, 1995). 
Keeping these effects in mind, it is a priori very likely that UV radiation can cause a broad 
range of effects in the skin. The skin needs to be very well adapted to this continuous 
photochemical stress. During evolution the skin has adapted itself to UV radiation inter alia by 
the presence of hair (animals), the relatively fast turnover of epidermal cells and the repair of 
damaged cells. Nevertheless, UV radiation is able to penetrate the skin and cause substantial 
damage. 
The acute effects of UV radiation on the skin are erythema and pigmentation, but also the 
formation of vitamin D3. Other effects of UV radiation are photo-aging of the skin, tumor 
induction, together with a suppression of tumor rejection (Gensler et al, 1995), and reduced 
immunization against microbial pathogens (Halliday and Norval, 1997; Jeevan et al, 1995). 
The latter two effects are due to immunosuppression brought about by UV-B and UV-A II (315 
- 340 nm). 
All of these effects, except for the formation of vitamin D3 and perhaps pigmentation, are 
considered adverse effects of UV radiation. When considered more closely, one can argue that 
UV-induced suppression of cellular immunity can be thought of as a primarily sound 
physiological reaction. First of all, we are continuously exposed to UV radiation and all of us 
display this immunosuppression at sufficiently high doses (Cooper et al, 1992). Consequently, 
this immunosuppression could well prevent us from mounting a disruptive (auto)immune 
response against (neo)antigens that are created by UV-induced modification of proteins and 
other organic molecules in the skin (Natali and Tan, 1973; Norris et al, 1989b). 
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Diminishing the UV-induced immunosuppression could be beneficial for tumor rejection and 
immunization but one should be aware of the possible harmful side effects. An inadequate 
immunosuppression could allegedly develop into a UV-trigged sun allergy, e.g. polymorphous 
light eruption (PLE). 
 
 
POLYMORPHOUS LIGHT ERUPTION 
 
PLE, an idiopathic photodermatosis, was first described by Robert Willan in 1798 (Stratigos et 
al, 2002), who called it ‘eczema solare’. Since then several names have been used to describe 
this skin disorder. Names such as summer prurigo, summer itch, solar dermatitis, benign 
summer eruption were used or are still used. However, the most commonly used name today 
is ‘polymorphous light eruption’, which was first introduced by the Dane Rasch in 1900 
(Stratigos et al, 2002). 
PLE is most common in temperate climate zones, with increasing prevalences towards the 
poles. In (sub)tropical areas with a more or less constant amount of sunlight throughout the 
seasons, PLE is hardly seen. PLE does not appear to be restricted to any race, skin color or 
gender and can occur at any stage of life. However, women are more frequently affected than 
men and the mean age of onset is usually lower in women (mean of 28 years) than in men 
(mean of 46 years) (Boonstra et al, 2000; Lecha, 2001). Twin studies show that there is a 
genetic component involved in PLE but candidate genes are not yet discovered (McGregor et 
al, 2000; Millard et al, 2001). 
PLE patients can be sensitive to UV-A and/or UV-B radiation or sometimes even to visible 
light. The majority of the PLE patients have a normal sunburn sensitivity, however, 10-20% of 
the patients has a sunburn sensitivity that can be ten times as high as in healthy individuals 
(Diffey, 1986; Holzle et al, 1982; Jansen, 1979). The clinical symptoms of PLE often start in the 
spring or early summer, decrease in the course of the summer, and are often absent during 
winter, indicative of a seasonal dependence. The symptoms consist of itching papules and/ or 
vesicles on sun-exposed areas of the skin (Epstein, 1997; Grabczyska and Hawk, 1997; 
Salomon et al, 1997). There is some discussion whether eczematous lesions belong to the 
diagnosis of PLE (Stratigos et al, 2002) or whether they are symptoms of photosensitive 
eczema or chronic actinic dermatitis (CAD, see below). Clinical symptoms often appear within 
hours or days after the actual sun exposure. Because of this delay between exposure and the 
appearance of skin lesions, PLE is often suggested to be a delayed type hypersensitivity 
reaction (type IV) (Epstein, 1997; Norris et al, 1989b; Verheyen et al, 1995). Skin lesions can 
disappear within one day to three weeks without scaring. Sometimes symptoms like fever, 
headache or general malaise occur. 
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The histology of the skin lesions is variable but shows dense infiltrates of lymphocytic cells. 
Characteristic of an early lesion is a normal epidermis with edema in the stratum papillare and 
lymphocytic infiltrates in the upper and mid-dermis. CD4+ T-cells dominate these infiltrates 
while older lesions contain more CD8+ T-cells (Holze, 1995; Norris et al, 1989b). Skin 
infiltrates also contain eosinophils and neutrophils. Furthermore, presence of spongiosis, 
vesicle formation as well as necrotic keratinocytes are described. Verheyen et al (1995) and 
Norris et al (1992) showed that most keratinocytes in provoked PLE lesions express HLA-DR 
and ICAM-1, which is comparable to other delayed type hypersensitivity reactions, such as 
allergic contact dermatitis. In PLE lesions CD45RO+ memory T-cells were predominantly 
present (Hasan et al, 1999; Lecha, 2001). An increase in Langerhans cells in epidermis and 
upper-dermis is also reported (Norris et al, 1989a). A delay between exposure and occurrence 
of skin lesions, the presence of papules or vesicles, a flare-up of previous lesions when distant 
skin areas are exposed and a histological resemblance to a delayed type hypersensitivity 
reaction, all these phenomena together indicate that a cellular-mediated immune reactivity is 
involved in PLE. 
DNA damage is the initiating event of many skin reactions caused by UV exposure, but DNA 
excision repair is normal in the (lesional) skin of PLE patients (Horkay et al, 1978; Ichihashi 
and Ramsay, 1976). 
The diagnosis of PLE is based on patient’s history and/or histology of skin lesions and 
sometimes on provocation by daily exposures to UV-A and UV-B radiation and visible light on 
restricted areas of the arm or other previously affected skin areas (Gonzalez and Gonzalez, 
1996; Jansen, 1982). At the department of Dermatology of the University Medical Center 
Utrecht (the Netherlands) the diagnosis of PLE is based on the combination of a patient’s 
history, phototesting and histology of lesions to exclude other photosensitive disorders such as 
lupus erythematodes. The phototesting is performed with UV-B radiation from Philips TL12 
lamps and with UV-A radiation from a Mutzhas UVASUN 3000. Phototesting with visible light is 
performed with a high pressure mercury arc with special glass lenses and filters (Boonstra et 
al, 2000). The occurrence of lesions is dependent on the size of the exposed skin area, the site 
of phototesting and on the number of (repeated) exposures (Hönigsmann, 1993). PLE lesions 
occur more easily on a relatively large area of skin (10*10 cm) which has previously been 
affected and which is exposed to an average of three (maximum 6) daily doses of UV radiation 
(or visible light). Phototesting is ceased as soon as skin lesions occur. In our hands, the 
majority of the patients (men and women together) react to UV-B as well as UV-A radiation 
(about 64%), while only minorities react to either UV-A I (340 - 400 nm) or UV-B radiation 
(Boonstra et al, 2000). Other groups report less (Honigsmann and Ortel, 1988; Lindmaier and 
Neumann, 1991) or no abnormal reactions to UV-B radiation (Bergner et al, 1993) and/or 
visible light (Holzle et al, 1982). 
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Prevention of PLE lesions by controlled exposure to the sun, the use of sunscreens and 
protective clothing are the most common advices given to PLE patients. If these measures are 
not sufficient, patients can receive photo(chemo)therapy (Boonstra et al, 2000; Gschnait et al, 
1983; Man et al, 1999; Murphy et al, 1987b) with initially low and then gradually increasing 
doses of UV radiation. When lesions are already present, patients can be treated with 
immunosuppressive drugs such as corticosteroids (Ferguson and Ibbotson, 1999) or 
azathioprine (Imuran) (Norris and Hawk, 1989) or with hydroxychloroquine (Murphy et al, 
1987a). Imuran may reduce Langerhans cell numbers (Bergfelt, 1993). Experimental treatment 
with fish oil capsules for 3 months resulted in moderate protection against a UV-A-induced 
papular response and in a decreased erythemal sensitivity to UV-B radiation (Rhodes et al, 
1994; Rhodes et al, 1995). Systemic treatment of PLE patients with vitamin C and E for 8 days 
had no protective effects (Eberlein-Konig et al, 2000). 
An excellent review was recently published by Stratigos et al (2002) describing inter alia the 
epidemiological, pathogenetic and clinical aspects of PLE. 
 
 
DIFFERENTIAL DIAGNOSES 
 
Juvenile spring eruption 
The term “ juvenile spring eruption of the ears” (JSE) was used by Andersen in 1954 to define 
symptoms of erythema, itching papules, vesicles and even blisters on the ears of a group of 
London school children on summer camp. JSE appears in early spring and can disappear 
spontaneously but often develops later in life into a classical PLE (Toonstra and van Weelden, 
1994). Histology of the lesions cannot distinguish JSE from PLE. Because of similarities of 
clinical symptoms and histology, JSE can be seen as a variant of PLE (Berth-Jones et al, 
1989; Berth-Jones et al, 1991; Hawk, 1996). Treatment with topical corticosteroids or 
application of sunscreens before sun exposure is often sufficient to prevent or control JSE. 
 
Actinic prurigo 
Actinic prurigo (AP) is most common in the indigenous population of the Americas, especially 
among Indians (Lane, 1997). AP belongs to the ten most common skin diseases in Mexico. AP 
occurs in most patients in early childhood.  
A genetic HLA-DR-associated component is often described in 50 – 75% of the patients (Hojyo 
Tomoka et al, 1997; Wiseman et al, 2001). Twice as many women as men have AP. A familial 
background of atopy has also been reported for AP patients (Ferguson and Ibbotson, 1999). 
Clinical symptoms comprise of very itchy papules, vesicles, scratch-effects and sometimes 
plaque-type lesions. The itch lasts even if sun exposure is limited; there is no clear seasonal 
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dependence although the symptoms are more severe during summer. Scratching often leads 
to erosion, ulceration and finally scaring. Lesions on covered skin areas may also occur 
(Lecha, 2001). 
Histological characteristics are almost similar to PLE and consist of spongiosis, hyper- and 
parakeratosis, sub-epidermal edema and a moderate number of lymphocytes. Prurigo lesions 
show acanthosis, hyperkeratosis, moderate perivascular lymphocytic infiltrates, fibrosis and 
thickening of capillary vessels in the stratum papillare. After 48 hours the lesional infiltrate 
contains CD4+ T-cells. Some research groups show a high expression of TNF-α (Arrese et al, 
2001), TGF-β and interleukin 13 (Santos-Martinez et al, 1997) in AP lesions. One group of 
investigators showed that Langerhans cells in AP patients did not disappear after 
overexposure of the skin to UV (Torres-Alvarez et al, 1998). 
AP is therapy resistant; corticosteroids, sunscreens or phototherapy have little or no effect. 
 
Chronic actinic dermatitis / Actinic reticuloid 
Chronic actinic dermatitis (CAD) is a collective term for persistent light reaction and actinic 
reticuloid (AR). The majority of the CAD patients are males over 50 years of age (for review 
see Menage and Hawk (1993) or Roelandts (1993)). CAD can start as an a-specific eczema 
on the hands or the face (photosensitive eczema) or as a PLE-like skin reaction with papules 
and vesicles which then increases in severity and light sensitivity. Many patients are found to 
react to (photo)contact allergens, but avoidance of the allergens does not lead to improvement 
of the symptoms. Etiology is unknown, but is probably multifactorial involving photoallergic, 
phototoxic, immunologic and metabolic factors (Vandermaesen et al, 1986). 
Clinical symptoms include a strong itching eczema, sometimes with papules and confluent 
plaques. In the most sever cases erythroderma, lasting for years, can occur. The majority of 
CAD patients has no obvious seasonal dependency of the disease. Patients often have a high 
sunburn sensitivity to UV-B and/or UV-A radiation and sometimes even to visible light (Lecha, 
2001). 
Histology of the lesions is variable, depending on the duration and severity of the disease. In 
less severe cases, photosensitive eczema, an eczema with or without eosinophils and mostly 
an excess of CD4+ T-cells is observed. When persistence and/or severity increases, 
spongiosis and vesiculation become less, while the epidermis shows more acanthosis, 
parakeratosis and infiltration of mostly CD4+ lymphocytes. At the department of Dermatology 
of the University Medical Center Utrecht the term ‘actinic reticuloid’ is used when three criteria 
are met: presence of a largely infiltrated (sun-exposed) skin or persistent erythroderma, 
sensitivity to UV-B as well as UV-A radiation and visible light and skin lesions containing 
dermal infiltrates with a-typical lymphocytes (Toonstra, 1991). The abundant presence of a-
typical lymphocytes makes it difficult to distinguish this skin disease from mycosis fungoides 
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and Sézary syndrome. The infiltrate can be present in the complete upper-dermis, but can also 
spread more scatteredly into the sub-cutis. Most of the a-typical lymphocytes in the AR lesion, 
but also in the blood, are CD8+ T-cells. A reversed CD4/CD8 ratio is the most important 
diagnostic criterion for differentiation from Sézary syndrome. 
Advice and treatment are the same, but more strict, for CAD patients than for PLE patients. 
Sunscreens, however, are usually not effective and can even increase the severity of the 
disease as they may contain (photo)contact allergens. For patients with severe AR cyclosporin 
(Gardeazabal et al, 1992) or azathioprine (Murphy et al, 1989) can be prescribed to suppress 
immune reactivity. 
Because of the resemblance in symptoms, histology and treatment but a difference in severity, 
one could arrange these idiopathic photodermatoses in a spectrum starting with JSE and 
ending with AR (figure 1). The exception to this is AP which seems to be a different entity 
because of a strong genetic component and therapy resistance. However, some investigators 
report that AP and PLE share some common genetic background (McGregor et al, 2000). 
Furthermore a photosensitive eczema (not part of this spectrum) may also eventually progress 
into CAD or AR. 
 
JSE CAD AR PLE 
Figure 1. Spectrum of idiopathic photodermatoses increasing in severity from left to right. 
 
 
ULTRAVIOLET-B-INDUCED IMMUNOSUPPRESSION 
 
One of the effects of UV radiation, especially UV-B, is immunosuppression. This first came to 
light as an adverse effect of UV exposure (allowing tumor growth and worsening of infections). 
However, as already mentioned in the first paragraph of this introduction, this 
immunosuppression could also be regarded as a primarily sound physiological reaction, 
because an inadequate UV-induced immunosuppression may possibly provoke a skin disease 
such as PLE. To investigate this potential pathogenic mechanism of PLE more closely, we can 
focus on cells and soluble factors that are involved in UV-B-induced immunosuppression. 
UV-B radiation can induce local as well as systemic immunosuppression (Morison, 1989). 
Application of a hapten on an irradiated area of the skin, induces local immunosuppression, 
probably because of a direct effect of UV-B radiation on the Langerhans cells, inhibiting their 
antigen-presenting capacity. A systemic or distant immunosuppression is induced when 
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immunization is performed on an unirradiated skin area (e.g. back) of an animal/human who is 
irradiated on a distant skin area (e.g. abdomen). A release of soluble factors like, urocanic acid 
(Noonan and De Fabo, 1992), neuropeptides (Garssen et al, 1998; Gillardon et al, 1995), 
nerve growth factor (Townley et al, 2002), neurohormones (Misery, 2000) and cytokines (e.g. 
prostaglandin E2) is most likely responsible for the induction of systemic immunosuppression. 
In this introduction I will only focus on cells and soluble factors, which are thought to be pivotal 
in UV-induced immunosuppression and consequently in the present research project. 
Moreover, UV-induced DNA-damage, DNA repair and apoptosis are important in primary 
cellular reactions and will therefore also be briefly discussed. 
 
Langerhans cells 
Langerhans cells were first identified by Paul Langerhans in 1868, who thought that these cells 
were neural cells (Langerhans, 1868). Later on, Langerhans cells were considered antigen-
presenting cells and participants of a skin immune system (Silberberg et al, 1976). Langerhans 
cells are located in the suprabasal layer of human and also murine skin. They have long 
dendrites (pseudo-podia) and can be distinguished from dendritic cells by the presence of 
specific cytoplasmatic organelles with unknown function, the Birbeck granules. Following 
exposure of the skin to various chemical or biological factors (irritants or immunizing haptens), 
Langerhans cells round-up, retracting their dendrites, and migrate via the afferent lymph 
vessels to the skin draining lymph nodes. During migration Langerhans cells mature and lose 
their antigen capturing and processing capacity and become more effective in antigen 
presentation for induction of a proper immune response. 
It is known from animal models (Dandie et al, 1998; Dandie et al, 2001; Sontag et al, 1995), 
but also from human models using lymph drainage (Yawalkar et al, 1998), that Langerhans 
cells migrate to the draining lymph nodes after exposure of the skin to UV. The putative 
antigen(s) that trigger(s) this Langerhans cell migration are still not known. It is speculated that 
proteins or other organic molecules modified by UV, could be recognized by the skin immune 
system as foreign antigens. These ‘neo-antigens’ are most likely taken up by Langerhans cells 
and after migration presented to the T-cells in the draining lymph nodes, leading to an immune 
response against this antigen. At the same time, UV radiation can be absorbed by 
chromophores, which initiate a signaling cascade leading to immunosuppression. Prominent 
chromophores are DNA and urocanic acid. The latter can be isomerized by UV radiation from 
the trans form to the cis form. Uptake of antigen and presentation in an immunosuppressive 
context leads to induction of antigen-specific tolerance (Cooper et al, 1992; Steinbrink et al, 
1997). 
Besides creating an immunosuppressive environment in the skin, UV-B radiation is also able to 
impair the antigen-presenting capacity of Langerhans cells, by affecting antigen processing 
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and production of mediators produced by keratinocytes which are needed for optimal T-cell 
responses (Stingl et al, 1983). Langerhans cell function can be influenced by cytokines like 
interleukin 10 (IL-10), which can inhibit migration and maturation of Langerhans cells 
(Steinbrink et al, 1997). Other UV-induced soluble mediators, such as the neuropeptide CGRP 
(calcitonin gene-related peptide) and nitric oxide can inhibit antigen presentation by dendritic 
cells in vitro (Gillardon et al, 1995). 
Expression of costimulatory molecules on dendritic cells is needed for proper antigen 
presentation and stimulation of T-cells. Some investigators report that costimulatory molecules, 
such as CD80 (B7-1), CD86 (B7-2) and HLA-DR are downregulated by UV (Rattis et al, 1998; 
Weiss et al, 1995). Conversely, Laihia and Jansen (Laihia and Jansen, 1997; Laihia and 
Jansen, 2000) show that these molecules are upregulated after in vivo UV (over)exposure of 
the skin. The costimulatory and adhesion molecule ICAM-1 can be downregulated by UV 
radiation leading to an impairment of clustering of Langerhans cells and T-cells (Tang and 
Udey, 1991). Inhibition of costimulatory signals can lead to abrogation of Th1 stimulation 
(Simon et al, 1991), while stimulation of Th2 cells is still possible (Simon et al, 1990). 
Langerhans cells themselves can also contribute to the immunosuppressive milieu by 
releasing neurohormones, such as alpha-melanocyte stimulating hormone, which can 
downregulate expression of costimulatory molecules on Langerhans cell and induce IL-10 
production (Luger et al, 1997; Luger et al, 1998). 
Another way to prevent Th1 stimulation is by apoptosis of Langerhans cells, which will prevent 
them from reaching the T-cells in the lymph nodes or which may induce aberrant T-cell 
activation signals leading to T-cell unresponsiveness (Kitajima et al, 1996). In vitro and in vivo 
(mice) experiments revealed that UV-exposed Langerhans cells undergo apoptosis, for 
instance via the production of reactive oxygen species. Whether this also occurs in human skin 
in vivo still had to be demonstrated (Meunier, 1999). UV-induced apoptosis of human 
Langerhans cells can be prevented, among others, by interaction between the costimulatory 
molecule CD40, present on Langerhans cells, and CD40 ligand (CD40L), present on T-cells in 
vitro (Rattis et al, 1998). Whether CD40 or CD40L is downregulated after UV exposure in vivo 
is still unknown. 
 
CD11b+ monocytic/ macrophagic cells 
Besides inducing an efflux of Langerhans cells, exposure of the skin to UV also results 
concomitantly in an influx and expansion of CD11b+ cells in the (epi)dermis (Meunier et al, 
1995). There are several indications that these CD11b+ macrophage-like cells are involved in 
UV-B-induced immunosuppression: Kang et al (1994 and 1998) reported that human CD11b+ 
cells produce and secrete IL-10 in vivo and had a low expression of interleukin 12 (IL-12). 
Hammerberg et al (1996a, 1996b and 1998) showed that a local state of in vivo tolerance in 
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the UV-exposed murine skin is closely associated with the influx of CD11b+ MHCII+ cells and 
that anti-CD11b treatment can even reverse UV-induced immunosuppression. Furthermore, 
UV radiation can activate complement component 3 (C3) in the skin. Experiments with C3-
deficient mice and prevention of the formation of iC3b, the ligand for the CD11b receptor, 
resulted in a reduction of the number of CD11b+ MHCII+ cells and a reversion of the failure to 
induce a contact hypersensitivity response in the UV-B-exposed murine skin (Hammerberg et 
al, 1998). The macrophages in UV-exposed skin appear to expand preferentially suppressor-
inducer CD4+ T-cells which activate CD8+ T-cells, thereby also contributing to UV-B-induced 
tolerance (Baadsgaard et al, 1988; Baadsgaard et al, 1990). 
 
Cytokines 
Cytokines are cellular proteins that are often pleiotropic; they can induce many cell functions 
and act on many cell types. The biological activity of cytokines depends on their binding to 
specific cytokine receptors. Cytokines can act in an autocrine, paracrine or endocrine manner 
having their effects on the cells of origin, the local environment or via the periphery 
respectively. Some cytokines can act in a juxtacrine manner by binding of a membrane-bound 
cytokine to a receptor on an adjacent cell. Furthermore, identical cytokines can be produced by 
different cell types. Cytokine release and activity can be regulated via several mechanisms: 
regulation of gene transcription, regulation of conversion from a pro-cytokine to an active 
cytokine, regulation of cytokine receptor expression, expression of cytokine receptors with 
different characteristics and effects, or via the release of soluble cytokine receptors (Sundy et 
al, 1999). 
Cytokines are important in the regulation of immune responses, they can either initiate or 
stimulate inflammatory processes (pro-inflammatory cytokines) or downregulate inflammation 
(anti-inflammatory cytokines). Interleukin (IL)-1, IL-6, IL-12, IL-18, tumour necrosis factor 
(TNF)-α, interferon (IFN)-γ are cytokines exhibiting pro-inflammatory activities. IL-4 and IL-10 
are examples of cytokines involved in Th2 skewing and downregulation of inflammation in the 
skin. UV-B radiation induces the release of both pro-inflammatory and anti-inflammatory 
cytokines eventually shifting the balance towards immunosuppression. 
 
Interleukin 1 (IL-1). IL-1 has two forms, IL-1-α and IL-1-β, with mostly indistinguishable 
biological activity. IL-1-α is fully active as a precursor but remains mostly intracellular. When 
cells are physically disrupted, pro-IL-1-α is released and cleaved by extracellular proteases or 
by membrane-associated calpains (Kobayashi et al, 1990; Watanabe and Kobayashi, 1994). 
IL-1-β precursor is not fully active and is activated and secreted in large amounts after 
cleavage by interleukin-1-β-converting enzyme (ICE, caspase 1). IL-1 can bind to two specific 
IL-1 receptors: IL-1 type 1 receptor, that induces signal transduction after binding of the 
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cytokine, and IL-1 type 2 receptor, that can bind IL-1 but does not transduce a signal and can 
thus act as a decoy receptor for IL-1-β. IL-1 receptor antagonist (IL-1-Ra) (Hannum et al, 1990) 
can bind to IL-1 type 1 receptor nearly irreversible preventing or disrupting the binding of IL-1 
without triggering a signal (Dripps et al, 1991) and leading to the inhibition of IL-1 activity.  
The epidermis contains a large amount of IL-1-α in keratinocytes. IL-1-α expression is 
upregulated by UV radiation and stimulates prostaglandin synthesis and increases TNF-α and 
IL-6 levels. UV radiation also induces the expression of IL-1-β by keratinocytes and 
Langerhans cells (Norval, 2001). IL-1-β, but also IL-1-α, is involved in the migration of 
Langerhans cells (Cumberbatch et al, 1997a; Cumberbatch et al, 1997b). Langerhans cell 
migration induced by antigen application was found to be dependent on IL-1-β and 
independent of IL-1-α while the converse was true for application of an irritant (Cumberbatch et 
al, 2002). Together with an increase in IL-1, IL-1-Ra expression was also elevated in the 
stratum corneum after UV exposure. The ratio IL-1-Ra:IL-1-α was over 100 in the UV-exposed 
skin compared to 8 in the unexposed skin (Hirao et al, 1996). The UV-induced rise in IL-1, with 
the concomitantly greater rise in IL-1-Ra may actually inhibit the activities of IL-1 and suppress 
an inflammatory response (Duthie et al, 1999). 
 
Tumour necrosis factor-α (TNF-α). The pro-inflammatory cytokine TNF-α is produced as a 
biologically active membrane protein which is secreted only after cleavage by TNF-α- 
converting enzyme. TNF-α mediates its effects by binding to TNF receptor-p55 or TNF 
receptor-p75. Human keratinocytes only express TNF receptor-p55. Soluble forms of both TNF 
receptors can neutralize the effects of TNF-α (Olsson et al, 1993). 
TNF-α is increased after UV irradiation and can be produced by keratinocytes (Kock et al, 
1990), mast cells (Walsh, 1995), dermal fibroblasts and Langerhans cells (Norval, 2001). UV-
induced TNF-α expression contributes to the apoptosis of keratinocytes (Schwarz et al, 1995) 
and the migration (Cumberbatch et al, 1997a; Cumberbatch et al, 1997b) and maturation of 
Langerhans cells (Streilein, 1993). Yokishawa and Streilein (1990) showed that TNF-α is 
involved in the UV-induced impairment of contact hypersensitivity responses by reversing the 
impairment with anti-TNF-α antibodies. 
 
Interleukin 4 (IL-4). IL-4 is a cytokine with intrinsic anti-inflammatory capacities in the skin. IL-4 
can be produced by activated T helper 2 (Th2) cells, basophils and neutrophils (Sundy et al, 
1999; Teunissen et al, 2002). Takayama et al (1999) showed, by using an in vitro migration 
model, that IL-4 inhibited Langerhans cell migration by downregulation of TNF receptor-p75 on 
Langerhans cells. Mice overexpressing IL-4 had increased epidermal Langerhans cell 
numbers which can be explained by a reduction in Langerhans cell emigration from the skin 
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(Elbe-Burger et al, 2002). Experiments performed in IL-4 knockout mice showed that IL-4 was 
important in UV-induced suppression of a delayed type hypersensitivity reaction (el Ghorr and 
Norval, 1997). Contact hypersensitivity reactions were only suppressed in IL-4 knockout mice 
when the sensitizer (oxazolone) was applied on irradiated skin (local model)(el Ghorr and 
Norval, 1997) but not on unirradiated skin (systemic model), showing that IL-4 is only important 
in UV-induced systemic immunosuppression of contact hypersensitivity reactions (Hart et al, 
2000). UV irradiation induces an infiltration of numerous IL-4+ neutrophils into the dermis and 
even the epidermis. These IL-4+ neutrophils support the development of a Th2 milieu in the 
UV-exposed skin, as depletion of these CD15+ neutrophils from dermal cell cultures from UV-
exposed skin abolished the Th2 response (Teunissen et al, 2002). 
 
Interleukin 6 (IL-6). IL-1 is a potent inducer of IL-6. IL-6 can be produced by keratinocytes and 
Langerhans cells and is detected in the serum after UV exposure (Urbanski et al, 1990). IL-6 is 
increased after UV exposure and has a wide range of pro-inflammatory effects including fever 
and synthesis of acute phase proteins. On the other hand, IL-6 has some anti-inflammatory 
capacities. It can induce the production of adrenocorticotrophic hormone from the central 
nervous system, increasing the synthesis of glucocorticoids (Tilg et al, 1997) which, in turn, 
can suppress IL-1 and TNF-α synthesis. Furthermore, IL-6 induces soluble TNF receptor-p55 
and promotes the synthesis of IL-1-Ra by increasing acute phase C-reactive protein (Tilg et al, 
1997; Urbanski et al, 1990). 
 
Interleukin 10 (IL-10). IL-10 has similar activities in the induction of anti-inflammatory 
processes as IL-4. It can be produced by keratinocytes, macrophages, melanocytes and 
activated T-cells, especially Th2 cells. IL-10 is increased after UV irradiation and is involved in 
the decrease of pro-inflammatory cytokines, like IL-1, TNF-α, IL-12 and IFN-γ (Norval, 2001), 
and the increase of IL-1-Ra (Cassatella et al, 1994). UV-induced upregulation of IL-10 in 
keratinocytes (Enk et al, 1995; Grewe et al, 1995), probably triggered by DNA damage 
(Nishigori et al, 1996), may induce systemic immunosuppression (Rivas and Ullrich, 1992) by 
itself or perhaps with the help of prostaglandin E2 or IL-4 (Shreedhar et al, 1998). Furthermore, 
IL-10 is shown to inhibit Langerhans cell migration, maturation (Wang et al, 1999) and antigen 
presentation (Peguet-Navarro et al, 1995), and convert them into tolerogenic antigen 
presenting cells (Steinbrink et al, 1997). In contrast Halliday and Le (2001) showed that IL-10 
from regressor tumors enhanced Langerhans cell migration from the skin. An IL-10-induced 
decrease of IL-12 and an inhibition of Langerhans cell activation of Th1 cells, but not Th2 cells 
(Enk et al, 1993), may skew the T helper population towards a Th2 phenotype. Kang et al 
(1994 and 1998) reported that CD11b+ macrophages are the major source of IL-10 production 
and secretion in the UV-exposed skin. Depletion of these cells by anti-CD11b treatment 
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reversed UV-induced immunosuppression of contact hypersensitivity responses (Hammerberg 
et al, 1996a). 
 
Interleukin 12 (IL-12) and interferon (IFN)-γ. The bioactive form of IL-12, IL-12p70, consists of 
the subunits p40 and p35. Monomers and homodimers of p40 are known to inhibit IL-12 
activity by blocking the receptor (Mattner et al, 1993). IL-12 is important in preferentially 
inducing Th1 immune responses and promoting the production of IFN-γ by T-cells and natural 
killer cells (Trinchieri, 1995). IL-12 can be produced by macrophages, dendritic cells (Kang et 
al, 1996), Th1 cells and keratinocytes (Aragane et al, 1994; Muller et al, 1994). Upon UV 
radiation the production of IL-12 by monocytes/macrophages is reduced (Kang et al, 1998; 
Yoshida et al, 1998). Antigen presentation by UV-irradiated monocytes in vitro resulted in 
reduced IFN-γ and IL-12 production by T-cells, limiting Th1 responses (Kremer et al, 1996). UV 
irradiation of keratinocytes in vivo or in vitro, however, induced the expression of IL-12p40 
(Enk et al, 1996; Kondo and Jimbow, 1998). A UV-induced increase in the production of 
biologically inactive IL-12p40 by keratinocytes or dendritic cells might result in a decrease of 
Th1 responses and an impairment of antigen presentation (Norval, 2001). IL-12 treatment can 
overcome UV-B-mediated local and systemic immunosuppression and tolerance by preventing 
the induction of suppressor T-cells (Schmitt et al, 1995; Schwarz et al, 1996), restoring the UV-
induced suppression of IFN-γ by T-cells (Ando et al, 2000) and inhibiting the UV-induced 
release of IL-10 (Schmitt et al, 2000). Furthermore, treatment of keratinocytes in vitro or in vivo 
with IL-12 resulted in suppression of UV-induced apoptosis by enhancing DNA repair (Schwarz 
et al, 2002). 
IFN-γ is reported to increase IL-12 production of macrophages and dendritic cells (Trinchieri, 
1995) and to inhibit the proliferation of Th2 cells, but not Th1 cells. A UV-induced reduction of 
IFN-γ favors Th2 development and is an important mechanism by which UV irradiation 
prevents tumor rejection (Gensler et al, 1995). Reeve et al (1999) reported that IFN-γ plays a 
role in UV-A-induced photoprotection from the suppressive effects of UV-B radiation. 
 
Interleukin 18 (IL-18). IL-18 was first discovered in 1989 by Nakamura et al (1989) as IFN-γ 
inducing factor (IGIF). Bazan et al (1996) showed that the amino acid sequence structure of 
the protein resembled very much IL-1. IL-18, like IL-1-β, needs to be cleaved by caspase 1 to 
generate an active protein (Gu et al, 1997). IL-18 binding protein can bind to IL-18 and block 
its activity, which resembles the mechanism of the IL-1 receptor 2 (Novick et al, 1999). 
IL-18 can be expressed by many cell types, e.g. dendritic cells, macrophages and epithelial 
cells. Keratinocytes express predominantly the unprocessed biologically inactive form of IL-18 
(Companjen et al, 2000a; Companjen et al, 2000b). Biologically active IL-18 is secreted by 
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keratinocytes after treatment with pro-inflammatory agents, such as PMA and LPS (Naik et al, 
1999). IL-18 is dependent on and synergizes with IL-12 to induce IFN-γ production by T-cells 
(Chang et al, 2000; Tominaga et al, 2000) and to skew the response towards Th1. IL-18 is also 
involved in IFN-γ production and activation of natural killer cells (Hunter et al, 1997; Lauwerys 
et al, 1999). Langerhans cell derived IL-18 mRNA and protein is upregulated in migrating 
hapten-modified Langerhans cells and contributes to the initiation of contact hypersensitivity 
(Wang et al, 2002). Intradermal administration of IL-18 resulted in Langerhans cell migration 
and accumulation of Langerhans cells in the draining lymph nodes. This migration was 
dependent on availability of TNF-α and the integrity of the IL-1 receptor 1 signaling 
(Cumberbatch et al, 2001). Contact hypersensitivity and Langerhans cell migration were 
inhibited in mice deficient for caspase 1, the cleavage enzyme for IL-18 (Antonopoulos et al, 
2001). Experiments with caspase 1 knockout mice revealed that IL-18 induced Langerhans cell 
migration required IL-1-β (Cumberbatch et al, 2001). Another biological property of IL-18 is its 
enhancing effect on apoptosis through Fas-Fas ligand interactions (Kodama et al, 2000), which 
is, at least in part, responsible for the anti-tumor effects of IL-18 (Hashimoto et al, 1999). There 
is only limited information on the effects of UV radiation on IL-18 expression. Nakagawa et al 
(1999) reported that ex vivo UV-B irradiation of epidermal sheets had no effect on IL-18 
production. 
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Figure 2. Simplified scheme of the effects of UV radiation on the cytokine cascade. Most cytokinesin this 
scheme are upregulated by UV exposure. Cytokines that are downregulated are indicated in bold. The 
dotted line illustrates a potential, but yet unknown, effect of IL-18 on UV-induced Langerhans cell 
migration.  = stimulation,  = suppression. 
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DNA DAMAGE, DNA REPAIR, AND APOPTOSIS 
 
The energy of UV radiation, especially of wavelengths in the UV-B band, can be absorbed by 
organic molecules like DNA. Upon UV-B exposure the DNA of cells is damaged. UV-induced 
DNA damage consists of DNA adducts (95%) and strand breaks (5%). Neighboring 
pyrimidines (C, T) are more sensitive to UV-induced dimerisation than purines (G, A). UV-B 
radiation induces cyclobutane pyrimidine dimers (CPD) and 6-4 pyrimidine-pyrimidones 
photoproducts (6-4PP). CPDs are more frequently formed and disturb the DNA helix less than 
6-4PP (Bykov and Hemminki, 1996; de Gruijl, 1997; Mitchell et al, 1992). 
The predominant DNA repair mechanism for UV-induced DNA damage is Nucleotide Excision 
Repair (NER). NER entails the action of many proteins which are involved in damage 
recognition, opening of the DNA-helix, excision of the damage-containing oligonucleotide 
followed by gap filling and strand ligation. NER consist of two pathways: one is involved in the 
excision of DNA damage throughout the entire genome, called Global-Genome Repair (GGR), 
and the other pathway, called Transcription-Coupled Repair (TCR) preferentially repairs DNA 
damage in the transcribed strands of actively transcribed genes. The two pathways are 
essentially the same except for the damage recognition part which is performed by different 
proteins. An enhancement or defect of DNA repair can have dramatic effects on cytokines 
produced in the skin. For instance, removal of CPDs by topical treatment with T4 
endonuclease V (T4N5) resulted in a decrease in UV-induced levels of IL-10 and TNF-α 
(Nishigori et al, 1996; Wolf et al, 2000). Furthermore, a defect in TCR gave rise to an 
increased production of TNF-α and IL-10 after UV exposure while a defect in GGR resulted in 
a decreased production of IFN-γ by lymph node cells (Boonstra et al, 2001). 
The consequences of a defect in either one of the pathways of the NER system are evident in 
patients suffering from rare recessive photosensitive disorders: Xeroderma Pigmentosum (XP) 
and Cockayne Syndrome (CS). Eight different subgroups of XP (XPA-XPG and XP variant) 
and two different subgroups of CS (CSA and CSB) have been identified, reflecting a defect in a 
distinct gene. Most of the XP patients, of which XPA is the most severe subgroup, are 
extremely sensitive to sunlight and are at a more than 1000-fold risk of developing skin cancer, 
mainly on sun-exposed skin areas. However, patients with only a defect in the GGR arm of the 
NER (XPC patients) are as susceptible to sunburn as healthy individuals (Berg et al, 1998; 
Kondo et al, 1992). CS patients exhibit an extreme photosensitivity but are apparently not 
predisposed to develop skin cancer. CS patients suffer from physical and mental retardation 
and often die at an early age because of a variety of complications (e.g. infections). Many of 
the clinical symptoms of CS are not displayed by XPA patients who are completely NER 
deficient, making it difficult to explain them via a partial NER defect. As CS proteins are 
involved in transcription, a transcription deficiency, perhaps aggrevated by DNA damage, 
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might also contribute to the clinical symptoms. A defect in repair of oxidative DNA damage was 
detected in CS cells but not XPA cells (Leadon and Cooper, 1993) (for review of the above see 
de Boer and Hoeijmakers (2000)). 
Gene-targeted mice with defects in both GGR and TCR (XPA), or either GGR (XPC) or TCR 
(CSB) have been generated to study the effects of UV radiation and other DNA damaging 
agents on the induction of DNA damage, DNA repair, apoptosis and immune reactivity. 
Another mechanism, besides DNA repair, to clear the UV-induced DNA damage is by the 
induction of apoptosis. This mechanism protects severely damaged cells from transforming 
into malignant cells. After UV-B exposure apoptotic keratinocytes, called sunburn cells, can be 
detected in the epidermis (Daniels et al, 1968; Murphy et al, 2001). Defects in TCR (as in CSB) 
are associated with a dramatic increase in sensitivity to UV-induced apoptosis (Van Oosten et 
al, 2000). 
UV-induced apoptosis is a multifactoral event that can be initiated from many cellular targets 
(e.g. cell membrane, mitochrondia). UV radiation can lead to apoptosis via de induction of 
reactive oxygen species (especially by UV-A I), cross linking and activation of death receptors, 
like Fas (CD95) (especially by UV-B) (Aragane et al, 1998; Kulms et al, 1999), the production 
of apoptosis-inducing cytokines, like TNF-α (Schwarz et al, 1995), or the activation of 
transcription factor AP-1 or p53, which in their turn can increase the expression of FasL 
(CD95Ligand) or the pro-apoptotic protein Bax respectively (Sheehan and Young, 2002). 
Execution of apoptosis occurs via depolarization of the mitochrondial membrane potential, 
release of cytochrome C and/or activation of several caspases. Caspases can be divided into 
two subgroups: the initiator caspases and the effector caspases. Upon induction of apoptosis 
the pro-caspases are proteolytically cleaved to form active caspases. Activation of effector 
caspases, like caspase 3, is irreversible and once activated can no further be regulated (for 
review see Sheehan and Young (2002)). 
 
 
OUTLINE OF THE THESIS 
 
As described in the preceding paragraphs, UV radiation, especially UV-B, has various effects 
on the skin immune system. All-together this leads to the induction of a local and/or systemic 
immunosuppression. This immunosuppression was first considered as a harmful effect of UV 
radiation, leading for instance to the suppression of tumor rejection. However, it can also be 
thought of as a perfectly sound physiological reaction: if we do not display this 
immunosuppression we might develop a disruptive immune reaction when we are exposed to 
UV. This seems to be exactly what is happening in the skin of patients with polymorphous light 
eruption (PLE) or sun allergy. Therefore we hypothesized that the UV-induced 
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immunosuppression is disturbed in PLE patients. In this thesis I will describe how we try to 
unravel the pathogenesis of PLE step by step, based on this hypothesis. 
As described previously, CD11b+ macrophage-like cells infiltrate the UV-B-exposed skin and 
produce and secrete the immunosuppressive cytokine IL-10. Treatment of mice with anti-
CD11b resulted in a reversion of the UV-B-induced immunosuppression. These data led us to 
the speculation that these CD11b+ cells must be absent or non-functional in the skin of PLE 
patients. To test this hypothesis we first established an experimental model in healthy 
individuals to reproduce the data on CD11b+ cells described by other investigators. A nearly 
complete UV-B-induced depletion of CD1a+ Langerhans cells, as reported by these 
investigators, was used as a guideline for our irradiation protocol. We then exposed the skin of 
PLE patients to UV-B radiation, according to our irradiation protocol, and investigated the 
presence of CD11b+ cells in the (un)exposed skin. These data are presented in Chapter 2. As 
we were investigating our model in PLE patients, we found a remarkable difference in the 
behavior of CD1a+ Langerhans cells: they did not disappear after UV (over)exposure! 
With this striking difference in mind and knowing that Langerhans cells, the antigen-presenting 
cells of the skin, are reported to be associated with immunosuppression, we then focused on 
these cells. 
We hypothesized that in PLE patients there is a defect in the mechanism(s) responsible for a 
normal UV-B-induced depletion of Langerhans cells. But before we could investigate this 
defect in PLE patients we first had to establish the mechanism(s) that are at the root of this 
UV-induced Langerhans cells depletion in healthy individuals. The two potential mechanisms 
that are described in literature, namely apoptosis or migration, were examined in healthy 
volunteers (Chapter 3). A novel method was developed to detect Langerhans cell migration in 
vivo. 
The main mechanism responsible for UV-B-induced Langerhans cell depletion in healthy 
individuals turned out to be migration. With this knowledge we could now specify our former 
hypothesis: Langerhans cells in the skin of PLE patients show an impaired migration to UV-B 
radiation. Furthermore, we speculated that the Langerhans cells that remain in the epidermis 
after UV-B overexposure of the skin of PLE patients are activated and/or matured. This 
active/mature state of the Langerhans cells might result in antigen presentation at a wrong 
location, namely in the skin instead of the lymph nodes. The outcomes of these experiments 
are presented in Chapter 4. 
Several cytokines are involved in UV-induced Langerhans cell migration and 
immunosuppression. The data we had collected from our experiments so far led us to two 
hypotheses: first, cytokines involved in UV-B-induced Langerhans cell migration (e.g. IL-1, 
TNF-α) are produced in lesser amounts in PLE patients compared to healthy individuals, and 
secondly, UV-B radiation induces an imbalance between pro-inflammatory and Th1-skewing 
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cytokines (IL-6, IL-12, IL-18, IFN-γ) and cytokines involved in Th2-skewing and 
immunosuppression (IL-4, IL-10) leading to a Th1 milieu in the skin of PLE patients. Because 
of a scarcity of material and the number of cytokines we wanted to investigate and because we 
wanted to localize cytokine-expressing cells, we used immunohistochemistry on microscopic 
sections for an exploratory study. The results for a series of cytokines in (un)exposed skin of 
PLE patients and healthy individuals are presented in Chapter 5. 
When we investigated the UV-induced migration of Langerhans cells in healthy individuals and 
PLE patients we found that only a minority of the migrating Langerhans cells had UV-B-
induced DNA damage (pyrimidine dimers). Therefore, we speculated that DNA damage and 
DNA repair might be involved in determining whether and when Langerhans cells migrate. To 
test this hypothesis a mouse model with DNA repair-deficient mice (XPC, XPA, CSB), was 
used. In this model we were also able to link data on DNA repair and Langerhans cell 
migration with immunosuppression. These experiments are described in Chapter 6. 
In Chapter 7 the studies described in this thesis will be integrated and discussed, giving an 
overview of the present knowledge on the pathogenesis of PLE. 
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CD11b+ and CD1a+ cells in PLE 
ABSTRACT 
 
After ultraviolet (UV) overexposure the Langerhans cells (epidermal CD1a+ cells) disappear 
from the healthy skin, and CD11b+ macrophage-like cells, which are reported to produce IL-
10, appear in a matter of days. These phenomena are related to the UV-induced local 
suppression of contact hypersensitivity reactions. A defect in this suppression might allow 
inadvertent immune reactions to develop after UV (over)exposure; i.e., it could cause UV-B-
induced polymorphous light eruption (PLE). In order to test this we first exposed buttock skin of 
8 healthy volunteers to 6 MED (minimal erythema dose) from Philips TL12 lamps, and indeed 
observed a dramatic disappearance of CD1a+ cells 48 and 72 hours later, at which time the 
number of CD11b+ cells increased in the dermis, and some occurred in the epidermis. The 
epidermis thickened and showed large defects, with CD11b+ cells lodged into them, just below 
the stratum corneum. In 10 patients with PLE (5 with a normal MED and 5 with a low MED) 
CD1a+ cells were present epidermally as well as dermally before exposure. Strikingly, these 
cells were still present in considerable number at 48 and 72 hours after exposure to 6 MED. A 
substantial number of CD11b+ cells was already present dermally before UV exposure, and 
this number increased further after UV overexposure, and subsequently also invaded the 
epidermis. Despite the 6 MED, there were no apparent defects in the epidermis of the PLE 
patients. This deviant early response to UV radiation is likely to be of direct relevance to the 
PLE and is perhaps useful as a diagnostic criterion. 
 
 
INTRODUCTION 
 
Solar UV radiation, especially UV-B (280-315 nm), is a very potent activator of photochemical 
reactions: we are all familiar with resulting effects like ‘photochemical smog’ and 
‘photodegradation’ of plastics and other compounds. Organic molecules such as proteins and 
DNA can react to UV-B and be damaged (de Gruijl, 1997; Jung and Bohnert, 1995). It is 
therefore likely that UV radiation induces a broad range of effects and physiological reactions 
in the skin. Obviously, the skin needs to be very well adapted to this natural photochemical 
stress. The skin has, for example, efficient mechanisms to repair or replace photo-damaged 
cells. Another plausible adaptive mechanism of the skin to UV-B radiation lies in the 
modulation of the immune system: Exposure to UV-B causes suppression of cellular immunity 
(Cooper, 1996; Yoshikawa et al., 1990). In previous research this came to light as an adverse 
effect on health. Tumor rejection and the immunization against microbial pathogens are 
markedly reduced in animal models after exposure to UV radiation (Gensler et al., 1995; 
Halliday and Norval, 1997; Jeevan et al., 1995). However, on reconsideration this UV-induced 
 41
 
Chapter 2 
immunosuppression can be thought of as a primarily sound physiological reaction. First of all it 
should be noted that all healthy humans consistently display this UV-induced immune 
suppression at sufficiently high dosages (Cooper et al., 1992). Because of its photochemical 
activity, UV radiation can modify proteins and other molecules, and thus create neo-antigens 
that could provoke (auto-) immune reactivity (Natali and Tan, 1973; Norris et al., 1989). From 
this perspective UV-induced immunosuppression is a very desirable mechanism to prevent a 
persistent, disruptive immune reactivity against sun-exposed skin. What if this 
immunosuppression is not adequate? What kind of pathology would evolve? A UV-induced 
‘sun allergy’ would be most plausible. UV-B-triggered polymorphous light eruption (PLE) would 
therefore seem a likely candidate for exploring this possible pathogenic mechanism. 
Patients with PLE are sensitive to UV-B, UV-A and sometimes even to visible light. These 
patients develop papules and eczema, mostly on areas that are exposed to sunlight (Epstein, 
1997; Grabczyska and Hawk, 1997; Salomon et al., 1997). It is often suggested that PLE is a 
delayed type hypersensitivity reaction (type IV) because there is usually a clear delay (hours to 
days) between the exposure to UV and the appearance of skin lesions (Epstein, 1997; Norris 
et al., 1989; Verheyen et al., 1995). The histology of lesional PLE skin shows dense 
lymphocytic infiltrates. These infiltrates are initially dominated by CD4+ lymphocytes, but at 72 
hours after the UV provocation CD8+ T-cells outnumber CD4+ T-cells (Holze, 1995; Norris et 
al., 1989). These phenomena indicate that a cellular-mediated immune reactivity is involved in 
PLE.  
UV-B can inhibit the antigen-presenting capacity of e.g. Langerhans cells (Bacci et al., 1996; 
Beissert and Granstein, 1996; Goettsch et al., 1993; Krutmann et al., 1994; Ullrich, 1995b). 
After UV radiation,  Langerhans cells with UV-damaged DNA migrate from the epidermis and 
become detectable in the draining lymph nodes (Sontag et al., 1995) but UV-B exposure can 
also kill epidermal Langerhans cells in the epidermis (Mommaas et al., 1993). Furthermore, 
immunomodulatory compounds such as IL-10, PGE2 and TNF-α are released in the UV-
exposed skin (Boonstra and Savelkoul, 1997; Cooper, 1996; Halliday and Norval, 1997). 
CD11b+ macrophage-like cells infiltrate the dermis and epidermis after UV-B exposure and 
were found to be potent IL-10 producers (Kang et al., 1994; Kang et al., 1998). UV-B-modified 
antigen presentation can render Th1 cells, which are involved in delayed type hypersensitivity 
reactions, anergic (for reviews see Ullrich (1996), Boonstra and Savelkoul (1997), Halliday and 
Norval (1997), Ullrich (1995a)). 
Hence, in the epidermis of healthy individuals Langerhans cells disappear after UV-B (over) 
exposure and within a few days CD11b+ macrophage-like cells appear, which can suppress 
cellular immunity. As was also suggested by Dr. Cooper (personal communication), we 
hypothesized that a defect in this influx of CD11b+ macrophage-like cells would lead to illicit 
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immune reactivity. This immune reactivity could be involved in the pathogenesis of a UV-B-
induced PLE. 
To investigate this possible pathogenic mechanism, a group of PLE patients was studied. All 
patients reacted pathologically to UV-B radiation, developing vesicles, papules or eczema. For 
comparison a control group consisting of healthy volunteers was studied. A small area of 
unaffected buttock skin of all participants was overexposed to UV-B and skin biopsies were 
taken at successive time points following the exposure. In order to assess whether 
immunocellular responses were altered in the unaffected skin of PLE patients, 
immunohistochemical stainings were done to study shifts in CD1a+ (Langerhans cells) and 
CD11b+ (macrophage-like cells) cell populations. These cells were further phenotyped by 
double staining. 
 
 
MATERIALS AND METHODS 
 
Subjects 
Five patients with PLE and normal sunburn sensitivity (2 males and 3 females, ages between 28 and 49 
years), five patients with PLE and extreme sunburn sensitivity (5 males, ages between 45 and 82 years) 
and eight healthy individuals (4 males and 4 females, ages between 21 and 43 years) were studied. The 
diagnosis PLE was based on the patient’s history and on provocation with daily exposures of UV-B, UV-
A I and visible light on restricted areas of the upper arms, a standard procedure in our dermatological 
clinic. In all patients who were included, papular or eczematous lesions occurred in the UV-B exposed 
skin either with or without a similar reaction in the UV-A exposed skin. In some patients, who were 
extremely sensitive to sunburn a pathological reaction to visible light was also observed. With the 
exception of two extremely sunburn sensitive patients, most included patients had a season-dependent 
exacerbation of the disease. Patients who had received photo-therapy or who were under medication 
(e.g. corticosteroids) and patients and volunteers whose buttock skin was exposed to sunlight less than 
two months ago, were excluded. Informed consent was obtained from patients and volunteers. This 
study was approved by the medical ethical committee of the University Hospital in Utrecht. 
 
Phototesting procedures 
The minimal erythema dose (MED) of the buttock skin of the participants in this study was determined 
using a Philips TL12 lamp (57.5% of UV output in UV-B (280-315 nm)) and a testing device with nine 
windows (2*9 mm each) which open and close sequentially to expose the underlying skin for different 
periods of time (in a geometrical series e.g. from 12.5 to 200 sec). The small areas of irradiated skin 
were examined at 6 and 24 hours and the area showing minimal perceptible redness, not necessarily 
with discernable borders, was taken to correspond to the MED. MED ranged from 350 to 750 J/m2 UV in 
healthy individuals, from 245 to 490 J/m2 UV in PLE patients with a normal MED, and from 8.8 to 70 
J/m2 UV in PLE patients with a low MED. Subsequently, the (unaffected) buttock skin was exposed to 6 
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MED UV (again with Philips TL12). 3-mm punch biopsies were obtained 24 hours and 48 hours or 48 
hours and 72 hours after UV exposure, together with one additional control biopsy from the unirradiated 
skin. Specimens were snap frozen in liquid nitrogen, embedded in O.C.T-compound (Tissue-Tek, 
Sakura, Zoeterwoude, the Netherlands) and stored at - 40oC until further processing.  
 
Antibodies 
As primary antibodies, monoclonal antibodies CD1a (DAKO A/S, Glostrup, Denmark, diluted 1:60), 
CD11b (Immunotech, Marseille, France, diluted 1:50), and CD68 (DAKO A/S, diluted 1:50) were used. 
The fluorescein isothiocyanate (FITC)-conjugated primary antibodies CD1a and CD11b were purchased 
from Ortho Diagnostic systems Inc. (Beerse, Belgium, diluted 1:20) and Immunotech (diluted 1:60) 
respectively. The murine monoclonal antibody Lag was a kind gift from Prof. Imamura (Dept. 
Dermatology, Kyoto University, Kyoto, Japan). Biotinylated horse anti-mouse immunoglobulin (Vector, 
Burlingame, CA, diluted 1:800) was used as a secondary antibody. Alkaline phosphatase (AP)-labeled 
F(ab) fragments of sheep anti-FITC (Boehringer Mannheim GmbH, Mannheim, Germany, diluted 1:400) 
or horseradish peroxidase (HRP)-conjugated avidine-biotin complex (DAKO A/S, diluted 1:50) were 
used as detecting reagents. 
 
Immunohistochemistry 
Frozen skin sections (6 µm) on 3-aminopropyltriethoxysilane-coated glass slides were fixed for 10 
minutes in 100 ml dry acetone containing 50 µl 30% H2O2 at room temperature (RT) and incubated for 
20 minutes with a blocking reagent (PBS containing 10% normal human serum, 10% normal horse 
serum and 10% normal mouse serum) to prevent non-specific binding. The skin sections were incubated 
with the primary antibody (diluted in blocking reagent) for 1 hour. The glass slides were then washed 
three times with PBS, containing 0.05% Tween 20. 
Subsequently, skin sections were incubated for 1 hour with a biotinylated horse anti-mouse antibody 
(diluted in blocking reagent) following incubation with an HRP-conjugated avidine-biotin complex (diluted 
in PBS/0.05% Tween) for 30 minutes. Antibody binding was visualized by incubating the sections in 0.1 
M acetate buffer (pH=5) containing 20 mg 3-amino-ethyl-carbazole (AEC)(Sigma Chemical Co., St. 
Louis, MO) and 100 µl 30% H2O2 per 100 ml. The skin sections were counter-stained with Mayer’s 
hematoxylin. Double staining reactions were done to further characterize the CD1a+ and CD11b+ cells. 
For the double staining (Lag/CD1a-FITC and CD68/CD11b-FITC) the skin sections were fixed and 
preincubated as described above. The skin sections were then incubated with the unconjugated 
antibody (Lag or CD68; diluted in blocking reagent) for 1 hour and with a biotinylated horse anti-mouse 
antibody (diluted in blocking reagent) also for 1 hour. The sections were incubated for 20 minutes with a 
blocking reagent containing PBS and 10% normal mouse serum and subsequently incubated for 1 hour 
with the FITC-conjugated antibody CD1a or CD11b (diluted in 10% normal mouse serum). Then the 
sections were incubated simultaneously with an AP-labeled sheep anti-FITC antibody and an HRP-
conjugated avidine-biotin complex (both diluted in PBS/0.05% Tween 20) for 1 hour. Antibody binding 
was visualized by incubating the skin sections first in a Tris-HCl buffer (pH=8.5), containing 25 mg Fast 
Blue BB salt, 12.5 mg naphtol AS-MX phosphate and 35 mg levamisol per 100 ml, all purchased from 
Sigma Chemical Co.. The slides were subsequently incubated with a 0.1 M acetate buffer (pH=5) 
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containing 20 mg AEC and 100 µl 30% H2O2 per 100 ml. Negative staining controls were used in single 
and double staining experiments in which the first antibody was omitted or was replaced by an irrelevant 
antibody of the same isotype. All antibody incubations were performed in a humidified chamber at room 
temperature. After each antibody incubation the slides were rinsed three times in PBS containing 0.05% 
Tween 20. 
The skin sections were evaluated using a light microscope at 250 times magnification with a standard 
eyepiece. The number of positive cells in the skin sections was assessed independently by two 
investigators. The prevalence of cells was graded as: no or hardly any positive cells present (-), 
presence of scattered positive cells (±), clear abundant presence of positive cells (+), closed maze of 
positive cells (++).  
The staining for epidermal CD1a+ cells and epidermal CD11b+ cells was also determined quantitatively 
by image processing: The percentage of epidermal cross sectional area that was stained CD1a+ or 
CD11b+ was measured, using a camera mounted on a light microscope together with the Optimas 6.1 
and Microsoft Excel software (the targeted interfollicular epidermal area was demarcated manually). 
 
Statistical analysis 
After logarithmic transformation (as the distribution of the percentages of stained cross sectional areas is 
skewed to the right), a Student t-test was performed on the CD1a+ log-% values to compare PLE 
outcomes with those of healthy volunteers. Median values were estimated as means of log-% values. A 
Wilcoxon rank sum test was performed on the quantitative data of the epidermal CD11b+ area. The 
same test was also used on the semiquantitative data (scored -, ±, +, ++) to compare the number of 
CD1a and CD11b positive cells either in the epidermis or the dermis, e.g. comparing PLE patients with 
healthy volunteers at 48h after 6 MED (fig 2 and 4 and table 1 and 2). 
 
 
RESULTS 
 
Phototesting assay 
In making a reproducible assay for analyzing the reactions of CD1a+ Langerhans cells and 
CD11b+ macrophage-like cells, we varied the UV-B dose (3 - 6 MED) and location of exposure 
in a group of healthy individuals. It appeared that buttock skin, which had not been exposed to 
sunlight for at least two months, was the location that showed the most consistent effects of 
UV-B on the CD1a+ and CD11b+ cell populations. In our hands, a UV-B dose of 6 MED turned 
out to be adequate for the virtually complete disappearance of CD1a+ Langerhans cells from 
the epidermis and a clear influx of CD11b+ cells in all healthy volunteers tested. These results 
are in accordance with earlier reports that Langerhans cells disappeared and CD11b+ cells 
infiltrated the skin of healthy individuals 48 hours after UV-B (Aberer et al., 1981; Cooper et al., 
1986; Meunier et al., 1995). After establishing this assay in healthy volunteers, PLE patients 
and more healthy volunteers were included in the study. PLE patients were divided into two 
subgroups: one with normal MEDs and one with extremely low MEDs. 
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UV radiation induces disappearance of Langerhans cells in healthy individuals but not 
in PLE patients 
The buttock skin of PLE patients looked normal and unaffected before UV-B exposure. After 6 
MED UV-B exposure the skin was red and a little swollen, but no pathology could be observed. 
In the unaffected and unexposed skin of PLE patients CD1a+ cells were present in vast 
amounts in the epidermis (fig 1B), especially in the low MED group (fig 1C). All PLE patients 
demonstrated CD1a+ cells in the upper-dermis (table 1). The number of epidermal CD1a+ 
cells in the unexposed skin of healthy volunteers (example in fig 1A) varied widely. Forty-eight 
hours after UV-B irradiation CD1a+ Langerhans cells had disappeared from the epidermis of 
the healthy volunteers (fig 1D). In the dermis there were hardly any CD1a+ cells present. A 
considerable number of CD1a+ cells was still present in the epidermis of PLE patients (fig 1E) 
48 hours after the overexposure, especially in the epidermis of PLE patients with a low MED 
(fig 1F). Counting of Langerhans cells in microscopic cross-sections is cumbersome owing to 
scattered presence of dendrites. To quantify objectively whether the number of Langerhans 
cells in patients was significantly different from the numbers seen in healthy volunteers, we 
compared percentages of epidermal cross-sectional areas that stained CD1a+. The cross 
sectional area that stained CD1a+ in the epidermis of PLE patients (median of 7% for PLE 
patients with a normal MED and 13% for PLE patients with a low MED) was significantly larger 
(p<0.01) than in healthy individuals (median of 0.55%) 48 hours after 6 MED UV-B exposure 
(fig 2). No correlation could be found between the absolute UV dose and the % change in 
CD1a+ area after UV irradiation among healthy volunteers or among PLE patients with a 
normal MED or among healthy individuals and PLE patients with a normal MED combined. 
The semiquantitative scoring of the CD1a staining, analyzed by the Wilcoxon rank sum test 
(table 1), also confirmed this significant difference (p<0.01) between the number of epidermal 
CD1a+ cells in healthy volunteers and PLE patients 48 hours after UV-B radiation. The number 
of CD1a+ cells in the dermis of the UV-B-exposed skin of PLE patients was significantly larger 
compared to healthy volunteers (p<0.05). The number of epidermal and dermal CD1a+ cells in 
the unexposed buttock skin did not differ significantly (p>0.05) between healthy volunteers and 
PLE patients with a normal MED. In PLE patients with a low MED, however, the number of 
dermal CD1a+ cells in the unexposed skin was significantly larger than in healthy individuals 
(p<0.05). The number of epidermal CD1a+ cells did not differ significantly between PLE 
patients with low MED and healthy volunteers (p>0.05). The changes in CD1a+ cells after UV-
B exposure are only significant for epidermal CD1a+ cells in healthy individuals (p<0.01) and 
PLE patients with a normal MED (p<0.05). 
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Figure 1. CD1a staining of buttock skin, unexposed (- UV) and 48 hours after UV-B exposure (+ UV + 
48h). Scale bar = 50 µm. 
 
 
Table I. Semi-quantitative analysis of CD1a+ cells (median) in the unexposed and UV-B irradiated 
buttock skin of healthy volunteers and PLE patients. 
 
  PLE patients 
 Healthy volunteers (n=8) normal MED (n=5) low MED (n=5) 
 epidermis dermis epidermis dermis epidermis dermis 
- UV-B +  / ++ - / ± ++ - ++ ± 
(p<0.05) 
+ UV-B 
+ 48h 
- - + 
(p<0.01) 
± 
(p<0.05) 
++ 
(p<0.01) 
+ 
(p<0.05) 
 
Statistical significance (p-value) is given for PLE patients compared to healthy individuals. Where no p-
value is given, no significant difference was observed. 
 
++, closed maze of positive cells; +, clear abundant presence of positive cells; ±, presence of scattered 
positive cells;  -, no or hardly any positive cells present 
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Figure 3. CD11b staining of buttock skin, unexposed (- UV) and 48 hours after UV-B exposure (+ UV + 
48h). Scale bar = 50 µm. 
 
 
Table II. Semi-quantitative analysis of CD11b+ macrophage-like cells (median) in the unexposed and 
UV-B irradiated buttock skin of healthy volunteers and PLE patients.  
 
   PLE patients 
 Healthy volunteers (n=8) normal MED (n=5) low MED (n=5) 
 epidermis dermis epidermis dermis epidermis dermis 
- UV-B - +  - ± - + 
+ UV-B 
+ 48h 
+ ++ ± 
(p<0.05) 
+ ± 
(p<0.05) 
++ 
 
Statistical significance (p-value) is given for PLE patients compared to healthy individuals. Where no p-
value is given, no significant difference was observed. 
 
++, closed maze of positive cells; +, clear abundant presence of positive cells; ±, presence of scattered 
positive cells;  -, no or hardly any positive cells present 
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Differences in epidermal morphology 
When comparing the epidermis of healthy volunteers and PLE patients 48 hours after UV-B 
irradiation, a clear difference in the condition of the epidermis was observed. In healthy 
volunteers thickening of the epidermis occurred and the epidermis showed gross defects just 
below the stratum corneum (fig 1D and 3D). In PLE patients there was also a thickening of the 
epidermis, but the epidermis appeared completely intact (fig 1E-F and 3E-F). Near and in the 
defects that appear in the epidermis of the healthy volunteers great numbers of CD11b+ cells 
could be observed (fig 3). Hardly any CD3+ cells could be observed in the UV-exposed 
epidermis (data not shown). 
 
Characterization of the CD11b+ cells 
To test if the CD11b+ cell was indeed belonging to the macrophage cell lineage, an 
immunohistochemical double staining was performed with the macrophage marker CD68 
(Azzawi et al., 1997; Davidson et al., 1997). In healthy volunteers and PLE patients CD11b 
single positive, CD68 single positive and CD11b/CD68 double positive cells could be observed 
in the unexposed and UV exposed buttock skin (fig 5).  
In the unexposed buttock skin of healthy volunteers CD11b/CD68 double positive cells were 
present in the upper- and mid-dermis. CD68 single positive cells were mostly present in the 
deeper part of the dermis. There were hardly any CD11b single positive cells present in the 
dermis of healthy volunteers (fig 5A). No single- or double-stained cells could be observed in 
the epidermis.  
Forty-eight hours after UV-B exposure the number of CD11b single positive cells increased 
markedly in the upper-dermis of healthy volunteers, while the number of CD11b/CD68 double 
 50 
 
CD11b+ and CD1a+ cells in PLE 
positive cells and CD68 single positive cells did not change or only increased modestly (fig 
5C). The CD11b+ cells that infiltrated the epidermis of healthy volunteers after UV-B 
overexposure were nearly all CD11b single positive (fig 5), some were CD68 single positive or 
CD11b/CD68 double positive. 
In contrast, nearly all CD11b+ cells in the unexposed skin of PLE patients were also CD68 
positive (fig 5B). A small number of CD68 single positive cells could be observed in the mid-
dermis and in the deeper parts of the dermis. After UV-B exposure the number of dermal 
CD11b/CD68 double positive cells increased markedly (fig 5D). In some PLE patients the 
number of CD68 single positive cells also increased. Hardly any CD11b single positive cells 
could be observed. The few cells that infiltrate the epidermis after UV-B irradiation were also 
all CD11b/CD68 double positives, very much in contrast with the influx of CD11b single 
positive cells in the epidermis of healthy individuals. 
 
 Figure 5. Double staining 
of CD11b (blue) and 
CD68 (red) of buttock 
skin, unexposed (- UV) 
and 48 hours after UV-B 
exposure (+ UV + 48h). 
The epidermis was 
demarcated manually. 
Scale bar = 50 µm. 
 
 
 
 
 
DISCUSSION 
 
The present study was based on the supposition that a pathological skin reaction may be 
evoked by UV-B exposure if a defect occurs in the normally induced suppression of cellular 
immunity. We hypothesized that the influx of immunosuppressive, IL-10 producing CD11b+ 
cells (Kang et al., 1994; Kang et al., 1998) could be absent or dysfunctional in some way in 
PLE patients, in whom pathological reactions could be provoked by UV-B radiation. CD11b+ 
cells were present in the dermis of the unexposed and UV-exposed buttock skin of PLE 
patients. The number of dermal CD11b+ cells did, however, increase in the uninvolved buttock 
skin of these patients after UV-B irradiation, and was not significantly different from that in 
healthy individuals. No CD11b+ cells could be observed in the epidermis of the unexposed 
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buttock skin of healthy volunteers and PLE patients. Remarkably, after UV exposure the influx 
of CD11b+ cells in the epidermis of PLE patients with normal MED was indeed significantly 
less than in healthy volunteers, but in PLE patients with low MEDs the influx of CD11b+ cells 
was comparable to that in healthy volunteers. 
A far more striking difference between healthy volunteers and PLE patients occurred, however, 
in the response of CD1a+ Langerhans cells to UV-B overexposure. Persistent CD1a+ cells 
could be observed in the epidermis of PLE patients 48 hours after 6 MED UV-B exposure, 
while in healthy individuals the Langerhans cells completely disappeared from the epidermis. 
Because the UV dose varied between healthy volunteers and PLE patients, the question arose 
whether the disappearance of CD1a+ cells was correlated to the absolute UV dose. There 
was, however, no correlation between UV dose and % change in CD1a+ area: not among 
healthy individuals nor among PLE patients with normal MED, and not even among these two 
groups combined. The image processing which was used to quantify CD1a+ cells did not 
distinguish between lesser number of cells and a loss of dendrites by rounding up of the cells. 
In healthy individuals it is obvious that the effect of UV on Langerhans cells is a near complete 
depletion (well over 80% decrease in stained area in 7 out of 8, one with 64% reduction). In 
PLE patients the effect of UV on Langerhans cells is due to decreases in cell number and 
partially due to changes in cell morphology (all, n=10, decreases in stained area well below 
70%). This means that the differences between CD1a+ cells of healthy volunteers and PLE 
patients after UV irradiation are even underestimated. Immunohistochemical double staining of 
the CD1a+ cells with the Lag antibody, directed against Birbeck granules, confirmed that the 
persistent epidermal CD1a+ cells were indeed Langerhans cells. CD1a+ cells in the dermis 
were mostly Lag negative. 
The CD11b+ cells were further characterized by double staining with the pan-macrophage 
marker CD68 (Azzawi et al., 1997; Davidson et al., 1997). The CD11b+ cells that infiltrate the 
UV-irradiated epidermis in healthy volunteers are mostly CD68 negative, whereas the few 
CD11b+ cells that infiltrate the UV-exposed epidermis of PLE patients are all CD68 positive. 
The dermal CD11b+ cells in the unexposed and UV-exposed buttock skin of PLE patients and 
healthy volunteers were mostly CD68 positive. The CD11b+ cell population of PLE patients is 
therefore at least partially different from the CD11b+ cell population of healthy volunteers: 
different cells or cells in a different state of activation. 
Another interesting difference between PLE patients and healthy individuals was observed: 
PLE patients appeared to have no epidermal defects after UV-B exposure, while all healthy 
individuals clearly did. In a study of Hammerberg et al. (1996) anti-CD11b treatment, of mice, 
partially protected against epidermal UV injury: the epidermal structure was better preserved 
and keratinocytes appeared less damaged. Knowing that the UV irradiated epidermis of the 
PLE patients showed a low influx of CD11b+ cells and that the CD11b+ cells are lodged into 
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the defects in healthy volunteers, it is tempting to speculate that these CD11b+ cells are, at 
least partially, responsible for the development of the epidermal defects. In this regard, it is 
also noteworthy that the epidermal CD11b+ cells of PLE patients are of a different phenotype 
than those in healthy volunteers: CD68+ versus CD68- respectively. Our hypothesis is that the 
CD11b+CD68- cell population in skin of the healthy volunteers consists to a large extent of 
granulocytes, which by their release of tissue destructing enzymes, can be responsible for the 
epidermal defects. 
In mice UV-exposed Langerhans cells migrate from the epidermis to present antigen to the T-
cells in the paracortex of the lymph nodes (Halliday and Norval, 1997). The cytokine TNF-α, 
which is released in the skin after UV exposure, is involved in this migration of Langerhans 
cells (Boonstra and Savelkoul, 1997; Cumberbatch and Kimber, 1992; Moodycliffe et al., 
1994). Persistence of UV-irradiated Langerhans cells in the epidermis of PLE patients might 
thus be the result of a lack of TNF-α secretion. Another potential effect of TNF-α is induction of 
apoptosis (Norris et al., 1997; Romano et al., 1998). Apoptosis could also contribute to the 
depletion of Langerhans cells in the skin of healthy individuals after UV irradiation (Mommaas 
et al., 1993). Furthermore, a massive apoptosis induced by high levels of TNF-α might be 
responsible for the epidermal defects observed in healthy volunteers, and a lack of TNF-α in 
PLE would then explain the absence of epidermal defects. 
One patient, who was initially included in the PLE group with a normal MED, was later 
diagnosed with subacute cutane lupus erythematodes (LE) (Nyberg et al., 1997) and excluded 
from the study. The Langerhans cells in the epidermis of this person did also not disappear 48 
hours after 6 MED UV-B (data not shown). Thus, UV resistance of Langerhans cells might be a 
prerequisite for UV-B induced photodermatoses in general, and not specific for PLE. The 
differences in UV-B-triggered photodermatoses may then lie in the differences in the antigenic 
stimuli that evoke the pathological reaction, e.g. UV-damaged DNA in case of LE.  
In an initially extremely sun-sensitive PLE patient who received a successful UV hardening 
therapy, we found that the Langerhans cells disappeared from the epidermis 48 hours after 6 
MED overexposure. This preliminary first observation on re-adaptation would appear to 
confirm and emphasize the importance of persisting Langerhans cell in a photoreactive 
disease like PLE. These first results need to be confirmed in our follow-up studies. The 
importance of UV adaptation is also indicated by the observation that PLE increases in 
prevalence and severity towards higher Northern latitudes, where the relative differences in 
UV-B between summer and winter are bigger. Loss of adaptation of the skin to UV radiation 
(UV-B) in winter would therefore appear to be of paramount importance to the disease (van der 
Leun and de Gruijl, 1993). 
UV-resistant Langerhans cells were also observed by Torres-Alavarez et al. (1998) in actinic 
prurigo patients, but the difference with healthy controls after 20 MED (!) UV irradiation were 
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considerately smaller than in our study. These researchers used an unfiltered high-pressure 
quartz mercury lamp, a UV-C/ UV-B source, for skin irradiation, whereas we used TL-12 lamps 
which have their main output in the UV-B. Overexposure to UV-C is better tolerated than 
overexposure to UV-B (UV-B erythema shows a steeper dose-gradient), which could explain 
the marginal differences that were observed by Torres-Alavarez et al. (1998). 
PLE is often provoked with UV-A sources (Holze, 1995): e.g. with fluorescent lamps like the 
Philips TL09. But these broad band sources often do contain significant traces of UV-B. The 
UV-A I region (340-400 nm) is more distinct from UV-B (280-315 nm) than the UV-A II (315-
340 nm) region in the type of biological response it evokes. Most PLE patients react 
pathologically to UV-A II as well as to UV-B1. Some patients also react to visible light. In our 
study only PLE patients who reacted pathologically to UV-B irradiation alone, or to UV-B and 
UV-A, were included. The patients who were included reacted stronger to UV-B than to UV-A. 
As UV immunosuppression by UV-A I or visible light is not commonly observed in healthy 
individuals, it is more likely that PLE reactions evoked by pure UV-A I or visible light are 
predominantly due to the generation of a neo-antigen to which these individuals are sensitized. 
UV-A I in absence of UV-B will not induce the appropriate immunosuppressive response. UV-A 
I may actually enhance cellular responses by inducing IFN-γ2. 
The observed deviations in the epidermal infiltration of CD11b+ cells after UV-B exposure may 
well play a role in the initial immune reactivity leading to PLE skin lesions, because the 
CD11b+ cells appear to mediate immunosuppression in healthy individuals (Hammerberg et 
al., 1996; Kang et al., 1994; Kang et al., 1998). UV-exposed Langerhans cells can also 
contribute to immunosuppression, as demonstrated in mice (Simon et al., 1991). A 
consequence of the abnormal persistence of Langerhans cells in the overexposed epidermis of 
PLE patients could well be the presentation of  UV-induced neo-antigens at the wrong location, 
namely in the skin instead of in the draining lymph nodes, thus resulting in an illicit immune 
reaction in the skin instead of an immunosuppressive response in the lymph nodes. This 
persistence of CD1a+ cells after UV-B overexposure may serve as an important diagnostic 
criterion for UV-B related photodermatoses.  
Clearly, the precise mechanisms for photodermatoses and PLE in particular need further 
elucidation, but the aberrant reaction of Langerhans cells to UV irradiation appears to be a 
prerequisite.  
 
 
 
                                                          
1 Boonstra HE, van Weelden H, Toonstra J, van Vloten WA, manuscript submitted. 
2 Reeve V.E., Bosnic M., Nishimura, N.: Role of interferon-γ in protection by UV-A (320-400 nm) radiation against UV-B (280-320 
nm)-induced immunosuppression. 26th Annual Meeting American Society for Photobiology, Snowbird, Utah, July 1998 (abstr) 
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UV-induced apoptosis or migration of human Langerhans cells 
ABSTRACT 
 
UV-B radiation can suppress cellular immunity. One of the mechanisms related to this 
immunosuppression is the disappearance of Langerhans cells from the epidermis. The aim of 
the present study was to establish the mechanism of UV-B-induced Langerhans cell 
disappearance in healthy individuals. The two most likely mechanisms for Langerhans cell 
disappearance are apoptosis and migration. Apoptosis was assessed in vivo by exposing 
buttock skin of ten healthy volunteers to six minimal erythema doses UV-B. Only very few 
apoptotic Langerhans cells could be observed in sections from the UV-B-exposed skin. 
Migration of Langerhans cells cannot be established in skin sections and we therefore raised 
suction blisters in an attempt to trap migrating Langerhans cells in the sub-basal membrane 
blister fluid. Blisters were raised on the flexor side of the lower arm of thirty healthy volunteers 
at several time points after exposure of the skin to six minimal erythema doses UV-B. Blister 
fluid was collected and blister roofs were removed to check for Langerhans cell 
disappearance. Langerhans cells were detected in the blister fluid of the UV-B-exposed skin 
and not of the unexposed skin. The number of Langerhans cells in the blister fluid peaked 
around 18h after UV exposure, which coincided with the largest depletion of Langerhans cells 
in the blister roof. A fraction (20-30%) of the Langerhans cells in the blister fluid stained 
positive for DNA damage (cyclobutane pyrimidine dimers), showing that they originated form 
the epidermis. UV-B-induced Langerhans cell disappearance appears to be mainly attributable 
to migration. 
 
 
INTRODUCTION 
 
Ultraviolet (UV) radiation, especially UV-B radiation (280-315 nm) has several effects on the 
skin immune system. There are several primary photochemical reactions that could trigger 
these events. The most studied are: isomerization of urocanic acid and DNA damage 
(cyclobutane pyrimidine dimers and 6-4 photoproducts) in epidermal cells. Subsequently, the 
production of cytokines is induced, such as IL1-β, TNF-α, IL-10 and PGE2. Cellular functions 
are altered e.g. natural killer cell activity is inhibited, antigen presentation is changed and the 
microenvironment becomes favorable to the development of T-helper 2-like immune responses 
(for review Duthie et al., 1999). (Over)exposure of the skin to UV-B leads to an influx of IL-10 
producing macrophagic cells (Kang et al., 1994;Kang et al., 1998) and a depletion of 
Langerhans cells. These effects are associated with suppression of cellular immune reactions. 
A disturbance in these immunosuppressive mechanisms may lead to the development of a 
UV-induced “sun allergy” (polymorphous light eruption (PLE)). Patients with PLE are sensitive 
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to UV-B (as clinically tested by challenges with a Philips TL12 lamp), UV-A and sometimes 
even to visible light. These patients develop papules, vesicles or eczema on sun-exposed 
areas of the skin (Boonstra et al., 2000; Grabczyska and Hawk, 1997 ;Epstein, 1997; Salomon 
et al., 1997). PLE is suggested to be a delayed-type hypersensitivity reaction (Epstein, 1997; 
Norris et al., 1988; Verheyen et al., 1995). In earlier experiments we found that Langerhans 
cells in the skin of PLE patients persisted after overexposure to UV-B in contrast to what was 
observed in healthy volunteers (Kölgen et al., 1999). We hypothesize that this persistence of 
Langerhans cells in the epidermis may contribute to the pathogenesis of the disease. To 
understand this defect in PLE patients, the main mechanism that is responsible for the UV-
induced Langerhans cell disappearance in healthy individuals needs to be established.  
The paramount mechanism underlying Langerhans cell depletion, especially in humans, is still 
unknown. Some authors suggest that a deficiency of growth factors for Langerhans cells or a 
downregulation of growth factor receptors is responsible for Langerhans cell depletion 
(Takashima, 1995). The best studied and two most likely mechanisms for epidermal 
Langerhans cell depletion are apoptosis and/or migration. 
In vitro experiments revealed that irradiated human Langerhans cells undergo apoptosis 
(Rattis et al.,1998). Experiments with mice showed that apoptosis of Langerhans cells is 
induced by UV-B radiation through, among others, the production of reactive oxygen species 
(Takashima, 1995). Whether this also occurs in humans in vivo has still not been 
demonstrated (Meunier, 1999). 
We know from animal models that Langerhans cells migrate to the lymph nodes after exposure 
of the skin to UV-B (Sontag et al., 1995; Dandie et al., 1998). UV-induced migration of 
Langerhans cells in humans has been described by Yawalker et al (1998). But these last 
experiments involve lymph drainage, and are very encumbering and difficult to perform; 
moreover they were not approved of by the ethical committee of our institute. We therefore had 
to resort to a novel technique. 
To investigate the relative importance of apoptosis versus migration in UV-induced 
Langerhans cell depletion in vivo we studied a group of healthy volunteers. A small area of the 
buttock skin or of the flexor side of the arm was overexposed to UV-B. Biopsies were taken 
from buttock skin at successive time points after the exposure. Furthermore, we developed a 
novel method to detect migrating Langerhans cells in vivo by catching them in blister fluid: 
suction blisters were raised on (un)exposed areas of the skin of the flexor lower arm and blister 
roofs and blister fluid were collected at several time points after UV-B exposure. 
Immunohistochemical stainings for CD1a (Langerhans cells), cyclobutane pyrimidine dimers 
(DNA damage), and for active caspase 3 and TUNEL (both markers for apoptosis) were 
performed on frozen skin sections, blister roofs and cytospins of blister fluid. 
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MATERIALS AND METHODS 
 
Subjects 
30 healthy individuals (9 males and 21 females, ages between 19 and 55 years) were studied for 
Langerhans cell migration (see below) while 10 healthy individuals (3 males and 7 females, ages 
between 22 and 31 years) were studied for apoptosis. Volunteers whose buttock skin or skin of the 
lower arm was exposed to sunlight less than 2 months ago were excluded. Informed consent was 
obtained from all volunteers. This study was approved by the Medical Ethical Committee of the 
University Medical Center Utrecht. 
 
Phototesting procedure 
The UV dose required to cause a just perceptible redness, the minimal erythema dose (MED), was 
determined on the skin area to be experimented on i.e., the buttock skin or the flexor side of the lower 
arm. For MED determination a test device with 9 windows (3 x 10 mm each) was used. Through these 
windows the underlying skin was exposed to a Philips TL12 lamps for different periods of time (a 
geometrical series, e.g. from 12.4 to 200 s). The TL12 lamp emitted 58% of the UV output in UV-B (280-
315nm) and 5% of the UV output below 290 nm. Erythemally weighted, 98% stemmed from the UV-B 
band (18% below 290 nm). The erythema was assessed 24h later. The MED for the buttock skin ranged 
from 212 to 750 J/m2 UV-B (median of 410 J/m2, 95% C.I. 180 - 940 J/m2). The MED for the flexor side 
of the arm was 4 to 5 times higher and ranged from 352 to 4840 J/m2 UV-B (median of 1650 J/m2, 95% 
C.I. 470 - 5820 J/m2). After determination of the MED the test areas of skin on the buttock or lower arm 
were exposed to 6 MED UV (Philips TL12).  According to Barr et al. (1999) this dose is about equal to 4 
MED for an erythema defined by clear borders, as used by Cooper et al. (1992) to suppress contact 
hypersensitivity in humans. 
 
Biopsies 
Three-millimeter punch biopsies were taken from the irradiated buttock skin 24h and 48h after exposure 
to 6 MED UV, together with one control biopsy from the unexposed buttock skin. Biopsies were snap 
frozen in liquid nitrogen, embedded in OCT compound (Tissue-Tek, Sakura, Zoeterwoude, the 
Netherlands) and stored at –30oC until further processing. 
 
Suction blisters  
Suction blisters were raised (Black et al., 1977; van der Leun et al., 1974) for operational convenience 
on the irradiated skin of the flexor side of the lower arm at several time points after the exposure to 6 
MED UV (18h, 24h, 30h, 42h, 48h) and on an unexposed side (2 blisters per volunteer). Blisters were 
raised over a period of around 2h, using airtight cups with circular ports exposing skin areas of 10mm in 
diameter to an atmospheric pressure of minus 200 mmHg. Suction blister formation was further 
stimulated by gently warming the skin via an electric heating coil in each suction cup. Skin temperature 
was measured with a copper-constantan thermocouple touching the skin, and did not exceed 40oC. 
Blisters occurred at a dermal-epidermal junction. Blister fluid was collected using a microneedle with a 
diameter of 0.36 mm. Blister roofs were removed with a sterilized skin surgery set. Each volunteer was 
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sampled at only 1 time point after irradiation. The yield of blister fluid varied among individuals, but 
slightly more blister fluid was consistently recovered from UV irradiated blisters when compared to 
controls, as found earlier by Barr et al. (1999). Cytospin preparations were made of the blister fluid by 
centrifugation for 10 min at 55g onto 3-amino-propyltriethoxysilane coated glass slides. The slides were 
stored at –30oC until further processing. The removed blister roofs were used immediately for 
immunohistochemistry. 
 
Antibodies 
As primary antibodies monoclonal antibodies CD1a (DAKO A/S, Glostrup, Denmark, diluted 1:60), 
fluorescein isothiocyanate (FITC)-conjugated CD1a (DAKO A/S, diluted 1:60) and biotinylated H3 
antibody (directed against cyclobutane pyrimidine dimers, a kind gift from Dr. L. Roza; T.N.O., Zeist, the 
Netherlands), diluted 1:20) and the polyclonal antibody rabbit anti-active caspase 3 (Becton Dickinson, 
San Diego, CA, diluted 1:100) were used. Biotinylated horse anti-mouse immunglobulin (Vector, 
Burlingame, CA, diluted 1:800) and biotinylated goat anti-rabbit antibody (Vector, diluted 1:300) were 
used as secondary antibodies. Alkaline phosphatase (AP)-labeled F(ab) fragments of sheep anti-FITC 
(Boehringer Mannheim GmbH, Mannheim, Germany, diluted 1:400), AP-labeled avidin-biotin complex 
(DAKO A/S, diluted 1:50) horseradish peroxidase (HRP)-conjugated avidin-biotin complex (DAKO A/S, 
diluted 1:50) were used as detecting reagents. 
 
Immunohistochemistry 
Single staining of CD1a and anti-active caspase 3. Blister roofs and frozen skin sections (6 µm) on 3-
amino-propyltriethoxysilane-coated glass slides were fixed for 10 min at room temperature in dry 
acetone containing 100 µl 30% H2O2 per 100 ml. The slides were incubated for 20 min with a blocking 
reagent [phosphate-buffered saline (PBS) containing 10% normal human serum/ 10% normal horse 
serum or 10% normal goat serum (depending on the secondary antibody species)] to prevent aspecific 
binding. The skin sections were subsequently incubated with the primary antibody (CD1a or rabbit-anti 
active caspase 3) for 1h and with a secondary antibody (biotinylated horse anti-mouse immunoglobulin 
or biotinylated goat anti-rabbit immunoglobulin respectively) for 1h. Subsequently, the blister roofs and 
skin sections were incubated for 30 min with HRP-labeled avidin-biotin complex (CD1a) or AP-labeled 
avidin-biotin complex (active caspase 3). Peroxidase activity was visualized by incubation in 0.1 M 
acetate buffer (pH=5) containing 20 mg 3-amino-9-ethyl-carbazole (AEC; Sigma, ST. Louis, MO) and 
100 µl H2O2 per 100 ml, resulting in a red staining. Rabbit anti-active caspase 3 binding was visualized 
by incubating the sections in Tris-HCl (pH=8.5) containing 25 mg levamisol, 250 µl New Fuchsin, 250 µl 
0.6 M sodium nitrate solution and 50 mg naphthol AS-BI phosphate, resulting in a pink staining. 
 
Double staining of CD1a-FITC and H3-biotin. CD1a-FITC/H3. Double staining was performed as 
described previously (Sontag et al., 1995) without modifications. In short, blister roofs, cytospins of 
blister fluid and frozen skin sections were fixed, preincubated with blocking reagent (PBS containing 
10% normal human serum) and incubated with the primary antibody CD1a-FITC, as described above. 
After incubation for 1h with AP-labeled sheep anti-FITC F(ab) the AP activity was visualized by 
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incubation in a BCIP/NBT solution of 5-bromo-4-chloro-3-indolyl phosphate/4-nitro blue tetrazolium 
chloride in 0.1 M Tris-HCL (pH=9.5), 0.1 M NaCl, 0.05M MgCl2 and 2.5 mg levamisole per 10 ml. The 
bluish-black reaction product is water and ethanol insoluble and withstands the subsequent harsh 
treatment. The preparations were fixed in 25% acetic acid (vol/vol) containing 100 µl 30% H2O2 per 100 
ml. After washing two times for 10 min in PBS the slides were incubated for exactly 2 min in 0.07 N 
NaOH in 70% ethanol. After washing with PBS the preparations were incubated for 20 min with PBS 
containing 10% normal human serum and 10% normal mouse serum, followed by a 1h incubation with 
H3-biotin.The preparations were incubated with HRP-labeled avidin-biotin complex for 30 min and 
developed in an AEC substrate solution, as described above. 
 
Double staining of CD1a-FITC and anti-active caspase 3. CD1a-FITC/active caspase 3 double staining 
was performed on blister roofs and frozen skin sections. Fixation and preincubation of the skin sections 
was performed as described above. The sections were then incubated simultaneously with CD1a-FITC 
and anti-active caspase 3 antibody for 1h. The preparations were subsequently incubated 
simultaneously with biotinylated goat-anti-rabbit and AP-labeled sheep anti-FITC for 1h, followed by 
incubation for 30 min with HRP-labeled avidin-biotin complex. Alkaline phosphatase activity was 
visualized by incubating the sections first in a Tris-HCl buffer (pH=8.5), containing 25 mg Fast Blue BB 
Salt, 12.5 mg naphthol AS-MX phosphate, and 35 mg levamisol per 100 ml, all purchased from Sigma, 
resulting in a blue staining. For visualization of the peroxidase activity the sections were then incubated 
with an AEC solution, as described above. Negative staining controls were used in single and double 
staining experiments in which the first antibody was omitted or replaced by an irrelevant antibody of the 
same isotype. All antibodies were diluted in the suitable blocking reagent except for the AP- and HRP-
labeled antibodies, which were diluted in PBS/0.05% Tween 20. All antibody incubations were 
performed in a humidified chamber at room temperature. After each antibody incubation the slides were 
washed three times with PBS containing 0.05% Tween 20. 
 
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL). To detect DNA 
breaks in situ, TUNEL staining was performed using a commercially available detection kit (Boehringer 
Mannheim GmbH). Frozen skin sections (6 µm) on 3-amino-propyltriethoxysilane-coated glass slides 
were stained according to manufacturer's instruction. Incorporation of FITC labeled nucleotides was 
checked using a Zeiss microscope equipped for epifluorescence. Converter-AP (anti-FITC antibody 
supplied in the kit) was then added and antibody binding was visualized by incubation in a Fast Blue BB 
Salt substrate solution, as described above. To detect whether the apoptotic cells were Langerhans cells 
the TUNEL assay was combined with a CD1a staining. CD1a antibody was incubated simultaneously 
with the TdT reaction mixture. The sections were then incubated simultaneously with biotinylated horse 
anti-mouse immunoglobulin and converter-AP followed by incubation with HRP-labeled avidin-biotin 
complex. Antibody binding was visualized by incubation with Fast Blue BB Salt substrate solution 
(TUNEL) and AEC solution (CD1a), as described above. 
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Statistical analysis 
After logarithmic transformation (to correct for the right skewed distribution) a Student T-test was 
performed to ascertain the significance of the observed differences (significance level p< 0.05). The 
numbers of CD1a single positive and CD1a/H3 double positive cells in the blister fluid after UV exposure 
were compared to the numbers of unexposed, control skin. 
 
 
RESULTS 
 
Exposure to 6 MED causes apoptosis in the epidermis, but not Langerhans cells 
Caspase 3 is an effector caspase which is cleaved during apoptosis in a wide variety of cells 
and commits a cell to apoptosis (for review see Harvey and Kumar (1998), Thornberry and 
Lazebnik (1998)). 
Active caspase 3-positive cells are present in the epidermis 24h and 48h after UV-B irradiation 
and are abundantly present in blister roofs within 18h after 6 MED UV-B irradiation. The 
number of caspase 3-positive cells 24h after UV-B exposure varies greatly among volunteers. 
Active caspase 3-positive cells are found scattered throughout the epidermis 24h after 
irradiation, while after 48h the cells are mainly located in the upper part of the epidermis just 
below the stratum corneum (fig 1). These apoptotic cells are mainly found in conjunction with 
epidermal defects. Active caspase 3-positive cells were not found in unirradiated skin. Similar 
results were obtained with the TUNEL staining, but the TUNEL assay had a higher background 
staining (data not shown). 
To test whether the caspase 3-positive cells found in the UV-B-irradiated skin were 
Langerhans cells, a double staining was performed with the dendritic cell marker CD1a. No 
double positive cells could be detected in the UV-B-irradiated skin (fig 1). The Langerhans 
cells tended to be low in the epidermis or in the dermis whereas the apoptotic cells were higher 
up in the epidermis. A few (<1% of the total number of Langerhans cells from unirradiated skin 
and <3% of the total number of Langerhans cells from UV-B-exposed skin) caspase 3-positive 
or TUNEL positive Langerhans cells could occasionally be observed in the blister roofs of the 
UV-B-irradiated skin. 
 66 
 
UV-induced apoptosis or migration of human Langerhans cells 
 
Figure 1. Double staining of CD1a (blue) and active-caspase 3 (red) of buttock skin, unexposed (- UV), 
24h (+ UV +24h) and 48h after UV-B exposure (+ UV +48h). Scale bar =50 µm  
 
CD1a+ Langerhans cells can be detected in the blister fluid of the UV-B-exposed skin, 
but not of the unexposed skin  
To test whether UV-B-induced Langerhans cell depletion was caused by migration, suction 
blisters were raised on UV-B-irradiated skin and unirradiated skin. Blister roofs and blister fluid 
were sampled at several time points after irradiation. CD1a staining of blister roofs showed a 
significant decline (p<0.0001) in the number of Langerhans cells after UV-B irradiation (median 
of 259 cells/mm2, 95% C.I. 146 - 462 cells/ mm2) when compared to the unirradiated control 
(median of 720 cells/mm2, 95% C.I. 520 - 996 cells/ mm2) (fig 2). The largest decrease 
appeared to occur over the first 18-h period (60%), while between 18h and 48h there was a 
further decrease of only 10%.  
Blister fluid was sampled to collect migrating Langerhans cells. Very few other cells were 
detected in the fluid (except for a minor admixture of about 50 cells in 3 out of 30 cases in 
which blisters developed more quickly around 1.5 hours). CD1a staining performed on cytospin 
preparations of blister fluid showed a significant difference (p <0.0001) between UV-B-
irradiated and unirradiated skin. CD1a+ Langerhans cells could be detected in blister fluid of 
the UV-B-exposed skin, but not in the blister fluid of the unirradiated skin. The number of 
CD1a+ cells varied strongly among the healthy individuals (median of 115 cells / 100 µl 
sample, 95% C.I. 17 - 796 cells / 100 µl sample) (fig 2). The blister fluid from the earliest time 
point (18h) showed the largest number of Langerhans cells (median of 268 cells/ 100 µl 
sample, 95% C.I. 44 –1623 cells/ 100 µl sample). However, the number of Langerhans cells 
that were found in the blister fluid of an individual did not correlate with the number of 
Langerhans cells that disappeared from the blister roofs of the UV-B-exposed skin (rho = -
0.355, p =0.089, Spearman rank order correlation test). The individual UV-B doses (in J/m2) 
showed a negative correlation with the numbers of Langerhans cells in the blister fluid (rho = -
0.421, p = 0.04, Spearman rank order correlation test) while the UV-B doses showed positive 
correlation with the decrease of Langerhans cells in the blister roofs (rho = 0.565, p =0.001, 
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Spearman rank order correlation test). The maximum in the number of Langerhans cells in the 
blister fluid at 18h coincided with the largest decrease in Langerhans cells in the blister roof. 
 
Figure 2. Number of 
CD1a+ Langerhans 
cells (mean+SEM) in 
blister roofs (bullets) 
and blister fluid 
(CD1a+ cells 
(squares) and 
CD1a+/H3+ cells 
(triangles) of arm 
skin, unexposed (0h) 
and UV-B-exposed 
(18h, 24h, 30h, 42h, 
48h). Average n per 
time-point = 5 
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Cyclobutane thymidine dimers are detectable 18h after 6 MED UV-B in epidermal cells 
but only in a fraction of the migrating Langerhans cells 
Skin biopsies, blister roofs and blister fluid were stained with H3 to detect UV-induced DNA 
damage, containing thymidine dimers. After a single dose of 6 MED UV-B most cells in blister 
roofs and skin biopsies are H3-positive. Blister roofs or skin biopsies from unexposed skin did 
not contain H3-positive cells (fig 3). H3 staining was performed on cytospin preparations of 
blister fluid to confirm that the CD1a+ cells originated from the UV-exposed epidermis. 
CD1a/H3 double positive cells could be observed in the blister fluid at different time points (18h 
– 48h) after UV irradiation (fig 4). But only a minority of the CD1a+ cells was H3-positive 
(mean of 27%). The percentage CD1a/H3 double positive cells of the total amount of CD1a+ 
cells in the blister fluid was the least at 42h (15.3%) and the greatest at 24h (38.8%) (fig 2). 
Because of layering of cells and excessive H3 staining it was difficult to interpret the CD1a/H3 
staining in skin sections and whole blister roofs. Therefore, single cell suspensions of blister 
roofs and sections of skin biopsies were double stained for CD1a and H3 to check whether 
Langerhans cells in the UV-exposed skin also contained UV-damaged DNA (fig 3). The 
majority of the CD1a+ cells in single cell suspensions of blister roofs were H3-positive.  
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Figure 3. Double staining 
of CD1a (blue) and H3 
(red) of buttock skin, 
unexposed (- UV) and 24h 
after UV-B exposure (+ 
UV) with an example of a 
doubled stained cell, 
migrating out of the 
epidermis (black arrow). 
Scale bar = 50 µm 
 
 
Figure 4. Double staining of CD1a (blue) and H3 (red) in 
blister fluid of the UV-B-exposed skin. 
 
 
 
 
 
 
 
 
DISCUSSION 
 
It is well known that UV-B can induce immunosuppression in the skin. One of the important 
processes associated with immunosuppression is the disappearance of the primary antigen 
presenting cells of the skin, the Langerhans cells. Here we investigated whether apoptosis or 
migration dominated this prominent effect on the epidermal antigen presenting cells. The 
disruption of Langerhans cell function can be fundamental to UV-induced immunosuppression 
either by incorrect, inappropriate or inefficient antigen presentation (Duthie et al., 1999). 
Alternatively, depletion of Langerhans cells could lead to modified antigen presentation by 
another cell type, e.g., infiltrating monocytoid cells (Meunier et al., 1995). 
In our study we first focussed on the role of apoptosis in UV-B-induced Langerhans cell 
depletion, as the occurrence of this phenomenon in humans in vivo still has not convincingly 
been demonstrated (Meunier, 1999). We show that only a few epidermal CD1a+ Langerhans 
cells in skin biopsies or blister roofs undergo apoptosis after UV-B exposure, as detected by 
active-caspase 3 or TUNEL. These results are in line with experiments of Okamoto et 
al.(1999), who showed in mice that after UV radiation only 1.5 cell per 900 Langerhans cells/ 
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mm2 were apoptotic, which was far too few to contribute substantially to the observed 
Langerhans cell depletion. Hollis and Scheibner (1988) found that Langerhans cells in UV-
irradiated skin of Aboriginals were apoptotic. The evidence is, however, circumstantial as the 
number of apoptotic Langerhans cells was very low and the time frame used was not optimal 
(2h or 5d). In vitro experiments demonstrated that Langerhans cells did go into apoptosis after 
UV-B irradiation and 2 days of culture (Rattis et al., 1998). Tang and Udey (1992a) found that 
death of cultured murine Langerhans cells is augmented by UV-B irradiation. A population of 
HLADR+ cells migrating from cultured, ex vivo irradiated skin explants are shown to be 
apoptotic (Nakagawa et al., 1999). Mommaas et al. (1993) showed by electron microscopy that 
some human Langerhans cells become necrotic when irradiated with UV-B in vitro. However, 
necrotic cells also become TUNEL positive, but were not detected as Langerhans cells in our 
study. Furthermore, lack of swollen, disintegrated Langerhans cells (detected by CD1a, Lag or 
HLADR)(data not shown) indicates that necrosis is negligible for UV-induced Langerhans cell 
depletion. 
A possible explanation for the difference in UV-induced death of Langerhans cells between the 
in vitro or ex vivo and the in vivo situation could be the difference in environment. In human 
skin, which consists of several layers of epidermal cells, Langerhans cells might be protected 
by the surrounding cells. This might be due to protective shielding, but also by cell-cell 
contacts, cell surface molecules and cytokines that are lacking or different in vitro (Tang and 
Udey, 1992b; Laihia and Jansen, 2000). One could argue that the CD1a marker may be lost 
during apoptosis and that this is the reason why we could hardly detect any apoptotic CD1a+ 
cells. But Nakagawa et al. (1999) showed in their in vitro experiments that annexin V positive 
apoptotic cells from UV-B-irradiated skin exhibited a high expression of CD1a, which would 
imply that apoptotic Langerhans cells retain their CD1a surface marker. Taken together, our 
data show that apoptosis occurs abundantly in human epidermis after overexposure to UV-B. 
However, Langerhans cells apparently do not go into apoptosis and this mechanism can 
therefore not explain the UV-B-induced depletion of Langerhans cells in the epidermis. 
The next step in unravelling the mechanism of UV-B-induced Langerhans cell depletion was 
investigating Langerhans cell migration. Pilot experiments had shown that it is feasible to catch 
migrating Langerhans cells in vivo in the fluid of suction blisters. Using this method we were 
indeed able to detect Langerhans cells with pyrimidine dimers reproducibly in the blister fluid of 
the UV-B-exposed skin, and not in the blister fluid of the unexposed skin. Blocking the 
emission of the Philips TL12 lamps below 290 nm (using a WG305/3 and a WG295/1 filter 
simultaneously) to simulate a solar-simulting irradiation source resulted in an equal number of 
Langerhans cells in the in blister roofs and blister fluid of the UV-exposed skin as compared to 
the unfiltered TL12 lamps (tested on 2 persons, data not shown). The decrease in Langerhans 
cell number in the blister roof after UV-B radiation did not correlate with the number of 
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Langerhans cells found in the blister fluid of the UV-B-exposed skin, although the largest 
decrease in the blister roof coincided with the largest increase in Langerhans cell number in 
the blister fluid. The correlation is, however, likely to be affected by factors like variations 
between individuals in time over which blisters were raised, differences in adherence of 
Langerhans cells to the dermal blister floor, amount of blister fluid and blister cross-section. 
The presence of cyclobutane pyrimidine dimers in the CD1a+ cells in the blister fluid confirmed 
that the cells originated from the UV-B-exposed epidermis. Overall 27% of Langerhans cells in 
the blister fluid, but most of the epidermal cells (mainly keratinocytes), had detectable levels of 
pyrimidine dimers. One could think of several explanations for this low percentage of 
Langerhans cells with detectable pyrimidine dimers. First of all, one could speculate that the 
CD1a single positive cells do not originate from the epidermis but are new dendritic cells 
coming from the blood stream or hair follicles (Gilliam et al., 1998), or entering the blister fluid 
as a result of the suction blister technique. It is, however, unlikely that the undamaged 
Langerhans cells come from the dermis as their dominant occurrence in blister fluid does not 
coincide with a repopulation of the epidermis (Kölgen et al., 1999). Furthermore, it does not 
appear to be an artefact of the method used, no influx of Langerhans cells could be observed 
in the blister fluid of the unexposed skin. Moreover, a cytokeratin 14 staining on basal 
keratinocytes in the blister roof of the UV-B-irradiated skin showed that the integrity of the 
blister roof was not affected by the method used nor by UV-B irradiation (data not shown). 
Hence, Langerhans cells are not likely to be released from the epidermis through defects 
caused by the blister formation. Alternatively, it could be that the Langerhans cells had a low 
initial damage level (Vink et al., 1994) or a rapid DNA repair. The undamaged Langerhans 
cells may show selective responsiveness to migratory signals, such as TNF-α. By staining 
single cell suspensions of blister roofs (18h time point) we were indeed able to see a clear 
enrichment of DNA-damaged Langerhans cells (approx. 80-90%) in blister roofs compared 
with blister fluid. Of note is the difference in percentage of double positive cells between 18h 
(20.1% of Langerhans cells) and 24h (38.8% of Langerhans cells). These percentages are 
mainly influenced by the number of CD1a single positive cells because the absolute number of 
damaged Langerhans cells in the blister fluid is almost the same between 18h and 30h. This 
also suggests that undamaged Langerhans cells are quicker to migrate. 
In this study, we have shown that raising of suction blisters is an easy-to-use method to catch 
migrating Langerhans cells in human beings in vivo. Our data show that UV-B-induced 
Langerhans cell depletion in human skin is mainly caused by migration and not by apoptosis. 
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Langerhans cell migration and activation in PLE 
ABSTRACT 
 
Ultraviolet-B radiation induces a local immunosuppression which is associated with a migration 
of Langerhans cells from healthy skin. An inadequate immunosuppression might lead to the 
development of a ultraviolet-B-induced sun allergy (polymorphous light eruption). After 
(over)exposure of the skin of patients with polymorphous light eruption to ultraviolet-B a 
considerable number of Langerhans cells still remained in the epidermis. The aim of this study 
was to investigate whether Langerhans cell migration was impaired in patients with 
polymorphous light eruption. In addition, we examined if the Langerhans cells that remained in 
the ultraviolet-B-exposed skin of patients with polymorphous light eruption were activated 
and/or matured. In order to study these phenomena we exposed buttock skin of patients with 
polymorphous light eruption and healthy controls to six minimal erythema doses of ultraviolet-
B. Suction blisters were raised 18h after ultraviolet exposure. The decrease of Langerhans 
cells in blister roofs and the number of migrating Langerhans cells in the blister fluid was 
significantly less in patients with polymorphous light eruption compared to healthy controls. No 
activated (CD86, CD40, CD54) or matured (CD83) epidermal Langerhans cells could be 
observed in skin biopsies from ultraviolet-B-exposed skin of patients with polymorphous light 
eruption. However, the number of epidermal HLA-DR+ Langerhans cells and dermal 
activated/matured Langerhans cells was larger in the ultraviolet-B-exposed skin of patients 
with polymorphous light eruption than in healthy controls. A defective Langerhans cell 
migration, and an accumulation of dermal activated/matured Langerhans cells, might be 
involved in the pathogenesis of polymorphous light eruption. 
 
 
INTRODUCTION 
 
Ultraviolet radiation (UV), especially UV-B (280-315 nm) is able to modulate the immune 
system. Exposure of the skin to UV-B can lead to a cascade of events starting with the 
formation of urocanic acid and DNA damage leading to the production of cytokines, such as 
interleukin (IL)-1-β, tumor necrosis factor (TNF)-α and IL-10 and the disappearance of 
Langerhans cells and influx of IL-10 producing macrophage-like cells (for review see Duthie et 
al, 1999). These events together may ultimately lead to the local and systemic 
immunosuppression that can be observed after exposure of the skin to UV-B radiation 
(Cooper, 1996; Morison, 1989; Yoshikawa et al, 1990). 
UV-B irradiation is able to alter organic molecules and proteins which may act as ‘neo-
antigens’ in evoking an immune reaction (Natali and Tan, 1973; Norris et al, 1988). UV-B-
induced immunosuppression could therefore be a very desirable mechanism to prevent a 
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disruptive immune reactivity against sun-exposed skin. A disturbance of this 
immunosuppression may lead to the development of a UV-induced “sun allergy” 
(polymorphous light eruption (PLE)). PLE patients are sensitive to UV-B and/or UV-A radiation 
and sometimes even to visible light. They develop papules and/or vesicles on sun-exposed 
areas of the skin (Epstein, 1997; Grabczyska and Hawk, 1997; Salomon et al, 1997). PLE is 
suggested to be a delayed type hypersensitivity reaction (type IV) because of a delay (hours-
days) between the UV exposure and the appearance of the skin lesions (Epstein, 1997; Norris 
et al, 1988; Verheyen et al, 1995). 
In previous experiments we showed that Langerhans cells still persisted in the epidermis of 
PLE patients after exposure of the skin to UV-B in contrast to healthy volunteers (Kölgen et al, 
1999). As the predominant mechanism underlying UV-B-induced Langerhans cell depletion in 
healthy individuals in vivo was found to be migration instead of apoptosis (Kölgen et al, 2002), 
we hypothesize that Langerhans cell persistence in PLE patients is caused by a defect in 
migration. Furthermore, we speculate that the Langerhans cells that remain in the UV-B-
exposed epidermis are either activated and/or matured, leading potentially to antigen 
presentation in the skin instead of the lymph nodes. These phenomena might then contribute 
to the pathogenesis of PLE. 
To investigate these hypotheses we studied a group of PLE patients and for comparison a 
control group of healthy controls. All PLE patients reacted pathologically to UV-B exposure. A 
small area of unaffected buttock skin of all participants was exposed to UV-B radiation. Suction 
blisters were raised on the (un)exposed area of the skin to study Langerhans cell migration. 
Immunohistochemical staining was performed for CD1a (Langerhans cells) and cyclobutane 
pyrimidine dimers (DNA damage) on blister roofs and cytospins of blister fluid. Skin biopsies 
were obtained from UV-B-irradiated and unirradiated skin of PLE patients and healthy 
volunteers to study Langerhans cell activation and maturation. Frozen skin sections were 
stained immunohistochemically for CD1a together with a Langerhans cell activation marker 
(CD86, CD40, CD54, HLA-DR) or the Langerhans cell maturation marker CD83. 
 
 
MATERIALS AND METHODS 
 
Subjects 
Six patients with PLE and normal sunburn sensitivity (3 males and 3 females, ages between 30 and 52 
years) and five healthy individuals (5 females, ages between 21 and 27 years) were studied for 
Langerhans cell migration while four PLE patients (2 males and 2 females, ages between 31 and 49 
years) and four healthy volunteers (1 male and 3 females, ages between 21 and 35 years) were studied 
for activation of Langerhans cells. The diagnosis PLE was based on the patient’s history and on a 
provocation with cumulative UV-B, UV-A I, and visible light exposure on restricted areas of the upper 
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arms, a standard procedure in our dermatological clinic. All patients developed papules and/or vesicles 
after exposure to UV-B radiation, sometimes accompanied by a similar reaction to UV-A radiation. All 
patients included had a season-dependent exacerbation of the disease. Patients receiving phototherapy 
or medication (e.g. topical or oral corticosteroids) and patients and volunteers whose buttock skin was 
exposed to sunlight less then 2 months ago were excluded. Informed consent was obtained from 
patients and volunteers. This study was approved by the Medical Ethics Committee of the University 
Medical Center Utrecht. 
 
Phototesting procedure 
The dose required to cause a just perceptible redness, the minimal erythema dose (MED), was 
determined on the buttock skin. For MED determination a test device with 9 windows (2 x 9 mm each) 
was used. The underlying skin was exposed through these windows to a Philips TL12 lamp for different 
periods of time (a geometrical series, e.g. from 12.4 to 200 s). The TL12 lamp emitted 58% of its UV 
output in UV-B (280-315nm) and 5% of its UV output below 290 nm. Erythemally weighted, 98% of the 
effectivity stemmed from the UV-B band (18% below 290 nm). The erythema was examined 24h later. 
The MED ranged from 245 to 750 J/m2 in PLE patients (median of 473.4 J/m2, 95% C.I. 206.4-1085.7 
J/m2) and from 650 to 1500 J/m2 in healthy controls (median of 1022.5 J/m2, 95% C.I. 540.2-1935.3 
J/m2) and differed significantly (p=0.009) between PLE patients and healthy controls. After determination 
of the MED the (unaffected) buttock skin was exposed to 6 MED UV (Philips TL12). After UV-B 
exposure the skin of PLE patients and healthy volunteers was red and a little swollen but no pathology 
could be observed. 
 
Suction blisters  
Suction blisters were raised (Black et al, 1977; van der Leun et al, 1974) 16-18h after exposure to 6 
MED on the irradiated buttock skin and on an unexposed side (2 blisters per individual). The optimal 
time point (18h) for raising suction blisters to catch migrating Langerhans cells in the blister fluid was 
determined in a previous study (Kölgen et al, 2002). Blister fluid was collected using a microneedle with 
a diameter of 0.36 mm. Blister roofs were removed with a sterilized skin surgery set. Cytospin 
preparations were made of the blister fluid by centrifugation for 10 min at 55g onto 3-amino-
propyltriethoxysilane-coated glass slides. The slides were stored at –30oC until further processing. The 
removed blister roofs were used immediately for immunohistochemistry. 
 
Biopsies 
After local anesthesia (xylocaine/adrenaline) three millimeter punch biopsies were obtained from the 
irradiated buttock skin 24h and 48h after UV-B exposure, together with one control biopsy from 
unirradiated skin. Biopsies were snap-frozen in liquid nitrogen, embedded in OCT compound (Tissue-
Tek, Sakura, Zoeterwoude, the Netherlands) and stored at –30oC until further processing. 
 
Antibodies 
As primary antibodies monoclonal antibodies CD1a (DAKO A/S, Glostrup, Denmark, diluted 1:60), 
fluorescein isothiocyanate (FITC)-conjugated CD1a (DAKO A/S, diluted 1:60), biotinylated H3  antibody 
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(directed against cyclobutane thymine dimers, a kind gift from Dr. L. Roza; T.N.O., Zeist, The 
Netherlands, diluted 1:20), CD86 (diluted1:10), CD40 (diluted 1:900), CD54 (diluted 1:10), CD83 (diluted 
1:20)(all purchased from Serotec, Oxford, United Kingdom) and HLA-DR (Becton Dickinson, Heidelberg, 
Germany, diluted 1:100) were used. Biotinylated horse anti-mouse immunoglobulin (Vector, Burlingame, 
CA, diluted 1:800) was used as a secondary antibody. Alkaline phosphatase (AP)-labeled F(ab) 
fragments of sheep anti-FITC (Boehringer Mannheim GmbH, Mannheim, Germany, diluted 1:400) and 
horseradish peroxidase (HRP)-conjugated avidin-biotin complex (DAKO A/S, diluted 1:50) were used as 
detecting reagents. 
 
Immunohistochemistry 
Single staining of CD1a. Blister roofs were fixed for 10 min at room temperature in dry acetone 
containing 100 µl 30% H2O2 per 100 ml. The slides were incubated for 20 min with a blocking reagent 
(phosphate-buffered saline (PBS) containing 10% normal human serum and 10% normal horse serum) 
to prevent aspecific binding. The blister roofs were subsequently incubated with primary antibody 
(CD1a) for 1h and with a secondary antibody (biotinylated horse anti-mouse immunoglobulin) for 1h. 
Subsequently, the blister roofs were incubated for 30 min with HRP-conjugated avidin-biotin complex. 
Peroxidase activity was visualized by incubation in 0.1 M acetate buffer (pH=5) containing 20 mg 3-
amino-9-ethyl-carbazole (AEC; Sigma, ST. Louis, MO) and 100 µl H2O2 per 100 ml, resulting in a red 
staining.  
 
Double staining of CD1a-FITC and H3-biotin. CD1a-FITC/H3 double staining was performed as 
described previously (Sontag et al, 1995). Blister roofs and cytospins of blister fluid were fixed in dry 
acetone, preincubated with blocking reagent (PBS containing 10% normal human serum) and incubated 
for 1h with the primary antibody CD1a-FITC. After incubation for 1h with AP-labeled sheep anti-FITC 
F(ab) the AP activity was visualized by incubation in a BCIP/NBT solution containing 37.5 µl 5-bromo-4-
chloro-3-indolyl phosphate, 50 µl 4-nitro blue tetrazolium chloride and 2.5 mg levamisole per 10 ml 0.1 
M Tris-HCL (pH=9.5), 0.1 M NaCl, 0.05M MgCl2. The bluish-black reaction product is water and ethanol 
insoluble and withstands the subsequent harsh treatment. The preparations were fixed in 25% acetic 
acid (vol/vol) containing 100 µl 30% H2O2 per 100 ml. After washing two times for 10 min in PBS the 
slides were incubated for exactly 2 min in 0.07 N NaOH in 70% ethanol. After washing with PBS the 
preparations were incubated for 20 min with PBS containing 10% normal human serum and 10% normal 
mouse serum, followed by a 1h incubation with H3-biotin.The preparations were incubated with HRP-
conjugated avidin-biotin complex for 30 min and developed in an AEC substrate solution, as described 
above. 
 
Double staining of CD1a-FITC and CD86, CD40, CD54, HLA-DR or CD83. Frozen skin sections (6 µm 
thickness) on 3-aminopropyltriethoxysylane-coated glass slides were fixed and preincubated with 
blocking reagent (PBS containing 10% normal human serum and 10% normal horse serum). The 
sections were then incubated with the primary antibody CD1a-FITC for 1h and subsequently for 1h with 
AP-labeled sheep-anti-FITC. AP activity was visualized by incubation in a 0.1M Tris-HCL buffer 
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(pH=8.5), containing 25 mg Fast Blue BB salt, 12.5 mg naphthol AS-MX phosphate, and 35 mg 
levamisole per 100 ml (all purchased from Sigma, St. Louis, MO). After washing the slides in PBS, the 
sections were incubated for 20 min with 10% normal mouse serum. Subsequently the sections were 
incubated for 1h with the primary antibody CD86, CD40, CD54, HLA-DR or CD83 and for 1h with 
biotinylated horse-anti-mouse immunoglobulin, followed by incubation for 30 min with HRP-conjugated 
avidin-biotin complex. Peroxidase activity was visualized by incubation with an AEC substrate solution, 
as described above. The skin sections were evaluated using a light microscope at 250 times 
magnification. The density of active/mature Langerhans cells as well as the percentage of active/mature 
Langerhans cells with regard to the total number of Langerhans cells were determined (mean of 2 or 3 
microscopic fields). The density of double positive cells was graded as: no active/mature Langerhans 
cells (0), a few active/mature Langerhans cells (1), presence of scattered active/mature Langerhans 
cells (2), clear abundant presence of active/mature Langerhans cells (3), a closed maze of active/mature 
Langerhans cells (4). The percentage of active/mature Langerhans cells were scored by assignment to 
one of the following categories: 0%, 0-10%, 10-50%, 50-80%, 80-100%. 
Negative staining controls were used in which the first antibody was omitted or replaced by an irrelevant 
antibody of the same isotype. All antibodies were diluted in the suitable blocking reagent except for the 
AP- and HRP-conjugated antibodies, which were diluted in PBS containing 0.05% Tween 20. All 
antibody incubations were performed in a humidified chamber at room temperature. After each antibody 
incubations the slides were rinsed three times with PBS/0.05% Tween 20. 
CD1a staining in the upper dermis was quantitatively determined by image processing: The percentage 
of a standardized dermal cross-sectional area that was CD1a positive was measured using a camera 
mounted onto a light microscope together with the Optimas 6.1 and Microsoft Excel software. CD1a 
staining in hair follicles or glands was not included. 
 
Statistical analysis 
After logarithmic transformation (to correct for the right-skewed distribution) a Students T-test was 
performed to ascertain the significance of the observed differences (significance level p< 0.05). The 
number of CD1a positive cells in the blister roofs and the number of CD1a positive and CD1a/H3 double 
positive cells in the blister fluid after UV exposure were compared to the numbers in unexposed, control 
skin. Furthermore, cell numbers from blister roofs and blister fluid and from skin biopsies of (un)exposed 
skin of PLE patients were compared to healthy controls. A Pearson correlation test (significance level p< 
0.05) was performed on the log-transformed data to test whether a correlation existed between MED 
and UV-induced Langerhans cell depletion in blister roofs and Langerhans cell increases in blister fluid. 
A Wilcoxon ranksum test was performed on the density of the epidermal HLADR+ CD1a+ Langerhans 
cells. 
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RESULTS 
 
Migrating CD1a positive Langerhans cells can be detected in the blister fluid of the UV-
B-irradiated skin of PLE patients but in smaller numbers than in healthy controls 
Previous experiments showed that Langerhans cells still remain in the epidermis after 
exposure of buttock skin of PLE patients to 6 MED in contrast to healthy controls (Kölgen et al, 
1999). To test whether this deviant Langerhans cell behavior in PLE is caused by a defect in 
Langerhans cell migration, we raised suction blister on UV-B-irradiated and unirradiated 
buttock skin of PLE patients and healthy controls. 
Blister roofs (epidermis) were removed to check for Langerhans cell disappearance. CD1a 
staining of blister roofs from UV-B-exposed skin of PLE patients (median of 408 cells/mm2, 
95% C.I. 303-548 cells/mm2) and healthy controls (median of 209 cells/mm2, 95% C.I. 77-562 
cells/mm2 ) showed a significant decrease (both p<0.001) in the number of Langerhans cells 
when compared to the respective unirradiated controls (median of 590 cells/mm2, 95% C.I. 
364-955 cells/mm2 and median of 646 cells/mm2, 95% C.I. 540-771 cells/mm2 resp.). The 
number of Langerhans cells disappearing from the blister roof after UV-B exposure was 
significantly larger in healthy volunteers (mean of 65.15%) than in PLE patients (mean of 
30.4%) (p=0.018). No difference could be observed in the number of Langerhans cells in the 
unexposed skin of PLE patients compared to healthy controls (p=0.44). Conversely, the 
number of Langerhans cells that were still present in the blister roofs of the UV-exposed skin 
was significantly higher in PLE patients than healthy controls (p=0.037) (fig 1). No correlation 
could be observed between the individual UV doses (MED) and the UV-induced depletion of 
Langerhans cells in the blister roofs (p=0.14). 
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Figure 1, Number of CD1a+ 
Langerhans cells (LC) (mean ± 
SEM) in blister roofs of the 
unexposed (- UV) and UV-B-
exposed (+UV+18h) skin of PLE 
patients (white bars) and healthy 
controls (gray bars). 
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Blister fluid was sampled to collect migrating Langerhans cells. The number of CD1a+ 
Langerhans cells found in the blister fluid of the UV-B-exposed skin of PLE patients (median of 
103 cells/ 100 µl sample, 95% C.I. 21-491.cells/ 100 µl sample) and healthy controls (median 
of 534 cells/ 100 µl sample, 95% C.I. 77-3692 cells/ 100 µl sample) was significantly higher 
(both p<0.001) than in the respective unexposed controls, where no Langerhans cells could be 
detected. The number of Langerhans cells in the blister fluid of the UV-B-exposed skin of PLE 
patients was significantly less (p=0.012) than in healthy controls (fig 2). Neither the individual 
UV dose (MED) (p=0.34) nor the decreases in Langerhans cell number in the blister roofs 
(p=0.078) correlated with the amount of Langerhans cells in the blister fluid. 
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Figure 2, Number of CD1a+ and 
CD1a/H3+ Langerhans cells (LC) 
per 100 µl blister fluid (mean ± 
SEM) from the unexposed (- UV) 
and UV-B exposed (+UV+18h) skin 
of PLE patients (white bars) and 
healthy controls (gray bars). 
 
 
 
 
 
The percentage of migrating Langerhans cells with cyclobutane pyrimidine dimers does 
not differ between PLE patients and healthy controls 
Blister roofs and cytospin preparations of blister fluid were stained biotinylated H3 antibody to 
detect UV-B-induced DNA damage and to confirm that the CD1a+ Langerhans cells originated 
from the epidermis. After a single exposure of 6 MED UV-B most cells in blister roofs are H3 
positive, while no H3 positive cells could be observed in blister roofs of the unexposed skin 
(data not shown; Kölgen et al, 2002). Single cell suspensions of blister roofs from UV-B-
exposed skin showed that the majority of the CD1a+ Langerhans cells were H3-positive (data 
not shown). 
CD1a/H3 double positive cells could be detected in the blister fluid of the UV-B-exposed skin 
of PLE patients and healthy controls. However, only a fraction of the Langerhans cells in the 
blister fluid of the UV-B-exposed skin of PLE patients and healthy controls was H3 positive (fig 
2). This subset of Langerhans cells with pyrimidine dimers did not differ between PLE patients 
(mean of 15.9%) and healthy controls (mean of 16.8%) (p=0.6). 
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Epidermal Langerhans cells in the UV-B-irradiated skin of PLE patients are not activated 
or matured, but do have an increased expression of HLA-DR compared to unexposed 
skin 
To investigate whether the persistent Langerhans cells in the UV-B-exposed skin of PLE 
patients are activated or matured, we stained frozen skin sections from UV-B-exposed and 
unexposed buttock skin of PLE patients and healthy controls with CD1a and several activation 
markers (CD86, CD40, CD54, HLA-DR) or the maturation marker CD83. Due to the dendrites 
it is difficult to determine the number of Langerhans cells quantitatively in frozen skin sections. 
Furthermore, the image processing equipment was unable to distinguish between the blue 
reaction product (CD1a) and the red reaction product (activation/maturation markers). 
Therefore we had to asses the number of activated/matured Langerhans cells semi-
quantitatively, as described in the Materials en Methods section. 
Similar to previous experiments (suction blisters and Kölgen et al, 1999) the number of 
Langerhans cells decreased after UV exposure but a considerable number of Langerhans cells 
was still present in the UV-B-exposed skin of PLE patients in contrast to healthy controls. The 
majority of the epidermal Langerhans cells of PLE patients and healthy controls had no 
detectable expression of the activation markers CD86, CD40 or CD54 or the maturation 
marker CD83. No active/mature epidermal Langerhans cells could be discovered in the 
unexposed skin of any of the participants. 
An exception to this is the expression of the activation marker HLA-DR, which was detected at 
0-10% of the epidermal Langerhans cells in the unexposed buttock skin and increased up to 
80-100% in the UV-B exposed skin of PLE patients as well as healthy controls (fig 3). 
However, the density of epidermal HLA-DR+ Langerhans cells was significantly larger (p<0.05) 
in the UV-exposed skin (at 24h) of PLE patients compared to healthy controls (fig 4). 
 
Figure 3, Number (n) of PLE 
patients (white bars) and healthy 
controls (gray bars)  with HLA-DR+ 
Langerhans cells (LC) (%) in the 
unexposed skin (- UV) or 24h 
(+UV+24h) or 48h (+UV+48h) after 
UV exposure. 
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Figure 4, Density score of HLA-
DR+ Langerhans cells 
(categories (0-4); see materials 
and methods section) in the 
epidermis of the unexposed 
skin (- UV) and 24h (+UV+24h) 
or 48h (+UV+48h) after UV-
exposure of PLE patients 
(white bars) and healthy 
controls (gray bars). 
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The density of dermal activated/matured Langerhans cells increased after UV exposure in PLE 
patients and healthy controls. Slightly more CD54, CD83, CD40 and HLA-DR positive (the 
latter two only 48h after irradiation) dermal Langerhans cells were detected in the UV-exposed 
skin of PLE patients compared to healthy controls. The density of dermal dendritic cells (% 
CD1a positive area) was significantly larger (p=0.005) in the UV-exposed skin (48h) of PLE 
patients (mean of 0.91%) compared to healthy controls (mean of 0.39%). The percentage of 
dermal Langerhans cells that are activated or matured increased after UV exposure but was 
comparable for PLE patients and healthy controls. 
 
 
DISCUSSION 
 
Previous experiments showed that after exposure of the skin of PLE patients to UV-B 
Langerhans cells still remain in the epidermis in contrast to healthy controls (Kölgen et al, 
1999). In healthy individuals UV-B-induced Langerhans cell depletion was caused by migration 
out of the skin and not apoptosis (Kölgen et al, 2002). Therefore, in this present study, we 
investigated whether Langerhans cell migration was impaired in PLE patients. We observed a 
decrease in the number of Langerhans cells in the blister roofs of the UV-B-exposed skin of 
PLE patients (30.4%), but the decrease was significantly less than in healthy controls 
(65.15%). In correspondence to this we found an increase in the number of migrating 
Langerhans cells in the blister fluid of the UV-exposed skin of PLE patients which was 
significantly less than in healthy controls. No correlation, however, was found between the 
individual decrease in the number of Langerhans cells in the blister roof and the number of 
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Langerhans cells in the blister fluid of the UV-exposed skin. But this correlation could be 
influenced by factors such as individual time over which blisters were raised, adherence of 
Langerhans cells to the dermal blister floor or blister cross sectional area. 
The number of Langerhans cells with UV-induced pyrimidine dimers varied per individual but 
did not differ significantly between PLE patients (15.9%) and healthy controls (16.8%). This low 
percentage of damaged Langerhans cells might be explained by a rapid DNA repair and a 
selective responsiveness of undamaged cells to migratory signals, as also discussed in Kölgen 
et al. (2002). 
One could speculate that the UV dose (MED), which was on average less in PLE patients, was 
responsible for the lower number of migrating Langerhans cells. However, no correlation could 
be detected between the MED and UV-induced Langerhans cell depletion in blister roofs or 
Langerhans cells increases in blister fluid. Moreover, a PLE patient with a MED similar to the 
MED of a healthy individual still had significantly less Langerhans cells disappearing from the 
skin. 
A possible explanation for the impairment of Langerhans cell migration in PLE patients might 
be an intrinsic inability (insensitivity) of the cells to migrate. Nevertheless, when the skin of PLE 
patients (n=2) was exposed to an even higher UV-B dose, namely 8.4 MED, an additional 
depletion of Langerhans cells occurred (data not shown). This indicates that the Langerhans 
cells were capable of migration. It is therefore most likely that signals required for Langerhans 
cell migration, such as the cytokines IL-1 and TNF-α, are present in lesser amounts in PLE 
patients compared to healthy controls. A significantly lower MED in PLE patients and the 
observation that Langerhans cells from PLE patients are able to migrate when given an higher 
UV dose point to an imbalance between erythema and immune responses. Increasing the 
MED by e.g. supplementation with dietary fish oil (Rhodes et al, 1995) or by phototherapy 
might therefore be therapeutical in bringing erythemal versus immunosuppressive responses 
back to normal, i.e. in balance. 
Another possible mechanism that might be involved in the pathogenesis of PLE is the 
activation and/or maturation of the Langerhans cells that remain in the epidermis of PLE 
patients after UV-exposure. During migration Langerhans cells mature and increase their 
expression of costimulatory molecules such as CD80, CD86 and CD40 as well as the 
proportion of MHCII molecules (HLA-DR) on their membrane. These transformations, among 
others, turn them into potent antigen presenting cells, capable of stimulating T-cells which 
reside in the draining lymph nodes (Cumberbatch et al, 2000; Flores-Romo, 2001). Presence 
of active or mature cells in the skin might lead to antigen presentation in the skin instead of the 
lymph nodes. Antigen presentation at this aberrant location might then lead to a disruptive 
immune reaction.  
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We were not able to detect active or mature Langerhans cells in the epidermis of the UV-B 
exposed skin of PLE patients. However, the expression of HLA-DR was upregulated in the UV-
B exposed skin of both PLE patients and healthy controls. The density of HLA-DR+ 
Langerhans cells in the epidermis was larger in PLE patients than healthy controls. An 
enhanced expression of HLA-DR as well as costimulatory molecules and the presence of T-
cells are required for proper antigen presentation. As no costimulatory molecules were 
detected and hardly any epidermal T-cells were observed (data not shown) antigen 
presentation by Langerhans cells in the epidermis of PLE patients will probably not occur. On 
the other hand, detection of costimulatory molecules by other, more sensitive techniques than 
immunohistochemistry (e.g. by FACS analysis), might still reveal an enhanced expression of 
these molecules. 
Some investigators report that costimulatory molecules like CD80, CD86 and CD54, and HLA-
DR are downregulated after UV exposure (Dittmar et al, 1999; Rattis et al, 1998; Weiss et al, 
1995). Others show that CD80, CD86, CD40, CD54 and CD83 (Nakagawa et al, 1999) or 
CD86 and HLA-DR (Laihia and Jansen, 2000) are upregulated after respectively ex vivo or in 
vivo irradiation of the skin. We showed that the number of dermal dendritic cells with 
costimulatory molecules or HLA-DR on their membranes increased after UV exposure in 
healthy controls as well as PLE patients. The density but not the percentage of dermal 
dendritic cells that express CD40, CD54, CD83 or HLA-DR was larger in the skin of PLE 
patients compared to healthy controls. A possible reason for this difference is that the majority 
of the Langerhans cells have already migrated out of the skin of healthy controls in contrast to 
PLE patients. The simultaneous presence of activated Langerhans cells and T-cells in the 
dermis might lead to antigen presentation in the skin instead of the lymph nodes. Presentation 
of (neo)-antigens to dermal T-cells (possibly Th1 cells) might contribute to the pathogenesis of 
PLE. 
Taken together, we showed that Langerhans cells migration was impaired in PLE patients. 
Furthermore, we were not able to detect any expression of activation or maturation molecules 
on the membranes of epidermal Langerhans cells in the UV-B exposed skin of PLE patients, 
except for the expression of HLA-DR. Therefore, we conclude that an impaired Langerhans 
cell migration and perhaps a higher number of activated/matured Langerhans cells in the 
dermis might contribute to the pathogenesis of PLE. Future experiments should focus on the 
expression of migration-inducing factors, such as the cytokines IL-1 and TNF-α, and their role 
in the pathogenesis of PLE. 
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Cytokine expression in PLE 
ABSTRACT 
 
Objective: Establish whether ultraviolet-B (UV-B) exposure induces aberrant cytokine 
expression in uninvolved skin of patients with polymorphous light eruption (PLE). Disturbances 
in normally induced Langerhans cell migration and skewing toward T helper (Th) 2 responses 
could be early steps in the pathogenesis of PLE. 
Design: Immunohistochemical staining of microscopic sections from UV-B-irradiated and 
unirradiated skin. 
Setting: University Hospital; Dutch National Center for Photodermatoses. 
Patients: PLE patients (n=6) with clinically proven pathological responses to repeated UV-B 
exposures, and with normal erythemal sensitivity. Healthy volunteers (n=5) were recruited from 
students and hospital staff. 
Main Outcome Measures: Expression of cytokines related to a) Langerhans cell migration 
(Interleukin (IL)-1-α, IL-1-β, IL-18 and Tumor Necrosis Factor (TNF)-α), b) Th2 responses (IL-
4, IL-10) and c) Th1 responses (IL-6, IL-12 and Interferon (IFN)-γ). Double staining was done 
for elastase (neutrophils), tryptase (mast cells) and CD36 (macrophages). 
Results: The number of cells expressing IL-1-β and TNF-α was reduced in the UV-B-exposed 
skin of PLE patients in comparison with healthy individuals (p<0.05 for TNF-α). No differences 
were observed in the expression of Th1-related cytokines but the expression of Th2-related 
cytokines was less in PLE patients: significantly fewer IL-4-expressing cells infiltrated the 
epidermis of PLE patients 24 hours post irradiation (p= 0.02). TNF-α, IL-4 and partly IL-10 
were predominantly expressed by neutrophils after UV exposure. 
Conclusions: The reduced expression of TNF-α, IL-4 and IL-10 in UV-B-irradiated skin of PLE 
patients appears largely attributable to a lack of neutrophils, and is indicative of less 
Langerhans cell migration and less Th2 skewing. 
 
 
INTRODUCTION 
 
Ultraviolet radiation (UV), especially UV-B (280-315 nm), can modify proteins and other 
organic molecules which may act as neo-antigens to provoke an (auto)immune reaction (Natali 
and Tan, 1973; Norris et al, 1989). This adverse immune reaction can be suppressed by 
another effect of UV radiation, i.e. the induction of cellular immunosuppression (Cooper, 1996; 
Yoshikawa et al, 1990). A defect in this immunosuppression might therefore allow an illicit 
immune reaction to UV radiation to occur i.e. polymorphous light eruption (PLE) could evolve. 
Key players in the effects of UV radiation on the skin immune system are cytokines. UV-B 
radiation can (in)directly induce cytokine release in the skin resulting in an efflux and influx of 
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several cell types. Interleukin (IL)-1-β and tumour necrosis factor (TNF)-α release by e.g. 
keratinocytes can induce Langerhans cell migration out of the skin (Cumberbatch et al, 1997; 
Cumberbatch et al, 1999). The pro-inflammatory cytokine IL-18, which can be produced by 
keratinocytes and Langerhans cells, is reported to be involved in Langerhans cells migration 
out of the skin, and is dependent upon IL-1-β and TNF-α (Cumberbatch et al, 2001). There is 
little data on the effect of UV radiation on IL-18 expression in the skin. Nakagawa et al (1999) 
showed that UV radiation had no effect on IL-18 production in an ex vivo irradiated epidermal 
sheet in culture. IL-18, together with IL-12, stimulates the production of interferon (IFN)-γ by T-
cells (Chang et al, 2000; Tominaga et al, 2000). When Langerhans cells are depleted after UV 
exposure macrophages concomitantly expand in the dermis and infiltrate the epidermis 
(Meunier et al, 1995). Kang et al (1994 and 1998) showed that these CD11b+ cells produce 
the immunosuppressive cytokine IL-10. There are some conflicting data on the effect of IL-10 
in Langerhans cell migration: Wang et al (1999) showed that Langerhans cell migration was 
enhanced in IL-10 knockout mice, which also have an increased TNF-α and IL-1 production, 
while Halliday et al (2001) observed an enhancement of Langerhans cell migration by IL-10 
from regressor tumors. 
Besides IL-10 from macrophages, UV-induced IL-10 from keratinocytes is also contributing to 
an immunosuppressive environment in the skin (Enk et al, 1995; Rivas and Ullrich, 1992). 
Furthermore, IL-10 counteracts IL-12 activity and inhibits the activation of Th1 cells but allows 
activation of Th2 cells (Enk et al, 1993). TNF-α release by dermal mast cells is involved in UV-
induced systemic immunosuppression (Walsh, 1995). Teunissen et al (2002) showed that IL-4-
producing neutrophils infiltrate the skin after UV exposure, supporting the development of a 
Th2 milieu in the skin. IL-4 is shown to be involved in the UV-induced suppression of delayed 
type hypersensitivity (el Ghorr and Norval, 1997) and contact hypersensitivity (Hart et al, 
2000). The production of IL-12 by monocytes / macrophages is decreased after UV-B 
irradiation (Kang et al, 1998; Kremer et al, 1996) as is the production of IFN-γ by T-cells. 
Conversely, the production of IL-12p40 homodimers, the natural antagonist of IL-12, by 
keratinocytes and Langerhans cells is increased after UV exposure (Norval, 2001; Schmitt and 
Ullrich, 2000). Most importantly a decrease in IL-12 activity and an increase in IL-4 favours the 
differentiation of Th0 cells into Th2 cells. 
All these cytokines have complex effects on each other and on cells of the skin immune 
system. The cytokine balance in the UV-exposed skin is ultimately shifted towards an 
immunosuppressive reaction in healthy individuals. 
One of the cellular mechanisms related to this immunosuppression is the disappearance of 
Langerhans cells. In previous experiments, we showed that in the skin of PLE patients 
Langerhans cells still persisted after overexposure of the skin to UV-B radiation, in contrast to 
what was observed in healthy individuals (Kölgen et al, 1999). The main mechanism 
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responsible for Langerhans cell depletion in healthy individuals, migration, was found to be 
impaired in PLE patients1. Additionally, when the skin of PLE patients was exposed to an even 
larger UV dose, Langerhans cells did disappear from the epidermis, thus revealing a larger 
gap between erythema and Langerhans cell migration-inducing UV doses in PLE patients. 
In the context of the possibility of a defective UV-induced immunosuppression PLE patients, 
these observations lead us to two hypotheses. Firstly, cytokines which are involved in 
Langerhans cell migration (e.g. IL-1, TNF-α) are induced less in the skin of PLE patients when 
compared to healthy volunteers. Secondly, we speculate that in PLE patients an imbalance 
exists between pro-inflammatory and Th1-skewing cytokines (e.g. IL-12, IFN-γ), and cytokines 
involved in Th2-skewing and Th1 suppression (e.g. IL-4, IL-10), ultimately shifting the balance 
to pro-inflammatory and Th1-skewed immune responses. 
To test these hypotheses six PLE patients and five healthy volunteers were studied. A small 
area of the (unaffected) buttock skin of all participants was overexposed to UV-B. Skin 
biopsies were obtained from all participants from the UV-B-exposed skin 24h and 48h after 
irradiation and one biopsy from the unexposed buttock skin as a control. As a first exploration 
of the cytokine patterns in the UV-B-exposed and unexposed skin of PLE patients and healthy 
volunteers we performed immunohistochemical stainings on frozen skin sections for a series of 
cytokines to locate and identify cytokine-expressing cells in the skin. 
 
 
MATERIALS AND METHODS 
 
Subjects 
Six patients with PLE and normal sunburn sensitivity (1 male and 5 females, ages between 32 and 64 y) 
and 5 healthy volunteers (2 males and 3 females, ages between 19 and 21 y) were included in the 
study. The diagnosis PLE was based on patient's history and photoprovocation testing with daily 
exposures of UV-A I, UV-B and visible light on restricted areas on the upper arms. In all patients, 
papules or vesicles occurred on the UV-B-irradiated skin area with or without a reaction on the UV-A I-
exposed skin. Patients who were under medication (e.g. corticosteroids) or who received phototherapy 
were excluded from the study. Patients and healthy volunteers whose buttock skin was exposed to 
sunlight less than 2 month ago were also excluded. The Medical Ethics Committee of the University 
Medical Center Utrecht, the Netherlands, approved of this study. 
 
Phototesting procedures 
The UV-B dose giving a minimal perceptible redness of the skin (MED) was determined on the buttock 
skin, using a Philips TL12 lamp. The TL12 lamp emitted 58% of the UV output in UV-B (280-315 nm) 
and 5% below 290 nm. Erythemally weighted, 98% of the effectivity stemmed from the UV-B band (18% 
                                                          
1 Kölgen et al, submitted 
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below 290 nm). For MED determination a test device with nine windows (3*10 mm) was used. These 
windows opened and closed sequentially exposing the underlying skin to UV-B for different periods of 
time (12.4 - 200 s). The erythema was assessed 24h after irradiation. MED ranged from 483 to 945 J/m2 
in PLE patients (median of 654 J/m2, 95% C.I. 396-1080 J/m2) and from 490 to 980 J/m2 in healthy 
controls (median of 734 J/m2, 95% C.I. 421-1279 J/m2). Subsequently, the (uninvolved) buttock skin was 
exposed to 6 MED UV-B (Philips TL12), resulting in a sunburn reaction, but no pathology. Three-
millimeter punch biopsies were obtained from UV-exposed skin 24h and 48h after irradiation, together 
with one control biopsy from the unexposed buttock skin. Biopsies were snap frozen in liquid nitrogen, 
embedded in OCT compound (Tissue-Tek, Sakura, Zoeterwoude, the Netherlands) and stored at -80oC 
until further processing. 
 
Antibodies 
As primary antibodies, monoclonal antibodies against IL-1-α and IL-1-β conjugated with biotine (both a 
gift from Dr. P. Ghiara, IRIS, Sienna, Italy), IL-4, IL-6, (both purchased from Genzyme, Cambridge, MA, 
diluted 1:100 and 1:50 resp.) IL-10 (Instruchemie, Delfzijl, the Netherlands, diluted 1: 400), IL-12 
p40/p70 (BD Biosciences Pharmingen, Erembodegem, Belgium, diluted 1: 150), IL-18 (MBL, Nagoya, 
Japan, diluted 1: 200), IFN-γ (U-Cytech, Utrecht, the Netherlands, diluted 1: 100), TNF-α (Biosource, 
Nivelles, Belgium, diluted 1:50), horseradish peroxidase (HRP)-conjugated elastase (a neutrophil 
marker; DAKO A/S Glostrup, Denmark, diluted 1:10), alkaline phosphatase (AP)-conjugated AA1 
(against tryptase; Chemicon, Temecula, CA, diluted 1:50 and fluorescein isothyocyanate (FITC) labelled 
CD36 (Immunotech, Marseille, France, diluted 1:80) were used. Biotinylated rabbit-anti-mouse 
immunoglobulin (Ig)(DAKO A/S, diluted 1:400) or biotinylated horse anti-mouse Ig (Vector, Burlingame, 
CA, diluted 1:800) were used as secondary antibodies. AP- or HRP-conjugated avidine-biotine complex 
(DAKO A/S, diluted 1:50), HRP-conjugated rabbit anti-mouse Ig (IL-10, DAKO A/S, diluted 1:100) or AP-
conjugated F(ab) fragments of sheep-anti-FITC (Boehringer Mannheim GmbH, Mannheim, Germany) 
were used as detecting reagents. 
 
Immunohistochemistry 
Single staining of cytokines. The technique to detect cytokines by immunohistochemistry in the 
cytoplasm of cells in microscopic sections has been described in detail by Hoefakker et al (1995). 
Frozen skin sections (6  µm thickness) on 3-aminopropyltriethoxysilane-coated glass slides were fixed 
for 10 min in 65 ml acetone containing 100 µl 30% H2O2. Endogenous peroxidase activity was 
additionally blocked by incubating the slides for 15 min in 65 ml 0.05 M Tris-HCl (pH 7.6) containing 26 
mg 4-Cl-1 naphthol diluted in absolute ethanol. 
Primary antibodies for cytokine detection were all diluted in PBS / 0.1% BSA and incubated overnight. 
Subsequently, slides were incubated for 30 min with biotinylated rabbit anti-mouse Ig (diluted in PBS / 
1% BSA / 1% normal human serum (nHus)) or for 60 min with HRP-conjugated rabbit anti-mouse Ig (for 
IL-10 staining; diluted in PBS/ 1%BSA). After incubation with biotinylated rabbit anti-mouse Ig, slides 
were incubated for 60 min with HRP-conjugated avidin-biotin complex diluted in PBS/1%BSA. Antibody 
binding was visualized by incubating the skin sections simultaneously in 65 ml 0.05 M acetate buffer 
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(pH=5.0) containing 26 mg 3-amino-9-ethyl-carbazole (AEC; Sigma, St Louis, MO) and 32,5 µl 30% 
H2O2, resulting in a red staining. The sections were counter-stained with Mayer’s hematoxylin. 
The skin sections were evaluated using a light microscope at 250 times magnification. The number of 
cytokine-expressing cells (TNF-α and IL-4) were assessed per mm2 epidermis or dermis. 
 
Double staining of TNF-α, IL-4 or IL-10 with elastase. After 10 min fixation in 65 ml acetone containing 
100 µl 30% H2O2 and 20 min preincubation with 10% nHus and 10% normal horse serum (nHos), the 
skin sections were incubated overnight with antibodies against TNF-α, IL-4 or IL-10 diluted in PBS / 
0.1% BSA. Subsequently, the slides were incubated for 60 min with biotinylated horse-anti mouse Ig 
(diluted in PBS/1% nHus, /1% nHos), followed by 30 min incubation with AP-conjugated avidin-biotin 
complex. After incubation of the slides with 10% normal mouse serum (nMs), the slides were incubated 
for 60 min with HRP-conjugated anti-elastase. AP activity was visualized by incubating the skin sections 
in a Tris-HCL buffer (pH=8.5) containing 25 mg Fast Blue BB salt, 12,5 mg naphtol AS-MX phosphate, 
and 35 mg levamisole (all purchased from Sigma), resulting in a blue staining. For visualization of the 
peroxidase activity the slides were then incubated with an AEC solution, as described above. 
 
Double staining of TNF-α with tryptase and IL-10 with CD36. Immunohistochemical staining for TNF-α 
and IL-10 was performed as explained above in the double staining except that HRP-conjugated instead 
of AP-conjugated avidin-biotin complex was now used as a detecting reagent. The slides were then 
incubated for 20 min with 10% nMs. Subsequently the skin sections were incubated for 60 min with AP-
labeled anti-AA1 (against tryptase)(for TNF-α double staining) or FITC-labelled CD36 (for IL-10 double 
staining). Incubation of the slides with CD36-FITC was followed by 60 min incubation with AP-
conjugated F(ab) fragments of sheep anti-FITC. AP en HRP activity were visualized as describe above. 
The antibodies used in this study were priory extensively tested for their suitability on microscopic (skin) 
sections. Negative staining controls were used by which the primary antibody was omitted or replaced 
by an irrelevant antibody of the same isotype. Sections of human tonsil were used as positive staining 
control. All antibody incubations were performed in a humidified chamber at room temperature except 
for incubation with the cytokine antibody, which was carried out at 4oC. After each antibody incubation, 
slides were rinsed in PBS containing 0.05% Tween 20. 
 
Statistical analysis 
A Student’s t test was performed to ascertain the observed differences (significance level of p<0.05). 
The numbers of TNF-α-expressing cells and IL-4-expressing cells in the UV-exposed skin were 
compared to the unexposed control skin. Furthermore, the number of cytokine-expressing cells (TNF-α 
and IL-4) in the (un)exposed skin of PLE patients were compared to healthy controls. A Spearman 
correlation test was carried out to reveal a possible correlation between the number of cells expressing 
TNF-α or IL-4 and the individual UV-dose (MED). 
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RESULTS 
 
The expression of cytokines involved in Langerhans cell migration is reduced in PLE 
patients compared to healthy controls 
Previous experiments showed that after overexposure of the skin to UV-B, Langerhans cells 
still persist in the epidermis of PLE patients and only a small number migrates out of the skin, 
in contrast to healthy individuals (Kölgen et al, 1999). Therefore we studied the expression of 
the pro-inflammatory cytokines IL-1-α, IL-1-β, TNF-α and IL-18, which are involved in the 
migration of Langerhans cells out of the skin. 
Cells expressing IL-1-β were found in the epidermis of the unexposed skin of PLE patients and 
healthy controls. After exposure of the skin to 6 MED UV-B an increase in the number of 
dermal cells expressing IL-1-β was observed in PLE patients and healthy controls. This 
increase, however, was far less in PLE patients when compared to healthy controls (fig 1). No 
appreciable change in the number of epidermal cells expressing IL-1-β was detected in the 
UV-B-exposed skin. Unfortunately, the variable and at times strong background staining 
hampered any good overall quantification of the IL-1-β expression. A semi-quantitative scoring 
(from ++ to --) was too crude to objectify this difference in any measure of statistical 
significance. 
In the unexposed skin of PLE patients and healthy controls, a limited number of cells 
expressing TNF-α (weak positive staining) were observed scattered throughout the dermis 
(mean±SEM= 29±9 cells/mm2 and 42±19 cells/mm2 resp.)(fig 2). We did not find any 
expression of TNF-α in the epidermis. However, 24h after UV-B exposure we observed a 
significant increase in the number of dermal cells (mean±SEM= 157±17 cells/mm2)(p=0.02) as 
well as an influx of epidermal cells expressing TNF-α (mean±SEM= 34±6 cells/mm2)(p=0.004) 
in the skin of healthy controls. Forty-eight hours post irradiation the number of TNF-α-
expressing cells in the dermis or epidermis of healthy controls decreased slightly again but not 
significantly (mean±SEM= 125±28 cells/mm2 and 24±12 cells/mm2 resp.). In the skin of PLE 
patients we observed a small, but significant, increase in the number of dermal TNF-α-
expressing cells 24h and 48h post irradiation (mean±SEM= 64±13 cells/mm2 and 68±16 
cells/mm2 resp.)(p=0.024 and p=0.037 resp.). However, no difference could be observed in the 
number of TNF-α-expressing in the UV-exposed epidermis 24h and 48h after irradiation 
(mean±SEM= 12±5 cells/mm2 and 7±3 cells/mm2 resp.) compared to the unexposed skin. The 
number of dermal and epidermal cells expressing TNF-α was significantly less (p=0.001 and 
p=0.014 resp.) in the UV-exposed skin (24h post irradiation) of PLE patients when compared 
to healthy controls. To summarize, the number of TNF-α-expressing cells in the dermis and 
epidermis of PLE patients and healthy controls increased after UV exposure but was 
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significantly less in the skin of PLE patients 24h after UV exposure in comparison with healthy 
controls. No correlation could be observed between the number of TNF-α expressing cells and 
the individual UV-dose (MED). 
Cells expressing IL-18 were found in the basal layer of the epidermis of healthy controls and 
PLE patients. The intensity of the expression was highly variable among all participants. Some 
IL-18-expressing cells could also be observed in the dermis. The number of dermal cells 
expressing IL-18 did not change after exposure of the skin to UV-B. Forty-eight hours after UV-
B exposure we noticed that the expression of IL-18 was no longer restricted to the basal layer 
of the epidermis but was now more diffuse and spread out into the suprabasal cell layers. 
Although the kinetics were mostly the same in PLE patients, the number of cells and intensity 
of the IL-18 expression in the UV-B-exposed skin was lower than in healthy controls, but the 
present technique is not suitable for quantification (data not shown). 
A constitutive, diffuse expression of IL-1-α was observed in the epidermis and a considerable 
number of dermal cells expressing IL-1-α were observed in the unexposed skin of PLE 
patients and healthy controls. Forty-eight hours after UV irradiation the intensity of the 
epidermal IL-1-α expression appeared to decrease slightly in the skin of most participants but 
the present technique is not suitable for quantification. The number of dermal cells expressing 
IL-1-α did not change after UV-irradiation (data not shown). 
To summarize, the number of dermal cells expressing IL-1-β or TNF-α increased after UV 
exposure, but less in PLE patients when compared to healthy controls. Furthermore, the influx 
of TNF-α-expressing cells into the UV-B-exposed epidermis was significantly less in PLE 
patients when compared to healthy controls. The expression of IL-18 and IL-1-α decreased 
slightly 48h post irradiation in both PLE patients and healthy controls. 
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Figure 1. IL-1-β expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE patient 
(c,d) and a healthy control (a,b), with an example of a rare cell expressing IL-1-β in the UV-exposed skin 
of a PLE patient (black arrow). Scale bar = 100 µm. 
 
 
Figure 2. TNF-α expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE patient 
(c,d) and a healthy control (a,b). Scale bar = 100 µm. 
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No differences in Th1-skewing cytokines (IL-6, IL-12, IFN-γ) are observed between PLE 
patients and healthy controls 
IL-6, which can be induced by IL-1, is upregulated after UV exposure (Urbanski et al, 1990). IL-
12 and IFN-γ are involved in cellular immune responses and skew T-cell responses towards a 
type 1 response (Kremer et al, 1996). 
Only very few epidermal and dermal cells expressing IL-6 were detected in the unexposed skin 
of PLE patients and healthy controls. We did not observe any difference in the number of cells 
expressing IL-6 between the unexposed and UV-B-exposed skin of all participants (data not 
shown). 
IL-12 was constitutively expressed by all epidermal cells although some cells showed a more 
pronounced IL-12 expression (fig 3). After UV exposure the epidermal IL-12 expression 
became less diffuse and more focal. A few brightly cells expressing IL-12 could be observed in 
the upper epidermis. The number of dermal cells expressing IL-12 did not differ between 
unexposed and UV-B-exposed skin. The above observations were made in both PLE patients 
and healthy controls. 
The number of epidermal and dermal cells expressing IFN-γ was very low in the unexposed 
and UV-B-exposed skin of PLE patients and healthy controls. We did not detect any difference 
in IFN-γ expression in the unexposed versus the UV-B-exposed skin or in PLE patients versus 
healthy controls (data not shown). 
 
Figure 3. IL-12 expression in unexposed skin (a,c) and 48h after UV exposure (b,d) of a PLE patient 
(c,d) and a healthy control (a,b). Black arrows indicate brightly IL-12-expressing cells. Scale bar = 100 
µm. 
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The expression of Th2-skewing and immunosuppressive cytokines (IL-4, IL-10) is 
reduced in PLE patients compared to healthy controls 
To investigate the hypothesis that a UV-induced suppression of cellular immunity is disturbed 
in PLE patients we determined the expression of IL-4, which is involved in UV-induced type 2 
T-cells responses (Teunissen et al, 2002), and IL-10, which is involved in UV-B-induced 
immunosuppression (Enk et al, 1995; Hammerberg et al, 1996; Kang et al, 1994), in the skin of 
PLE patients. 
The number of dermal cells expressing IL-4 in the unexposed skin of PLE patients and healthy 
controls was very low (mean±SEM= 4±2 cells/mm2 and 1±0,5 cells/mm2 resp.)(fig 4). No IL-4-
expressing cells could be detected in the epidermis of the unexposed skin of PLE patients and 
healthy controls. The number of dermal IL-4-expressing cells increased significantly 24h post 
irradiation in the skin of PLE patients and healthy controls (mean±SEM= 208±49 cells/mm2 and 
246±20 cells/mm2 resp.)(p=0.008 and p<0.001 resp.). Subsequently, 48h after UV exposure 
the number of dermal cells expressing IL-4 decreased slightly, but not significantly, in the skin 
of PLE patients and healthy controls (mean±SEM= 103±28 cells/mm2 and 196±46 cells/mm2 
resp.). Twenty-four hours and 48h after UV exposure cells expressing IL-4 infiltrated the 
epidermis of healthy controls and to a lesser extent of PLE patients (mean±SEM= 47±13 
cells/mm2 and 55±26 cells/mm2 and mean±SEM= 11±3 cells/mm2 and 9±4 cells/mm2 resp.). 
The number of epidermal IL-4-expressing cells 24h post irradiation differed significantly from 
the unexposed skin of PLE patients and healthy controls (p=0.018 and p=0.024 resp.). The 
number of IL-4-expressing cells that infiltrated the epidermis of PLE patients 24h after UV 
exposure was significantly less when compared to healthy controls (p=0.02). To summarize, 
the number of IL-4 expressing cells increased after UV exposure in the dermis and epidermis 
of PLE patients and healthy controls and was significantly less in the epidermis of PLE patients 
24h post irradiation in comparison with healthy controls. No correlation could be observed 
between the number of IL-4-expressing cells and the individual UV dose (MED). 
Cells expressing IL-10 were present in the basal layer of the epidermis and in the dermis of the 
unexposed skin (fig 5) of PLE patients and healthy controls. The intensity of the IL-10 
expression of these cells differed among all individuals. After irradiation the expression of IL-10 
in the basal layer appeared to increase at 24h and decreased again at 48h in the majority of 
the participants. A few brightly IL-10-expressing cells appeared in the epidermis within 24h 
(majority of healthy controls) or 48h (majority of PLE patients) after UV exposure. The number 
of dermal cells expressing IL-10 did not differ between the unexposed and UV-exposed skin of 
all participants. The diffuse staining of IL-10 in the epidermis hampered a good quantification 
of this expression, moreover, the difference seemed to be more in a time delay in the 
occurrence of densely stained cells in the PLE patients than in the absolute number of these 
cells (compare epidermises at 24h and 48h in fig 5). 
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Taken together, the number of dermal IL-4-expressing cells in the UV-exposed skin was 
reduced in PLE patients compared to healthy controls. The influx of IL-4-expressing cells in the 
UV-exposed skin of PLE patients was significantly less when compared to healthy controls. 
The level of IL-10 expression increased post irradiation but did not differ between PLE patients 
and healthy controls. 
 
 
Figure 4. IL-4 expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE patient (c,d) 
and a healthy control (a,b). Scale bar = 100 µm. 
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Figure 5. IL-10 expression in unexposed skin (a,d) and 24h (b,e) or 48h (c,f) after UV exposure of a PLE 
patient (d-f) and a healthy control (a-c). Black arrows indicate IL-10-expressing cells (a) or brightly IL-10-
expressing cells (b,f). Scale bar = 100 µm. 
 
IL-10 is predominantly expressed by keratinocytes while TNF-α, and IL-4 are expressed 
by neutrophils 
Since Meunier et al (1995) reported that CD36+ CD11b+ CD1a- cells infiltrate the skin after UV 
exposure and that the CD11b+ CD1a- cells produce IL-10 (Kang et al, 1994) and are involved 
in UV-induced immunosuppression (Hammerberg et al, 1996) we determined whether the 
brightly IL-10-expressing cells in the epidermis of the UV-exposed skin were CD36+ 
macrophages. Double-stainings were performed for IL-10 with antibodies against CD36 or 
elastase (neutrophil marker). In the skin of healthy controls 24 hours after irradiation almost all 
epidermal cells expressing IL-10 were neutrophils. However, in the UV-exposed skin of PLE 
patients and in the skin of healthy volunteers 48h post irradiation the brightly epidermal IL-10-
expressing cells did not co-express elastase (fig 6). Only very few cells expressing IL-10 were 
CD36+ macrophages. Therefore, the IL-10-expressing cells in the basal layer of the epidermis, 
and probably also a fraction of the brightly IL-10-expressing cells are most likely keratinocytes. 
Mast cells release large amounts of TNF-α upon activation by UV-B radiation (Walsh, 1995). 
On the other hand, the pattern of TNF-α expression resembled the pattern of neutrophil influx 
after UV irradiation. Therefore, double stainings were performed for TNF-α with antibodies 
against tryptase (mast cell marker) or elastase (neutrophil marker) to identify the cell type 
expressing this cytokine. All dermal and epidermal cells expressing TNF-α in the skin of 
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healthy controls and PLE patients turned out to be neutrophils (fig 6) and not mast cells. A 
minority of the neutrophils did not express TNF-α. 
Since Teunissen et al (2002) showed that neutrophils are the main source of IL-4 in the UV-B-
exposed skin we determined whether the IL-4-expressing cells in the skin of the healthy 
individuals and PLE patients were also neutrophils. Hence a double staining was carried out 
for IL-4 and elastase. All cells expressing IL-4 in the skin of healthy controls and PLE patients 
were indeed neutrophils (fig 6). A minority of the neutrophils did not express IL-4. 
 
Figure 6. Co-expression for elastase (red) and IL-10 (a-c), TNF-α (d) or IL-4 (e) (blue) in the skin of a 
healthy control (a,b,d,e) or a PLE patient (c) 24h (a,c,d,e) or 48h (b) after UV exposure. Black arrows 
and magnifications indicate double positive cells. Gray arrows indicate single positive cells. Scale bar = 
100 µm. 
 
 
DISCUSSION 
 
UV-induced immunosuppression is associated with the disappearance of Langerhans cells 
from the epidermis. In preceding experiments it was shown that Langerhans cells still persist in 
the UV-(over)exposed skin of PLE patients in contrast to healthy individuals (Kölgen et al, 
1999). This Langerhans cell persistence was caused by a disturbance in Langerhans cell 
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migration2. Here we investigated whether this defect in migration could be related to a lack of 
cytokines involved in Langerhans cell migration, such as IL-1, TNF-α, and IL-18. 
The expression of IL-1-β, but not of IL-1-α, was reduced in the UV-exposed skin of PLE 
patients compared to healthy controls. While the UV-induced increase in IL-1-β was mainly 
observed in keratinocytes and Langerhans cells (Norval, 2001), we observed an UV-induced 
increase of scattered dermal cells expressing IL-1-β, potentially macrophages. Although the 
number of cells expressing TNF-α was increased after UV exposure, it was significantly lower 
in PLE patients when compared to healthy controls. In contrast to healthy controls hardly any 
TNF-α-expressing cells infiltrated the epidermis of PLE patients. TNF-α is produced by 
keratinocytes (Kock et al, 1990) and mast cells (Bazzoni et al, 1994) upon UV exposure. The 
TNF-α-expressing cells that we observed in the (epi)dermis, however, were not mast cells but 
turned out to be neutrophils. Cumberbatch et al (2001) showed that IL-18 stimulates 
Langerhans cell migration after skin sensitisation. No significant differences could be seen in 
the number of cells expressing IL-18 between the unexposed and UV-exposed skin of PLE 
patients and healthy controls. The IL-18 antibody that was used was not able to discriminate 
between the non-active protein, which is expressed constitutively by keratinocytes and the 
biologically active IL-18 protein. Therefore it might still be possible that the expression of 
biologically active IL-18 differs between PLE patients and healthy controls. In summary, the 
reduced expression of IL-1-β and neutrophil-derived TNF-α support our hypothesis that 
migration-inducing cytokines are decreased in the UV-exposed skin of PLE patients thereby 
leading to an impairment in UV-induced Langerhans cell migration. The present data on 
migration-inducing cytokines are consistent with the data on disturbance of Langerhans cell 
migration in PLE patients, using the same irradiation protocol1. As some Langerhans cells in 
the skin of PLE patients are still able to migrate after UV exposure it seems reasonable to 
expect at least some degree of expression of migration-inducing cytokines. 
Another hypothesis we wanted to investigate was whether the Th1-skewing cytokines were 
expressed in larger amount in the UV-exposed skin of PLE patients in comparison with healthy 
controls, thereby contributing to the pathogenesis of PLE. 
There are very limited data on the cytokine profile in PLE patients and the only available data 
are on lesional skin. Norris et al (1999) showed an increased activity of IL-6, IL-8 and possibly 
IL-1 in experimentally provoked lesions of PLE patients compared to non-lesional skin. 
However, we did not detect any differences in the number of cells expressing IL-6 in the 
unexposed compared to the UV-exposed skin nor any differences in IL-6 expression between 
PLE patients and healthy controls. Some investigators describe an increase in secretion of the 
pro-inflammatory cytokine IL-6 after irradiation of cultured keratinocytes (Kirnbauer et al, 1991; 
                                                          
2 Kölgen et al, submitted 
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Petit-Frere et al, 1998) or an increase of IL-6 in human serum after a single dose of UV 
(Urbanski et al, 1990), but secreted cytokines are difficult to detect by the 
immunohistochemical method that we used. There was no detectable difference between the 
expression of IL-12 and IFN-γ in the skin of PLE patients and healthy controls. Only very few 
IFN-γ-expressing cells were observed in the UV-exposed as well as the unexposed skin. IL-12 
was constitutively expressed by keratinocytes, as also described by Yawalker et al (1996). UV 
radiation did not change the level of IL-12 expression but did change the expression pattern as 
brightly IL-12-expressing cells could now be observed in the epidermis. IL-12 expression was 
similar in PLE patients and healthy controls. The antibody used to detect IL-12 is not able to 
discriminate between the two subunits of IL-12 nor can it discriminate between heterodimers 
and homodimers of IL-12. Homodimers of IL12 p40 can be increased upon UV exposure 
(Schmitt and Ullrich, 2000) and can inhibit IL-12 activity by blocking its receptor (Mattner et al, 
1993), resulting in a decrease of Th1 responses instead of an increase. Collectively, the 
present findings show that expression Th1-skewing cytokines is similar in the UV-B exposed 
skin of PLE patients and healthy individuals. However, the expression of homodimers of IL-
12p40 still might be less in the skin of PLE patients in comparison with healthy controls. 
In order to investigate the balance between Th1-skewing and Th2-skewing and/or 
immunosuppressive cytokines further and to examine whether PLE patients are disturbed in 
their UV-induced immunosuppression, we performed immunohistochemical stainings for IL-4 
and IL-10. In line with the results from Teunissen et al (2002) we found a UV-induced increase 
in dermal IL-4-expressing neutrophils and an influx of these cells into the epidermis of healthy 
controls. The number of dermal neutrophils expressing IL-4 in the UV-exposed epidermis of 
PLE patients was significantly lower than in healthy controls, indicating that the balance is 
somewhat more shifted towards a Th1 response in PLE patients. UV radiation can induce the 
production of IL-10 by keratinocytes (Enk et al, 1995; Grewe et al, 1995) and macrophages 
(Kang et al, 1994). IL-12 treatment to inhibit IL-10 release (Schmitt et al, 1995) or depletion of 
macrophages by anti-CD11b treatment (Hammerberg et al, 1996) reversed the UV-mediated 
immunosuppression. Our results showed that IL-10 is expressed by keratinocytes, mainly in 
the basal layer. This expression is increased after UV exposure and brightly IL-10-expressing 
cells can be observed in the epidermis of PLE patients (mostly at 48h) and healthy controls 
(mostly at 24h). The number of cells expressing IL-10 did not differ between PLE patients and 
healthy controls. Only very few IL-10-expressing cells were CD36+ macrophages. The brightly 
epidermal IL-10-expressing cells in the skin of healthy controls 24h after UV exposure were 
neutrophils. However, 48h post irradiation and in the UV-exposed skin of PLE patients cells 
expressing IL-10 neither co-expressed CD36 nor elastase (neutrophil marker) and hence are 
most probably keratinocytes. CD11b is also expressed by neutrophils and anti-CD11b 
treatment (Hammerberg et al, 1996) will therefore also deplete neutrophils expressing IL-10 
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resulting in reversion of the immunosuppression. To summarize, our findings show that the 
expression of the Th2-skewing cytokine IL-4 was less in the epidermis of PLE patients, shifting 
the balance more towards a Th1 response. Furthermore, a difference in IL-10 expression, 
reflecting a difference in UV-induced immunosuppression, between PLE patients and healthy 
controls was restricted to infiltrating neutrophils in the epidermis of healthy controls. 
Interestingly, exposure of the skin of PLE patients to 8.4 MED resulted in a decrease and 
almost complete depletion of Langerhans cells 48h post irradiation. In addition, the expression 
of IL-1-β, TNF-α and IL-4 was increased compared to the 6 MED UV-B-exposed skin and more 
TNF-α-expressing and IL-4-expressing cells infiltrated the epidermis (data not shown). These 
observations indicate that the balance between erythema and immune responses is disturbed 
in PLE. Supplementation of dietary fish oil, containing omega 3 fatty acids, resulted in a 
reduction of UV-B erythemal sensitivity (Rhodes et al, 1994), a decrease of prostaglandin E2 
levels, which is involved in erythema (Rhodes et al, 2001), and in a protection against UV-A 
provocation of a papular response in PLE patients (Rhodes et al, 1995). Therefore it would be 
interesting to investigate whether the reduction in erythema and prostaglandin E2 levels by 
dietary fish oil supplementation is accompanied by a complete UV-B-induced depletion of 
Langerhans cells in PLE patients and a recovery of the cytokine levels of IL-1-β, TNF-α and IL-
4 (tested with the 6 MED protocol), and by protection against UV-B-provoked PLE lesions. 
Another remarkable observation (n=1) was made in a healthy individual, with no history of PLE 
or other (photosensitive) skin disorders, whose buttock skin had been exposed extensively to 
sunlight during a 6-weeks vacation in Australia. After exposure of the buttock skin to 6 MED 
UV-B two weeks after the vacation, Langerhans cells were only partially depleted and TNF-α 
and IL-4 expression was low and resembled the level of expression seen in PLE patients. IL-1-
α expression was almost completely absent except for very rare cells expressing IL-1-α 
scattered in the dermis (data not shown). Exposure of the skin to UV radiation increases the 
production of IL-1-Ra in the stratum corneum (Hirao et al, 1996), which can bind nearly 
irreversible to the IL-1 receptor and block its activity. An extensive, long-term exposure might 
perhaps not only lead to inhibition of IL-1 activity but also downregulation of the level of IL-1. 
Immunohistochemistry appears to be a very suitable method for localization of cytokines in 
cytoplasm and identification of the cells expressing certain cytokines in vivo (Asadullah et al, 
2002; Hoefakker et al, 1995). However, we are aware of the limitations of this technique. Most 
of all, this technique will not detect secreted cytokines, but only cytokines bound in the 
cytoplasm or on the cellular membrane. A clear intracellular staining and a difficulty in 
detecting very low levels of cytokines by immunohistochemistry lead to a visualization of 
cytokine producing cells rather than receptor-bound cytokines on target cells, although this 
cannot be excluded completely. 
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A first exploration of the cytokine patterns in UV-B-exposed skin of PLE patients versus 
healthy controls demonstrated that in conjunction with a diminished Langerhans cell migration, 
migration-inducing cytokines are also present to a lesser extent in PLE patients compared to 
healthy individuals. No difference in the Th1-skewing cytokines IL-12, IFN-γ and IL-6 could be 
observed in PLE patients. However, we found a smaller number of cells expressing IL-4 in the 
epidermis of PLE patients, shifting the cytokine response somewhat more to a Th1 response. 
This scarce expression of TNF-α and IL-4 in the UV-exposed skin of PLE patients appears to 
be largely attributable to a smaller influx of neutrophils. 
Based on the present cytokine data and on previous experiments we speculate that the 
following events occur in the skin of PLE patients upon UV exposure: Langerhans cells 
residing in the epidermis capture UV-induced neo-antigens. Subsequently these cells migrate 
out of the skin but their migration is impaired due to low levels of IL-1-β and TNF-α. The 
Langerhans cells that do migrate increase their expression of costimulatory molecules and 
HLA-DR3. Due to the impaired migration, activated Langerhans cells accumulate in the dermis 
where they stimulate T-cells. A reduced expression of IL-4 in the skin of PLE patients favours 
the development of a Th1-like response in contrast to a pronounced Th2 response in healthy 
controls. These events together might contribute to the pathogenesis of PLE. 
Future experiments on cytokine profiles in PLE patients should focus on the levels of 
expression of cytokines in vivo in suction blister fluids, e.g. by ELISA cytokine detecting 
techniques, as has been described for healthy individuals by Barr et al (1999), but this 
technique requires many blisters for an extensive study. Alternatively, one could determine 
cytokine mRNA levels by quantitative PCR, however, cytokine gene expression does not 
necessarily lead to protein synthesis because there are still several posttranscriptional 
regulatory bases (Asadullah et al, 2002). Additionally, cytokine expression kinetics can be 
extended by inserting more time points. Furthermore, it would be interesting to examine the 
effects of successful phototherapy on the UV-induced decrease in Langerhans cells and the 
expression of cytokines like IL-1-β, TNF-α and IL-4. 
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Langerhans cell depletion and local immunosuppression in NER-deficient mice 
ABSTRACT 
 
Exposure to ultraviolet-B radiation impairs immune responses in mammals by inhibiting 
especially Th1-mediated immune responses such as contact hypersensitivity. This 
immunosuppression seems to be associated with Langerhans cell migration. 
Immunomodulation is not restricted to the exposed skin (local immunosuppression), but is also 
observed at distant sites (systemic immunosuppression). DNA damage appears to play a key 
role since enhanced nucleotide excision repair, a pathway essential for elimination of 
ultraviolet-B-induced DNA lesions, strongly counteracts immunosuppression. To determine the 
effect of DNA repair on ultraviolet-B-induced local immunosuppression and Langerhans cell 
disappearance three mouse strains carrying different defects in nucleotide excision repair were 
compared. XPC mice who were defective in global genome repair were as sensitive to 
ultraviolet-B-induced local suppression of contact hypersensitivity to picryl chloride as their 
wildtype littermates. CSB mice who were defective in transcription-coupled repair were, 
however, far more sensitive for immunosuppression as were XPA mice who were defective in 
both transcription-coupled repair and global genome repair. In XPC mice Langerhans cell 
migration was observed at a similar UV dose as in the wildtype littermates. Ultraviolet-B-
induced Langerhans cell depletion was, however, enhanced in CSB en XPA mice compared to 
their wildtype littermates. Hence, the major conclusion is that local immunosuppression is only 
affected when transcription-coupled DNA repair is impaired. Furthermore, only a defect in 
transcription-coupled repair was linked to enhanced ultraviolet-B-induced Langerhans cell 
depletion. In combination with an earlier study by our group, it can be concluded that 
Langerhans cell disappearance is related to ultraviolet-B-induced local but not to systemic 
immunosuppression. 
 
 
INTRODUCTION 
 
Ultraviolet radiation (UV) causes a broad range of effects in the skin. One of these effects, 
predominantly caused by UV-B (280-315 nm), is the suppression of cellular immunity. This 
immunosuppression is associated with the disappearance of antigen-presenting cells, the 
Langerhans cells, from the epidermis. UV can be absorbed by organic molecules such as 
DNA, leading to the induction of cyclobutane pyrimidine dimers (CPDs) as well as 6-4 
pyrimidine pyrimidone photoproducts (6-4PPs). Cells with UV-specific DNA damage, i.e. 
Langerhans cells, were found in murine lymph nodes (Sontag et al, 1995) after exposure of the 
skin to UV radiation. Furthermore, migrating Langerhans cells were detected in the blister fluid 
of UV-exposed human skin (Kölgen et al, 2002). 
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In situ action spectra suggested that DNA damage is involved in UV-induced 
immunosuppression of allogeneic reactions in humans (Hurks et al, 1997). DNA damage can 
trigger the production of tumor necrosis factor (TNF)-α, interleukin (IL)-10 and IL-6 and thereby 
modulate Langerhans cell activity and local immune responses (Nishigori et al, 1996; 
O'Connor et al, 1996; Petit-Frere et al, 1998). Treatment of mice with thymidine dinucleotides 
(pTpT), mimicking DNA fragments that are released when UV-induced DNA damage is 
repaired, inhibits contact hypersensitivity and activates the TNF-α gene (Cruz, Jr. et al, 2000). 
Furthermore, removal of CPDs by photoreactivation enzyme (Reeve et al, 1996) or by 
treatment with liposomes containing T4 endonucleose V (T4N5) (Applegate et al, 1989; Vink et 
al, 1997) resulted in a reversion of UV-induced local as well as systemic immunosuppression. 
Topical treatment with T4N5 leads to a protection against UV-induced upregulation of the 
immunosuppressive cytokine IL-10 (Nishigori et al, 1996) and TNF-α (Wolf et al, 2000). The 
products released by UV-damaged cells can be transported by the circulation throughout the 
whole body, which may contribute to the systemic immunosuppressive effects. 
Depending on the type of DNA damage different DNA repair pathways can be activated (de 
Boer and Hoeijmakers, 2000). The most important mechanism for the repair of CPDs and 6-
4PPs in placental mammals is Nucleotide Excision Repair (NER). NER consists of two 
pathways namely Global Genome Repair (GGR) and Transcription-Coupled Repair (TCR). 
GGR is involved in helix-distorting repair of DNA damage throughout the entire genome. TCR, 
on the other hand, preferentially eliminates transcription-blocking damage in actively 
transcribed genes. A defect in NER can lead to rare photosensitive disorders like Xeroderma 
Pigmentosum (XPA-XPG) and Cockayne syndrome (CSA and CSB). The majority of the XP 
patients, of which XPA with a deficiency in GGR as well as TCR is the most severe subgroup, 
are extremely sensitive to sunburn and run a more than 1000-fold increased risk of developing 
skin cancer. XPC patients, who are deficient in GGR alone, have a normal sensitivity to 
sunburn but are highly cancer-prone. Morison et al (1985) showed that XP patients had an 
impaired development of CHS, depending on the severity of the disease. Patients with CS, 
who have an selective impairment in TCR, are extremely photosensitive and develop 
neurological abnormalities. However, these CS patients do not appear to be predisposed to 
develop skin cancer. 
Studies with NER-deficient mouse mutants, carrying defects in TCR (CSB), GGR (XPC) or 
both (XPA) have the advantage that confounding genetic background differences can be 
eliminated. Such studies have provided additional evidence for a significant role of DNA 
damage in UV-B-induced immunosuppression. Miyauchi-Hashimoto et al (1996) and Garssen 
et al (2000) demonstrated that in XPA mice UV-induced local and systemic 
immunosuppression were increased. However, systemic immunosuppression was not 
enhanced in XPC nor in CSB mice (Garssen et al, 2000). Furthermore, Boonstra et al (2001) 
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showed that the production of IL-10 and TNF-α was augmented in the lymph nodes of UV-
exposed XPA and CSB but not XPC mice. 
A decrease in Langerhans cell number could result in a disturbance in immune surveillance of 
UV-exposed skin. Langerhans cell densities in chronically sunlight-exposed skin of patients 
with XPA were remarkably reduced. In addition, the recovery of the epidermal Langerhans cell 
population was delayed in XPA patients compared to healthy controls (Jimbo et al, 1992). 
The aim of the present study was to determine the influence of GGR and TCR on the UV-
induced depletion of Langerhans cells and on UV-induced local immunosuppression. 
Subsequently, the relationship between local immunosuppression and Langerhans cell 
disappearance could be ascertained. 
In order to investigate these different features, experiments on DNA repair-deficient mice with 
defects in GGR and TCR (XPA), GGR alone (XPC) or TCR alone (CSB) were performed. After 
UV irradiation of the skin for five consecutive days a contact allergen (picryl chloride) was 
applied to the irradiated site. Following antigen challenge with picryl chloride on the ears of the 
animals, ear swelling was determined as a measure of cellular immunity, or conversely of UV-
induced local immunosuppression. Similar to this experiment a separate group of animals was 
subjected to the same UV exposure regimen. Two days prior to immunization and at the day of 
immunization these mice were sacrificed and their ears and lymph nodes were collected. 
Immunohistochemistry was performed for NLDC145 (a dendritic cell marker) and H3 (a CPD 
marker) on frozen sections of the ear skin and the lymph nodes. 
 
 
MATERIALS AND METHODS 
 
NER-deficient mouse models 
XPA, CSB, and XPC mice refer to NER-deficient mice homozygous for the targeted allele in the 
respective genes (Cheo et al, 1997; de Vries et al, 1995; van der Horst et al, 1997). XPA deficiency 
induces a virtual complete defect in transcription-coupled repair as well as global genome repair. CSB 
mice have only a total impairment of transcription-coupled repair, while XPC mice have a selective 
inactivation of global genome repair. 
Mixed 129-C57Bl/6 or pure C57Bl/6 littermates of the homozygous knockout mice were used as control 
animals (the background of all mutant strains used in this study). The genotype of each mouse was 
determined by PCR. Mice were kept at an ambient temperature of 25 + 1 °C. The room was illuminated 
with yellow fluorescent tubes (Philips TL40W/16) in a 12 hour cycle (switched on and off at respectively 
6.00 a.m. and 6.00 p.m.). These lamps do not emit any measurable UV radiation. No daylight entered 
the animal facilities. Animals were housed individually in macrolon type I cages for the entire 
experiment. Standard mouse chow (Hope Farms RMH-B, Woerden, the Netherlands) and tap water 
were available ad libitum. Formal permission for the animal experiments was granted by an independent 
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ethical committee of the National Institute of Public Health and the Environment, as required by Dutch 
law. 
 
Reagents 
Picryl chloride (PCl) (Chemotronix, Swannanoa, NC, USA) was used as contact sensitizer. It was 
recrystallized three times from methanol/H2O before use, and protected from light during storage at 4°C. 
 
UV exposure 
The animals were shaven (on the back) one day prior to UV exposure using an electric clipper under 
light ether anesthesia. The animals were exposed to broadband UV-B radiation from a filtered (Schott 
WG305 filter) Hanovia Kromayer Lamp Model 10S (Slough, United Kingdom). This is a hand-held lamp 
that allows short exposures to limited skin areas by placing the circular port (approximately 2 cm2) in 
close contact to the skin (Goettsch et al, 1999; Sontag et al, 1994). The dose rate was 150 J/m2/second 
(280-400 nm), as measured by a Kipp E11 thermopile. 
For determination of immunomodulation the animals were exposed to 5 consecutive UV doses (one 
exposure per day, last exposure 4 days prior to immunization). The NER-deficient mice and their 
respective wildtype controls were exposed in accordance to their acute UV sensitivity i.e. to 150 J/m2 
(XPA), 150 and 300 J/m2 (CSB) or to 300 J/m2, 600 J/m2, or 900 J/m2 (XPC) each day. 
 
Contact hypersensitivity to picryl chloride 
The mice were sensitized 4 days after the last day of (sham) irradiation by topical application of 150 µl of 
5% PCl in ethanol/acetone (3:1) to the UV-irradiated shaved back. Control mice were sham-sensitized 
by topical application of 150 µl ethanol/acetone (3:1). Four days after sensitization both ears of the mice 
were challenged by topical application of one drop (27-gauge needle) of 0.8% PCl in olive oil. Prior to, 
and at 24h after challenge duplicate measurements of ear thickness were made using an engineer’s 
micrometer in a blinded fashion. From earlier studies it is known that the maximal contact 
hypersensitivity response was 24h after topical ear challenge, also in UV-B pre-exposed animals 
(Sontag et al, 1994). In each experiment, the increase in ear thickness in similarly challenged, non-
sensitized, control mice was measured at the same time, and subtracted from increments in ear 
thickness in sensitized test animals (net ear swelling). The CHS response (net ear swelling) in sensitized 
mice that were not exposed to UV-B radiation (minus the negative background swelling found in non-
sensitized mice) was set at 100% in order to compare the effects of UV between the different mouse 
strains that were tested. 
 
Langerhans cell depletion 
Groups of mice were irradiated with different UV doses for 5 consecutive days on their ears as 
described above. One control group per mouse strain was not irradiated. Forty-eight hours before 
immunization (2 days post irradiation) or at the day of immunization (4 days post irradiation) the animals 
were sacrificed and the ears and the skin draining lymph nodes were removed. No immunization was 
performed on these animals. Ears and lymph nodes were snap-frozen in liquid nitrogen, embedded in 
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OCT compound (Tissue-Tek, Sakura, Zoeterwoude, the Netherlands) and stored at –80oC until further 
processing. 
 
Immunohistochemical staining of NLDC145 and pyrimidine dimers 
Frozen sections (6 µm thickness) of the ears and lymph nodes were mounted onto 3-aminopropyl 
triethoxysilane (Sigma, St Louis, MO, USA)-coated slides. A double staining was performed for 
NLDC145 (a dendritic cell marker; a kind gift from Prof. Dr. G. Kraal, department of Cell Biology, Free 
University, Amsterdam, the Netherlands) and biotinylated H3 (directed against thymidine-containing 
cyclobutane pyrimidine dimers; a kind gift from Dr. L. Roza, T.N.O., Zeist, the Netherlands) as described 
previously (Sontag et al, 1995). The sections were fixed in dry acetone for 10 min, preincubated with 
blocking reagent (PBS containing 10% normal rabbit serum) and incubated with the primary antibody 
NLDC145 overnight at 4oC. After incubation for 1h with biotinylated rabbit anti-rat immunoglobulins 
(DAKO A/S, Glostrup, Denmark) the sections were subsequently incubated for 30 min. with alkaline 
phosphatase (AP)-conjugated avidin-biotin complex (DAKO A/S). AP activity was visualized by 
incubation in a BCIP/NBT solution of 37.5 µl 5-bromo-4-chloro-3-indolyl phosphate, 50 µl 4-nitro blue 
tetrazolium chloride and 2.5 mg levamisole per 10 ml 0.1 M Tris-HCL (pH=9.5)/ 0.1 M NaCl/ 0.05M 
MgCl2. The bluish-black reaction product is water and ethanol insoluble and withstands the subsequent 
harsh treatment. The preparations were fixed in 25% acetic acid (vol/vol) containing 100 µl 30% H2O2 
per 100 ml. After washing in PBS the slides were incubated for exactly 2 min in 0.07 N NaOH in 70% 
ethanol. The slides were rinsed in PBS and incubated for 1h with biotinylated H3 antibody. 
Subsequently, the sections were incubated with horseradish peroxidase-conjugated avidin-biotin 
complex (DAKO A/S) for 30 min. Peroxidase activity was visualized by incubation in 0.1 M acetate buffer 
(pH=5) containing 20 mg 3-amino-9-ethyl-carbazole (AEC; Sigma ) and 100 µl 30% H2O2 per 100 ml, 
resulting in a red staining. 
After each antibody incubation the slides were rinsed in PBS containing 0.05% Tween 20. Antibody 
incubations were performed in a humidified chamber at room temperature except for incubation with 
NLDC145 which was performed at 4oC. Negative staining controls were used in which the primary 
antibody was omitted. 
The sections were evaluated using a light microscope at 250 times magnification. The NLDC145 
staining of the ears was determined quantitatively by image processing: the percentage of epidermal 
cross-sectional area that stained for NLDC145 was measured, using a camera mounted onto a light 
microscope together with the Optimas 6.1 and Microsoft Excel software (the targeted interfollicular 
epidermal area was demarcated manually). 
 
Statistical analysis 
 
CHS experiments: 
The CHS responses were statistically evaluated using an independent two-tailed T-test. P<0.05 
indicated a significant difference compared to the unexposed sensitized positive control. 
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Immunohistochemical studies: 
After logarithmic transformation (to correct for the right skewed distribution) an independent two-tailed T-
test was performed to ascertain the significance of the observed differences (significance level p< 0.05). 
The percentage of epidermal NLDC145+ area in the crosssection of UV-exposed ears of mutant mice 
and wildtype littermates were compared to their respective unexposed, control skin. Furthermore, the 
percentages of epidermal NLDC145+ area in the ears were compared between the mutant mice and 
their wildtype littermates for the different UV doses. 
 
 
RESULTS 
 
A defect in nucleotide excision repair does not affect contact hypersensitivity to picryl 
chloride 
Contact hypersensitivity (CHS) in XPA, CSB, and XPC mice and their respective wildtype 
littermates was measured 24h after ear challenge with PCl in olive oil. Significant CHS (ear 
swelling) responses (p<0.05) to PCl were observed in each strain of mice as compared to the 
background swelling responses found in the non-sensitized control animals from the same 
strain. The background ear swelling in non-sensitized animals of each strain was always less 
than 1*10-3 cm. CHS responses in the mutant mice (XPA, CSB and XPC) were not different 
from the CHS responses in the respective wildtype littermates. Thus, the various NER defects 
did not affect the normal T-cell dependent CHS response as compared to the repair-competent 
wildtype littermates (data not shown). 
 
Ultraviolet-B-induced suppression of contact hypersensitivity occurs at a lower dose in 
XPA and CSB but not XPC mice 
To compare the suppressive effects of UV exposure, the control response in unirradiated 
animals was set at 100%. In each study the mutant mice were compared to their wildtype 
littermates. The findings are depicted in figures 1-3. Each bar represents the percentual CHS 
response compared with the control response in the respective unirradiated animals (set at 
100%). A UV dose of 150 J/m2 was already sufficient for a significant immunosuppression in 
XPA mice (p<0.001) (fig 1) and CSB mice (p<0.001) (fig 2). In the respective wildtype 
littermates, however, CHS was not suppressed after exposure to 150 J/m2 or 300 J/m2. The 
CHS response of XPC mice was significantly suppressed only after irradiation with 900 J/m2 
(p<0.001)(fig 3). A minimal UV dose of 900 J/m2 was also required for a significant 
suppression of CHS in the respective wildtype littermates (p<0.01). 
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Figure 1, UV-induced local 
immunosuppression of CHS in XPA 
mice (white bars) and wildtype 
littermates (gray bars). Each bar 
represents net ear swelling (mean ± 
SEM). The ear swelling in sensitized 
unirradiated mice was set at 100%. 
p<0.001 (1). 
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Figure 2, UV-induced local 
immunosuppression of CHS in CSB 
mice (white bars) and wildtype 
littermates (gray bars). Each bar 
represents net ear swelling (mean ± 
SEM). The ear swelling in sensitized 
unirradiated mice was set at 100%. 
p<0.001 (1+2). 
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Figure 3, UV-induced local 
immunosuppression of CHS in XPC 
mice (white bars) and wildtype 
littermates (gray bars). Each bar 
represents net ear swelling (mean ± 
SEM). The ear swelling in sensitized 
unirradiated mice was set at 100%. 
p<0.001 (1); p<0.01 (2). 
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Ultraviolet-B-induced Langerhans cell depletion is enhanced in XPA and CSB but not 
XPC mice 
In order to examine the influence of GGR and TCR on UV-induced Langerhans cell depletion 
we exposed NER deficient mice and their wildtype littermates to different UV doses and 
determined the density of Langerhans cells in a crosssection of the (un)exposed skin of the 
ears. The density of epidermal NLDC145+ Langerhans cells in the unexposed skin of XPA, 
CSB and XPC mice did not differ significantly from their wildtype littermates. 
A UV dose of 150 J/m2 was sufficient for a significant decrease in epidermal Langerhans cell 
numbers in XPA (p=0.011) and CSB mice (p<0.001)(fig 4 and 5 res.). Wildtype littermates of 
CSB mice showed a significant decline in the density of epidermal Langerhans cells after 
irradiation with 300 J/m2 (p=0.009). A minimal UV dose of 900 J/m2 was required for a 
significant decrease in epidermal Langerhans cell density in the skin of wildtype littermates 
(p=0.006), but remarkably at this high dose the density of Langerhans cells in the skin of XPC 
mice was still not significantly reduced (fig 6). 
The density of epidermal Langerhans cells was significantly less in the UV-exposed skin (150 
and 300 J/m2) of XPA mice (p=0.012) and CSB mice (p=0.008 and p=0.017 resp.) compared 
to the respective wildtype littermates (fig 4 and 5 resp.). The density of epidermal NLDC145+ 
Langerhans cells in the UV-B-exposed skin (300 and 600 J/m2) did not differ between XPC 
mice and their wildtype littermates. The density of epidermal Langerhans cells was even 
significantly larger in the UV-B-exposed skin (900 J/m2) of XPC mice than in that of their 
wildtype littermates (p=0.015) (fig 6). 
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Figure 4, Percentage of epidermal 
NLDC145+ area (mean ± SEM) of 
the (un)exposed ear skin of XPA 
mice (white bars) and wildtype 
littermates (gray bars). p=0.011 (1); 
p=0.012 (2). 
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Figure 5, Percentage of epidermal 
NLDC145+ area (mean ± SEM) of 
the (un)exposed ear skin of CSB 
mice (white bars) and wildtype 
littermates (gray bars). p<0.001 (1); 
p=0.001 (2), p=0.009 (3), p=0.008 
(4), p=0.017 (5) 
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Figure 6, Percentage of epidermal 
NLDC145+ area (mean ± SEM) of 
the (un)exposed ear skin of XPC 
mice (white bars) and wildtype 
littermates (gray bars). p=0.006 (1); 
p=0.015 (2) 
 
 
 
 
Skin draining lymph nodes of the (un)exposed skin of all mouse strains were removed to check 
for the presence of dendritic cells with CPDs. NLDC145+ cells with CPDs were detected in the 
draining lymph nodes of the UV exposed skin, but not in those of the unexposed skin (checked 
in an a-select group of samples)(data not shown). 
 
 
DISCUSSION 
 
In this study we investigated whether TCR and/or GGR were involved in UV-induced local 
immunosuppression using genetically defined mouse mutants with specific defects in one or 
both of these DNA repair systems. An immunization with the contact allergen picryl chloride on 
an irradiated site and subsequent challenge of the ears was used as a tool to determine the 
susceptibility to UV-induced local immunosuppression. Previously, we found that CHS 
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responses to picryl chloride could be inhibited by low doses of UV-B radiation (Sontag et al, 
1994). This correlated with decreased levels of interferon (IFN)-γ and IL-12, which are 
important in the initiation and effector phase of Th1-mediated immunity (Garssen et al, 1999). 
Furthermore, it was shown that a complete defect in NER, as in XPA mice, increased the 
susceptibility to UV-induced systemic immunosuppression (Garssen et al, 2000; Miyauchi-
Hashimoto et al, 1996), while IFN-γ levels were decreased (Boonstra et al, 2001). Systemic 
immunosuppression was not observed in XPC and CSB mice with a defect in GGR or TCR 
respectively (Garssen et al, 2000). 
In the present study it was demonstrated that UV-induced local immunosuppression was 
enhanced in XPA and CSB mice but not in XPC mice or wildtype littermates. These 
observations are in line with and extend the findings by Miyaushi-Hashimoto et al (1996) who 
found that local immunosuppression was increased in XPA mice. However, importantly the 
present experiments give evidence that this increased susceptibility to local 
immunosuppression is not restricted to XPA mice but also applies for CSB mice and not to 
XPC mice. This implies that UV-B-induced local immunosuppression is influenced by TCR and 
not GGR, while systemic immunosuppression is only affected by a complete NER defect. 
Moreover, this research demonstrated that together with an increased local 
immunosuppression, Langerhans cell depletion was also enhanced in TCR-deficient mice 
(XPA and CSB) but not in GGR-deficient mice (XPC) in comparison with the respective 
wildtype littermates. This is in agreement with data from Jimbo et al (1992), who demonstrated 
that UV-induced Langerhans cell depletion was enhanced and Langerhans cell recovery was 
delayed in XPA patients compared to healthy controls. Boonstra et al (2001) showed that TNF-
α production was augmented in the draining lymph nodes of the UV-exposed skin of XPA and 
CSB but not XPC mice. TNF-α is involved in the induction of Langerhans cell migration from 
the skin to the draining lymph nodes (Cumberbatch et al, 1997; Cumberbatch et al, 1999). This 
suggests that the enhanced Langerhans cell depletion, induced by a defect in TCR, is the 
result of an increased expression of TNF-α. This needs to be confirmed further by 
determination of TNF-α expression in the skin where Langerhans cells reside and which is the 
site of UV-exposure. 
Dendritic cells with UV-specific DNA damage could be observed in variable numbers in the 
skin draining lymph nodes of UV-exposed XPA, CSB and XPC mice. The presence of dendritic 
cells with CPDs in the lymph nodes indicated that the observed Langerhans cell depletion in 
the skin is at least in part caused by migration. Other investigators showed that UV-induced 
Langerhans cell depletion in mice in vivo could be caused by migration (Sontag et al, 1995). It 
was found that UV-irradiated murine Langerhans cells show delayed apoptosis in vitro (Tang 
and Udey, 1992), but in vivo hardly any apoptotic Langerhans cells were found in the 
epidermis among the UV-induced apoptotic ‘sunburn cells’ (Okamoto et al, 1999). Van Oosten 
 124
 
Langerhans cell depletion and local immunosuppression in NER-deficient mice 
et al (2000) reported that apoptosis was increased in the UV-B-exposed skin of XPA and CSB 
but not XPC mice. An enhanced apoptosis could not only affect keratinocytes but also 
Langerhans cells. The experiments by Okamoto et al (1999), which showed a lack of 
Langerhans cells among the UV-induced apoptotic epidermal cells and the observed presence 
of UV-damaged Langerhans cells in the draining lymph nodes of NER-deficient mice indicate 
that UV-induced Langerhans cell depletion in the various mouse strains is most likely mainly 
caused by migration. This is in line with the results of a recent study from our group on healthy 
human volunteers (Kölgen et al, 2002). However, it cannot be excluded that the enhanced 
Langerhans cell depletion in XPA and CSB mice is (in part) caused by apoptosis. 
The present data together with experimental data from other researchers can give more insight 
into the pathogenesis of XP en CS and the influence of the different NER mechanisms on the 
skin immune system. In summary, TCR plays a crucial role in sunburn-sensitivity (Berg et al, 
1998; Garssen et al, 2000), UV-B-induced Langerhans cell depletion, production of TNF-α in 
the lymph nodes, UV-B-induced local immunosuppression and UV-B-induced apoptosis. In 
contrast both TCR and GGR play a significant role in systemic immunosuppression and 
inhibition of IFN-γ production by lymph node cells (Boonstra et al, 2001). These findings 
indicate that local and systemic immunosuppression have a different origin. Since XPA and 
XPC patients are very cancer-prone in contrast to CS patients, GGR seems to be involved in 
cancer-susceptibility, particularly in man. 
One should be careful in extrapolation of these observations from mice to man. One of the 
differences between mice and man is the repair of CPDs. The only CPDs that are removed are 
eliminated by TCR in mice, while being ‘overlooked’ by GGR. This difference in CPD repair 
between mice and man is predominantly caused by difference in the expression of p48 in the 
skin. As a consequence CPDs are hardly removed from the non-transcribed strand in mice 
(Ruven et al, 1993; Tan and Chu, 2002; Tang et al, 2000). However, this does not seem to 
have any consequences for UV-survival since this survival is equal for wildtype mice and 
human fibroblasts (for review see Hanawalt (2001)). 
Taken together, this work demonstrates that DNA damage is critical for depletion of epidermal 
Langerhans cells and local immunosuppression. In particular, the minor fraction of UV-induced 
lesions in the transcribed strand of active genes appears to be the culprit class of lesions, 
whereas the bulk of DNA injury in the remainder of the genome is of minor importance. 
Transcription-coupled repair, the DNA repair process that enables recovery of gene expression 
after DNA damage, is found to be crucial in order to prevent UV-induced depletion of 
epidermal Langerhans cells and local immunosuppression. Thus, restoration of gene 
expression is an important prerequisite for preventing this type of immunomodulation. 
Furthermore, evidence was given for a relationship between UV-B-induced Langerhans cell 
depletion and local but not systemic immunosuppression. Future studies should investigate in 
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more detail the impact of the different NER pathways on cytokine production in the skin in vivo 
and the possible correlation with Langerhans cell migration, immunosuppression, sunburn-
sensitivity and susceptibility to skin cancer. 
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The aim of our study was to unravel the pathogenesis of PLE by investigating the supposition 
that PLE is caused by an impairment in UV-B-induced immunosuppression. This hypothesis 
runs as a continuous thread through this thesis. The results obtained show that a defect in 
certain UV-induced cellular responses in the skin, i.e. an impaired Langerhans cell migration 
and a lack of influx of neutrophils into the epidermis of the uninvolved skin of PLE patients. Our 
data provide evidence for a disturbance of the relationship between erythema and 
immunosuppression in PLE. In this chapter the data described in the previous sections will be 
integrated and discussed in an overall synthesis of a model of the early pathogenic steps in 
PLE. 
 
 
EFFECT OF UV-B RADIATION ON CD11b+ CELLS 
 
Cooper and co-workers (Hammerberg et al, 1996b; Kang et al, 1994; Meunier et al, 1995) 
concluded from their experiments that interleukin (IL)-10 producing CD11b+ macrophage-like 
cells were involved in UV-B-induced immunosuppression. Treatment with anti-CD11b 
antibodies resulted in a reversion of this immunosuppression (Hammerberg et al, 1996a). 
Therefore we hypothesized that these cells were absent or non-functional in PLE patients. 
Initially we tested several UV exposure regimens on healthy individuals to reproduce the data 
found by Cooper and co-workers. Their observation of a nearly complete depletion of 
Langerhans cells and an influx of CD11b+ cells into the epidermis after exposure of the skin to 
4 MED (Minimal Erythema Dose) UV-B, was used as a guideline. At first, dorsal skin of healthy 
volunteers was exposed to 4 MED (Philips TL12 lamps). However, the skin area and the UV 
dose gave variable results on Langerhans cell depletion and influx of CD11b+ cells. A UV dose 
of 6 MED on buttock skin instead of dorsal skin gave more consistent results, comparable to 
that reported by the other investigators (chapter 2). Cooper and co-workers defined the MED 
as the UV dose causing a clear erythema with defined borders, while we defined the MED as 
the UV dose causing a just perceptible redness of the skin. Barr et al (1999) calculated that a 
dose of 4 MED according to Cooper and co-workers was comparable to 5.6 MED, according to 
our definition. 
Consecutively, buttock skin of PLE patients (with normal and extreme sunburn-sensitivity) and 
healthy individuals was exposed to 6 MED. CD11b+ cells were observed in the unexposed and 
UV-exposed skin of healthy individuals as well as PLE patients. The number of CD11b+ cells 
was even larger in PLE patients with an extreme sunburn sensitivity (low MED). However, 
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hardly any CD11b+ cells infiltrated the UV-exposed epidermis of PLE patients compared to 
healthy controls. Judging by the large number of CD11b+ cells in the dermis of PLE patients, 
the hypothesis that a mere lack of these cells would cause the suspected failure in 
immunosuppression in these patients proved wrong. However, the lack of these cells migrating 
into the epidermis was highly significant. The CD11b+ population in the skin of PLE patients 
consisted predominantly of macrophages (CD68+) (chapter 2). In healthy individuals the 
dermal and epidermal CD11b+ cells in the UV-exposed skin were primarily neutrophils 
(elastase+) (in agreement with Strickland et al (1997) and Teunissen et al (2002)). 
The question remained whether the macrophages in the UV-exposed skin of PLE patients 
were functional in producing the immunosuppressive cytokine IL-10. A small number of dermal 
neutrophils and CD36+ macrophages in the skin of healthy individuals and PLE patients 
expressed the immunosuppressive cytokine IL-10 in their cytoplasm (as detected by 
immunohistochemistry on microscopic sections). In contrast, infiltrating neutrophils in the 
epidermis of healthy controls expressed IL-10. Although the CD11b+ population in PLE 
patients is distinct from healthy controls, the difference in IL-10 expression is restricted to 
infiltrating (epidermal) neutrophils. This suggests that a lack of IL-10-expressing epidermal 
neutrophils is an aberrant UV response that contributes to the pathogenesis of PLE (chapter 
5). 
 
UV-B-INDUCED DEPLETION OF LANGERHANS CELLS 
 
An immunohistochemical staining for Langerhans cells (CD1a) was performed on skin biopsies 
from (un)exposed buttock skin to check the reproducibility of our irradiation protocol and to 
compare it with the protocol used by Cooper and co-workers. Unexpectedly, we noticed a 
striking difference in the UV-induced depletion of Langerhans cells between PLE patients and 
healthy controls. Whereas the Langerhans cell depletion was nearly complete after 6 MED UV-
B in healthy individuals, a considerable number of epidermal Langerhans cells was still present 
in the skin of PLE patients. Initially, we referred to these cells as ‘UV-resistant’. However, when 
PLE patients were exposed to an even larger UV dose (8.4 MED) a greater number of 
Langerhans cells disappeared from the epidermis. This indicated that these cells were not UV-
resistant but relatively less sensitive to UV-B radiation with regard to their migratory response 
(chapter 2 and 5). 
The MED of PLE patients with a normal MED was in the lower 50 percentile of the MED range 
of healthy controls. Therefore one might assume that the impaired Langerhans cell depletion in 
PLE patients is mainly caused by an on average lower UV dose. However, no correlation could 
be found between the decrease in Langerhans cell number and the absolute UV exposure. 
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Furthermore, a PLE patient receiving the same absolute UV dose as a healthy control still had 
a considerably smaller decrease in the number of epidermal Langerhans cells. 
The next step was to establish the mechanism underlying the impaired Langerhans cell 
depletion. To this end we first determined what mechanism was involved in UV-induced 
Langerhans cell disappearance in healthy individuals. The best studied and most likely 
mechanisms involved in this depletion were apoptosis and migration. Apoptosis was 
determined by using the TUNEL assay (identifying late apoptosis by labeling of DNA strand 
breaks) and by staining of active-caspase 3, a protease involved in the apoptotic cascade. A 
substantial number of apoptotic cells was detected in the UV-exposed skin of healthy 
volunteers, however no apoptotic Langerhans cells could be found. Migration of Langerhans 
cells was confirmed using a newly developed method to trap migrating Langerhans cells in the  
fluid of a blister raised on the UV-exposed skin (chapter 3). Migrating Langerhans cells could 
also be detected in the blister fluid of the UV-exposed skin of PLE patients, although the 
number of cells was significantly smaller than in healthy controls (chapter 4). PLE patients do 
have apoptotic cells in their UV-exposed skin but again no apoptotic Langerhans cells could be 
observed (data not shown). The number of apoptotic cells, predominantly keratinocytes 
(sunburn cells), in the UV-exposed skin of PLE patients is variable but less than in healthy 
controls. It seems, though, that the number of apoptotic cells is related to the UV-dose. 
However, this has to be confirmed in a follow-up study. In conclusion, the impaired UV-B-
induced Langerhans cell depletion in PLE patients is completely attributable to an impairment 
in migration. 
Cytokines such as IL-1-α and IL-1-β, tumour necrosis factor (TNF)-α and also IL-18 have been 
described to be involved in Langerhans cell migration (Cumberbatch et al, 1997a; 
Cumberbatch et al, 1997b; Cumberbatch et al, 2001). For that reason we investigated the 
expression of these cytokines in (un)exposed skin of PLE patients and healthy controls 
(chapter 5). The number of cells expressing IL-1-β and TNF-α was less in the UV-exposed 
skin of PLE patients compared to healthy controls. In contrast to healthy individuals, PLE 
patients had no TNF-α-expressing neutrophils in their UV-exposed epidermis. The impaired 
Langerhans cell migration in PLE patients appears, therefore, to be related to a diminished 
expression of the migration-inducing cytokines IL-1-β and TNF-α. 
 
LANGERHANS CELL MIGRATION AND IMMUNOSUPPRESSION 
 
How can a deficiency in Langerhans cell migration be linked to an impairment in 
immunosuppression? Although UV-induced Langerhans cell migration has been found to be 
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associated with immunosuppression, it had not been proven that this constitutes a causal 
relationship. 
In experiments with mice deficient in nucleotide excision repair (NER) we demonstrated that a 
defect in transcription-coupled repair (TCR) resulted in an enhanced local, but not systemic 
immunosuppression as well as in an enhanced UV-induced Langerhans cell depletion 
(chapter 6). These observations are indicative of a relationship between UV-B-induced 
Langerhans cell depletion and local immunosuppression. Hence, our finding of an impairment 
in UV-induced Langerhans cell migration in PLE patients would suggest an impaired local 
immunosuppression, as confirmed by a recent study (van de Pas et al, in press (Journal of 
Investigative Dermatology)). 
 
MED AND IMMUNOSUPPRESSION 
 
A relationship between MED and immunosuppression was confirmed in humans by Kelly et al 
(2000), who showed that a sensitivity to sunburn is associated with a susceptibility to UV-
induced local suppression of contact hypersensitivity (CHS). A lower MED correlated with an 
increased susceptibility to UV-induced immunosuppression. This correlation between 
erythema and immunosuppression appears to be disturbed in PLE patients. As mentioned 
before, the MED of most PLE patients is in the lower range of the MED of healthy individuals. 
Furthermore, the immune responses in the UV-exposed skin of PLE patients e.g. 
immunosuppression, Langerhans cells migration and the expression of migration-inducing as 
well as Th2-skewing cytokines (epidermal IL-4 and IL-10 expression), are reduced compared 
to healthy individuals. In addition, irradiation of the skin of PLE patients with 8.4 MED instead 
of 6 MED increased Langerhans cell depletion and the expression of IL-1-β, TNF-α and IL-4 
(chapter 5). Taken together, these observations suggest that the erythema response in PLE is 
too strong in comparison to the immunosuppressive response. Thus, the relationship between 
UV-B-induced erythema and immunosuppression is disturbed in PLE. Another indication for a 
disturbed relationship is given by the observation that supplementation of dietary fish oil or 
phototherapy given to PLE patients to prevent a pathological skin reaction to UV exposure, 
results in a decreased UV-erythemal sensitivity (increase of the MED) (Boonstra et al, 2000; 
Rhodes et al, 1994; Rhodes et al, 1995). Apparently, an elevation of the threshold for the 
erythema response normalizes the balance with respect to the immunosuppressive response. 
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DNA DAMAGE AND LANGERHANS CELL MIGRATION 
 
We demonstrated that only a minority of migrating Langerhans cells in the blister fluid of the 
UV-B-exposed skin had UV-specific DNA damage (chapter 3 and 4). The predominance of 
Langerhans cells without detectable DNA damage could not be explained by an artifact of the 
suction blister technique or by an influx of new dendritic cells from the bloodstream or hair 
follicles, because these cells were not found in blister fluid of the unirradiated skin. Moreover, 
we observed an enrichment of UV-damaged Langerhans cells in the blister roofs of the UV-B 
exposed skin. Hence, it appeared that undamaged or DNA-repaired Langerhans cells 
exhibited a selective responsiveness to migratoin signals. Repair of UV-B-induced DNA 
damage, e.g. cyclobutane pyrimidine dimers (CPDs), could then be a prerequisite for 
Langerhans cell migration. To investigate the relationship between DNA repair and 
Langerhans cell migration more closely we exposed transgenic mice with defects in nucleotide 
excision repair (NER) to different doses of UV-B radiation and studied the epidermal depletion 
of NLDC145+ Langerhans cells (chapter 6). CSB mice deficient in transcription-coupled repair 
(TCR) and XPA mice deficient in TCR and global genome repair (GGR) showed an enhanced 
UV-induced depletion of Langerhans cells compared to GGR-deficient XPC mice and the 
respective wildtype (wt) littermates. Correspondingly, the CSB and the XPA mice proved to be 
much more sensitive to the induction of local immunosuppression by UV exposure than the 
XPC and wt mice. The sunburn sensitivity of XPA and CSB is also much higher than XPC and 
wt mice. At very low UV doses, where XPC and wt show no detectable reaction at all, the CSB 
and XPA mice already show Langerhans cell migration and local immunosuppression. This 
suggests that the persistence of a low level of damage in active genes triggers migratory 
signals (presumably from keratinocytes) to which the Langerhans cells react. The low level of 
DNA damage in the Langerhans cells does apparently not obstruct their migration. The fact 
that Langerhans cells react even at higher UV doses in XPC mice, indicates that a persistence 
of higher levels of DNA damage in non-transcribed strands does not hinder migration either. 
This indicates that, at least in mice, DNA repair does not seem to be a prerequisite for UV-
induced Langerhans cell depletion. However, a persistence of a high level of DNA damage in 
transcribed strands could perhaps hinder the migration of Langerhans cells, but a suitable 
model to test this in transgenic mice is not available. 
 
LANGERHANS CELL ACTIVATION AND MATURATION 
 
Langerhans cells persisting in the epidermis of PLE patients after UV-B exposure might 
present antigen there instead of in the lymph nodes. This antigen presentation at an aberrant 
location might contribute to the pathogenesis of PLE. In order to present antigen efficiently 
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Langerhans cells need to upregulate their expression of costimulatory molecules as well as the 
number of antigen-HLA-DR complexes on their membrane. Furthermore, responding cells, e.g. 
T-cells, need to be present to carry out a specific immune response. No epidermal Langerhans 
cells in the UV-exposed skin of PLE patients expressed costimulatory molecules (chapter 4). 
However, the number of epidermal HLA-DR+ Langerhans cell was increased after UV 
exposure. Additionally, hardly any CD3+ T-cells could be detected in the epidermis of the UV-
exposed skin of PLE patients. Taken together, these data demonstrate that antigen 
presentation in the epidermis of the UV-B-exposed skin of PLE patients most likely does not 
occur. 
Langerhans cells expressing costimulatory molecules and HLA-DR as well as T-cells could be 
observed in the dermis of the UV-exposed skin of PLE patients and healthy individuals. The 
absolute number of activated and matured (CD83+) dermal Langerhans cells was substantially 
larger in PLE patients compared to healthy controls. Illicit antigen presentation could therefore 
occur in the dermis, with a greater likelihood in PLE patients. 
 
SKEWING TOWARDS A TH1 OR TH2 RESPONSE 
 
Cytokines are important in determining the outcome of an immune response, e.g. a type 1 
(Th1) or a type 2 (Th2) response, and most likely as a result, influence the induction of PLE. In 
healthy individuals UV-B radiation provokes the development of Th2 cells while suppressing 
Th1 cells (Simon et al, 1990; Simon et al, 1991). A first immunohistochemical exploration of 
the cytokine profiles in the skin of PLE patients revealed that the Th2-skewing cytokine IL-4 
was  expressed in fewer cells in the UV-exposed epidermis of PLE patients when compared to 
healthy controls (chapter 5). The number of cells expressing Th1-skewing cytokines IL-12, 
interferon (IFN)-γ and IL-6 did not differ between PLE patients and healthy individuals. Overall, 
the cytokine profile in the UV-exposed skin of PLE patients appeared to be shifted more 
towards Th1 in comparison to healthy individuals. 
 
FUNCTIONAL TESTING 
 
An impairment in immunosuppression can be tested functionally by immunization or challenge 
with a contact allergen on an irradiated site (local immunosuppression) or on an unirradiated 
site after irradiation of another skin area (systemic immunosuppression). The severity of the 
contact hypersensitivity reaction (CHS) in terms of erythema, edema and the appearance of 
papules or vesicles can be used as a measure for immune reactivity. Antigens, not yet 
encountered by the immune system (causing immunization), as well as recall antigens 
 136
 
General discussion 
(causing a challenge reaction) can be used as contact allergens. Application of immunizing 
contact allergens like DNCB or DCP not only encountered ethical objections but also carried 
the risk of sometimes provoking severe, traumatic skin reactions. Therefore, we used different 
concentrations (0.5% and 2%) of the recall antigen nickelsulphate (NiSO4) in petrolatum, which 
is also used in the clinic (at a concentration of 5%) for assessment of CHS. Before testing 
(nickel allergic) PLE patients we first wanted to establish a consistent standardized reaction in 
healthy individuals who had a positive skin reaction to nickel. In accordance with the UV 
exposure protocol in this project we exposed buttock skin of seven healthy individuals to 6 
MED UV-B (Philips TL12 lamps) and applied different concentrations of nickelsulphate to the 
UV-B-exposed and unexposed skin 48 hours post irradiation. Following the classical CHS 
protocol the allergen remained on the skin for 48h and the reaction was measured 24h after 
removal of the allergen. Assessment of CHS was done by eye and with a chromameter. We 
did not observe a consistent reaction in healthy individuals (n = 7). CHS reactions of the UV-
exposed skin fluctuated from an immunosuppressive reaction to an induction of immune 
reactivity compared to the unexposed skin. 
The increased skin reaction to NiSO4 after UV exposure was not anticipated as UV radiation is 
known to suppress delayed type (type IV) hypersensitivity reactions like these (Damian et al, 
1999). However, not only a type IV hypersensitivity reaction has been described for nickel but 
also a type I IgE-mediated hypersensitivity reaction (Estlander et al, 1993). An additional 
assessment of the skin reaction at 2h after application of the contact allergen might therefore 
have given a more reliable definition of the reaction in some individuals. Another parameter 
that had not been taken into account was the menstrual cycle of the participants (all were 
female). The menstrual cycle might be of influence on skin reactivity (Agner et al, 1991; Agner, 
1992). Damian et al (1999) were able to suppress a CHS on nickelsulphate with UV radiation. 
However, they used a different UV exposure regimen and applied the antigen immediately 
after UV exposure. 
The inconsistent and sometimes unpleasant reactions made us decide to discontinue these 
experiments. In the meantime van de Pas et al (in press (Journal of Investigative 
Dermatology)) were performing experiments in the United Kingdom on the suppression of 
immunization against DNCB. PLE patients and healthy volunteers were exposed to solar-
simulating radiation prior to application of DNCB onto the buttock skin. They showed that UV-
induced local immunosuppression was impaired in PLE patients compared to healthy 
individuals after exposure to 0.6 MED and 1 MED, but not after exposure to 2 MED. 
These results imply that there is a dose range in PLE patients over which the 
immunosuppression is lacking in comparison to the inflammatory (erythemal) response. 
Although these experiments have not measured the allergic response to UV radiation itself, 
one could envisage that there is a corresponding "UV dose-window" over which the PLE 
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patients can develop an allergic reaction to UV exposure. It could then be speculated that the 
allergic response would not develop if the UV exposure were high enough, resulting in a 
severe sunburn instead. 
Although the efflux of Langerhans cells and influx of neutrophils we observed at 6 MED in the 
PLE patients were low in comparison to the healthy volunteers, they may have been strong 
enough to attain to an adequate immunosuppression, as measured by van de Pas et al (in 
press (Journal of Investigative Dermatology)). 
 
EARLY EVENTS IN THE PATHOGENESIS OF PLE 
 
A model of the pathogenesis of PLE based on the aberrant responses in the skin to UV-B 
radiation, as described in this thesis, is presented in Figure 1. In this figure the effect of UV-B 
radiation on the skin of PLE patients is therefore compared to that in healthy controls. 
Epidermis 
Dermis 
 
PLEHEALTHY
 
= costimulatory molecules
= Langerhans cell
= HLA-DR
= IL-1-β + cell
= CD11b+ CD68+ macrophage
= IL-10+ CD36+ macrophage
= T-cell= IL-10+ neutrophil
= IL-4+ neutrophil
= TNF-α+ neutrophil
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Figure 1, Model of the early steps in the pathogenesis of PLE. After UV exposure [ ] Langerhans 
cells [ ] still persist in the skin of PLE patients (right panel) in contrast to healthy individuals (left 
panel). Fewer dermal cells expressing IL-1-β [ ] together with a decreased number of TNF-α-
expressing neutrophils [ ] in the dermis and an absence of TNF-α-expressing cells in the epidermis 
(above the curved line) lie at the root of this impaired Langerhans cell migration in PLE patients. This 
deficient Langerhans cell migration correlates with an impairment in UV-induced local 
immunosuppression in PLE patients. Langerhans cells in the epidermis of PLE patients do not express 
the activation markers CD86, CD40, CD54 or the maturation marker CD83 but these cells do express 
HLA-DR [ ] after UV exposure. Dermal Langerhans cells express costimulatory molecules [ ] as well 
as HLA-DR and are therefore capable of presenting (neo-)antigens to dermal T-cells [ ], thus 
activating these T-cells. Activated dermal Langerhans cells are present in larger numbers in PLE 
patients compared to healthy individuals. A decreased number of IL-4-expressing neutrophils [ ] 
(without a difference in the expression of Th1-skewing and pro-inflammatory cytokines) skews the 
balance to a type 1 T-cell response in PLE patients. The CD11b+ cell population in PLE patients 
consists predominantly of macrophages [ ], while in healthy individuals this population is dominated 
by neutrophils. The immunosuppressive cytokine IL-10 is expressed by infiltrating neutrophils [ ] and 
by a minority of the macrophages [ ]. The difference in IL-10 expression between PLE patients and 
healthy individuals is restricted to infiltrating neutrophils. Taken together, it appears that the normal, 
healthy immunosuppressive response to UV radiation is reduced in PLE patients while the erythemal 
response is increased (possibly by an increased expression of prostaglandin E2). This shift in immune 
responses together with the possibility of an activation of Th1 cells (instead of Th2 cells) in the dermis by 
slowly migrating Langerhans cells may underlie the pathogenesis of PLE. 
 
PLE DEMARCATION FROM OTHER PHOTODERMATOSES 
 
In our first study on the pathogenesis of PLE we included PLE patients with a normal MED as 
well as a low MED. Later on we focussed on PLE patients with a normal MED because there 
are no healthy individuals with a low MED who can be included as proper controls for PLE 
patients with a low MED. At first, we defined a pathological skin reaction in PLE patients 
clinically as papules, vesicles and eczema on sun-exposed areas of the skin. It appeared that 
an eczematous reaction to UV radiation in the PLE patients we included, was restricted to PLE 
patients with a low MED. Furthermore, a skin reaction to UV radiation in patients with 
photosensitive eczema at an early stage often resembles a PLE reaction with papules and 
vesicles which later develops into an eczematous lesion. To circumvent possible confounding 
from eczematous reactions we restricted the definition of PLE to papules and vesicles, 
excluding any history of (non-)photosensitive eczema. All PLE patients with a normal MED that 
were included fitted this definition. 
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These issues on MED and eczematous reactions highlight controversies on the definition of 
PLE. PLE may well be a diagnosis that entails different forms of photodermatoses. Some 
structure might be created by a division according to susceptibility to sunburn, sensitivity to 
different wavelengths, type of reaction (papules and vesicles versus eczematous), extent of 
the disease (seasonally dependent or not) and maybe even gender. Thus, one could construct 
the diagram in figure 2 to delineate the relationships between various forms of 
photodermatoses. The proposed demarcations and relationships between the separate 
photodermatoses are still very much open to debate, and need to be substantiated by well 
targeted future research. 
AP LE
Eczema
Eczema
MED
Gender
CPLEPLEJSE
chronicsevere
ARCAD(A)D PE
severesunlight chronic
 
 
Figure 2, A hypothetical diagnostic diagram (constructed by Soe Janssens, Frank de Gruijl  and Wendy 
Kölgen). This diagram consists of two main branches. The first branch represents a sunlight-induced 
pathological skin reaction dominated by  papules and vesicles. The course of the condition in this branch 
could start with juvenile spring eruption (JSE). In this diagnosis lesions are commonly restricted to the 
sun-exposed ears. If severity increases this disorder passes in adulthood into a PLE with a seasonal 
dependent (predominantly spring and summer) appearance of lesions on sun-exposed areas of the 
body. Skin disorders like actinic prurigo (AP) and lupus erythematodes (LE) need to be excluded from 
this diagnosis, although PLE has been reported to precede LE in some patients. When seasonal 
dependence is lost and skin lesions persist, this can be diagnosed as chronic PLE (CPLE). The other 
branch in the diagram is dominated by the appearance of eczematous lesions. A photo-provoked 
eczema could arise de novo or (atopic) dermatitis ((A)D) may evolve into a photosensitive eczema (PE) 
when the eczema is aggravated by sunlight. PE lesions often first appear as papules and vesicles and 
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( 
might therefore initially be (mis)diagnosed as PLE (  ). If these photosensitive eczematous lesions 
persist  a chronic actinic dermatitis (CAD) develops. An actinic reticuloid (AR), characterized by three 
diagnostic criteria (see introduction), will develop when CAD increases in severity. The major difference 
between PLE and PE ) is most likely the clinical appearance of lesions: PLE lesions are 
characterized by papules and vesicles while PE lesions are characterized by eczematous plaques. A 
distinction between CPLE and CAD (  ) may be characterized by a difference in type of lesions 
(papular and vesiculous versus eczematous resp.), a difference in MED (a normal MED versus an 
extremely low MED resp.) and possibly by a difference in gender (predominantly women >30 years 
versus predominantly men >50 years, resp.). 
 
Langerhans cell persistence in the UV-B-exposed skin does not seem to discriminate between 
different PLE subsets as all PLE patients and even a patient with sub-acute cutaneous lupus 
erythematoses display this persistence (chapter 2). Furthermore, Torres-Alvarez et al (1998) 
demonstrated that UV-resistant Langerhans cells were still present in the skin of patients with 
actinic prurigo after exposure to 20 MED from a UV-C/UV-B light source. An impairment in UV-
induced Langerhans cell depletion might, on the other hand, be used as a diagnostic criterion 
for photosensitivity of skin disorders because no persistence was observed in healthy 
volunteers and patients with (non-photosensitive) psoriasis. 
 
 
FUTURE RESEARCH 
 
Many investigations have been performed on immune parameters in lesional versus non-
lesional skin of PLE patients. However, the experiments presented in this thesis give 
information on the initial phase, not the lesional phase, of a UV-induced skin reaction in PLE 
patients. Knowledge of this early phase of the pathological skin reaction can give more insight 
into the pathogenesis of PLE as well as provide some potential tools for early preventive or 
therapeutic interventions. Therefore, it is important that investigations on the initial effect of UV 
on the skin of PLE patients are continued. To this end some suggestions will be made for 
future research. 
 
Besides the studied cytokines, chemokines and chemokine-receptors are important in the 
trafficking of Langerhans cells. Chemokines, like for instance MIP3-α and MIP3-β, are involved 
in the influx and efflux respectively of Langerhans cells from the skin. Immature dendritic cells 
respond to MIP3-α via chemokine-receptor CCR6. Mature dendritic cells, on the other hand, 
have lost responsiveness to MIP3-α but acquire a responsiveness to MIP3-β via upregulation 
of the chemokine-receptor CCR7 (Dieu-Nosjean et al, 1999). Thus, during migration and 
maturation Langerhans cells increase the expression of CCR7. In a pilot study we examined 
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the expression of CCR7 in the (un)exposed skin of PLE patients and healthy individuals. 
Curiously, as the Langerhans cells disappeared the expression of CCR7 in the epidermis 
increased and was at a maximum 48h post irradiation. No CCR7 expression was observed in 
the unexposed skin. The expression was slightly less in the UV-B-exposed skin of PLE 
patients (data not shown). These observations indicate that CCR7 in the UV-B-exposed skin is 
not expressed by Langerhans cells and most likely neither by lymphocytes, as hardly any 
epidermal T-cells could be detected in the UV-B-exposed skin. Which epidermal cells do 
express CCR7 after UV exposure needs to be determined. Future investigations on the 
expression of chemokines and chemokine-receptors could perhaps solve this problem and 
could give more information on the causes of an impaired Langerhans cell migration in PLE 
patients. 
The impairment in UV-B-induced Langerhans cell depletion may not be restricted to PLE 
patients but could be involved in other photosensitive skin disorders as well. An extensive 
evaluation of UV-induced Langerhans cell depletion in photosensitive skin disease (i.e. lupus 
erythematodes and photosenstive eczema) and non-photosensitive skin disorders (i.e. atopic 
dermatitis and psoriasis) could provide more information on similarities in the pathogenesis. In 
addition, this could demonstrate whether an impairment in UV-induced Langerhans cell 
depletion could be used as a diagnostic tool for photosensitivity. 
From this perspective it would be interesting to know whether this defect in UV-B-induced 
Langerhans cell depletion is also observed in PLE patients who only develop a pathological 
skin reaction to UV-A. If not, this would provide some evidence for a different pathogenesis in 
UV-A-induced PLE. 
It was shown that antigen presentation by Langerhans cells could not take place in the 
epidermis of the UV-exposed skin of PLE patients. However, an increased number of activated 
and matured dermal Langerhans cells was observed in the UV-B-exposed skin of PLE patients 
compared to healthy controls. It needs to be determined whether this is the result of an 
delayed reaction in PLE patients and whether this higher number of cells may also be found in 
healthy individuals earlier after UV exposure. A follow-up study identifying Th1 and Th2 cells 
by expression of specific chemokine-receptors (CCR5, CXCR3 and CCR3, CRTH2 
respectively) could give more information on the type of response (type 1 or 2) that evolves in 
the skin of PLE patients after UV exposure. Furthermore, the expression of activation markers 
on T-cells, e.g. CD25, should be evaluated to reveal whether these cells are indeed activated. 
Regulatory T-cells, which are recognized by the expression of CTLA-4 and the secretion of 
high levels of IL-10 and TGF-β and low levels of IFN-γ are probably involved in UV-induced 
immunosuppression (Schwarz et al, 2000). It would be interesting to investigate the presence 
of these regulatory T-cells in the skin of PLE patients in relation to the (impaired) 
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immunosuppression, as shown by van de Pas et al (in press (Journal of Investigative 
Dermatology)). 
In our experiments we looked at the cytokine expression in cytoplasm of cells in the skin in 
vivo. Measuring cytokine levels in a skin suspension by ELISA or in blister fluid of (un)exposed 
skin could give more quantitative data on the cytokine profile in the skin of PLE patients versus 
healthy controls. 
The induction of neo-antigens of unknown identity by UV radiation are probably responsible for 
immune reactivity in the skin. One could isolate T-cells from the skin and stimulate these cells 
with a suspension of UV-B-exposed skin (containing the putative neo-antigens). A comparison 
of T-cell proliferation, T-cell activation and cytokine production in T-cell clones of PLE patients 
and healthy controls could also give more information on the type of response. An ambitious 
follow-up study could focus on the identification of these neo-antigen(s) that are specifically 
responsible for the UV-induced immune reaction in PLE patients. 
Because we wanted to reproduce the data observed by Cooper and co-workers and because 
we could easily detect a difference between PLE patients and healthy controls we irradiated 
the skin with a single dose of 6 MED. However, when reproducing a pathological skin reaction 
by photoprovocation the skin is repeatedly exposed to UV-B doses of about 2 MED, depending 
on the size of the tested skin area (Boonstra et al, 2000). A follow-up study using a UV-B 
exposure regimen comparable to the photo-provocation protocol could give some more insight 
into the ultimate development of the pathological skin reaction in PLE. One should be aware 
though that these repeated exposures may give rise to a full-blown pathological reaction. In 
this case, skin biopsies will be taken from lesional skin which may make it hard to distinguish 
early events leading up to the pathological reaction from later non-specific inflammatory 
reactions. 
UV radiation, especially UV-A, can induce oxidative damage in the skin (Kielbassa et al, 1997). 
This oxidative damage is involved in the formation of erythema (Dreher and Maibach, 2001; 
Halliday et al, 1999). Future research on mediators involved in erythema, like nitric oxid and 
prostaglandin E2, could perhaps give an explanation for the moderately increased susceptibility 
to sunburn in most PLE patients. This could possibly clarify why the erythema response in PLE 
patients is enhanced compared to the immunosuppressive response and how this erythema 
response is dampened after e.g. phototherapy. 
Supplementation of dietary fish oil or phototherapy subdues the pathological skin reaction in 
PLE and increases the MED. It would be interesting to known whether UV-induced 
immunosuppression, as well as Langerhans cell migration and cytokine expression have also 
returned to a normal, healthy level after therapy. Knowledge of the immunologic effects of 
different therapies is of importance for refinement and increasing the effectiveness of 
therapies. 
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This thesis describes the first steps in unraveling of the pathogenesis of PLE. The present 
considerations on possible future research clearly delineate the complexity of the pathogenic 
mechanisms involved in PLE. Well-targeted experiments are likely to provide us with a good 
understanding of these mechanisms. Ultimately, such understanding may lead to highly 
specific and efficient therapies for PLE and other related photodermatoses. 
 
 
REFERENCES 
 
Agner T: Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients 
with hand eczema, atopic dermatitis and controls. Acta Derm Venereol Suppl (Stockh) 173:1-26, 1992 
Agner T, Damm P, and Skouby SO: Menstrual cycle and skin reactivity. J Am Acad Dermatol 24:566-570, 1991 
Barr RM, Walker SL, Tsang WL et al: Suppressed alloantigen presentation, increased TNF-α, IL-1, IL-1Ra, IL-10, 
and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 112:692-698, 1999 
Boonstra HE, van Weelden H, Toonstra J, and van Vloten WA: Polymorphous light eruption: A clinical, 
photobiologic, and follow-up study of 110 patients. J Am Acad Dermatol 42:199-207, 2000 
Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, and Kimber I: Interleukin (IL)-18 induces Langerhans 
cell migration by a tumour necrosis factor-α- and IL-1β-dependent mechanism. Immunology 102:323-330, 
2001 
Cumberbatch M, Dearman RJ, and Kimber I: Interleukin 1 beta and the stimulation of Langerhans cell migration: 
comparisons with tumour necrosis factor alpha. Arch Dermatol Res 289:277-284, 1997a 
Cumberbatch M, Dearman RJ, and Kimber I: Langerhans cells require signals from both tumour necrosis factor-
alpha and interleukin-1 beta for migration. Immunology 92:388-395, 1997b 
Damian DL, Barnetson RS, and Halliday GM: Low-dose UVA and UVB have different time courses for suppression 
of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 112:939-944, 1999 
Dieu-Nosjean MC, Vicari A, Lebecque S, and Caux C: Regulation of dendritic cell trafficking: a process that involves 
the participation of selective chemokines. J Leukoc Biol 66:252-262, 1999 
Dreher F and Maibach H: Protective effects of topical antioxidants in humans. Curr Probl Dermatol 29:157-164, 
2001 
Estlander T, Kanerva L, Tupasela O, Keskinen H, and Jolanki R: Immediate and delayed allergy to nickel with 
contact urticaria, rhinitis, asthma and contact dermatitis. Clin Exp Allergy 23:306-310, 1993 
Halliday GM, Russo PA, Yuen KS, and Robertson BO: Effect of inhibitors of oxygen radical and nitric oxide 
formation on UV radiation-induced erythema, immunosuppression and carcinogenesis. Redox Rep 4:316-
318, 1999 
Hammerberg C, Duraiswamy N, and Cooper KD: Reversal of immunosuppression inducible through ultraviolet- 
exposed skin by in vivo anti-CD11b treatment. J Immunol 157:5254-5261, 1996a 
Hammerberg C, Duraiswamy N, and Cooper KD: Temporal correlation between UV radiation locally-inducible 
tolerance and the sequential appearance of dermal, then epidermal, class II MHC+CD11b+ 
monocytic/macrophagic cells. J Invest Dermatol 107:755-763, 1996b 
 144
 
General discussion 
Kang K, Hammerberg C, Meunier L, and Cooper KD: CD11b+ macrophages that infiltrate human epidermis after in 
vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-
10 protein. J Immunol 153:5256-5264, 1994 
Kelly DA, Young AR, McGregor JM et al: Sensitivity to sunburn is associated with susceptibility to ultraviolet 
radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191:561-566, 2000 
Kielbassa C, Roza L, and Epe B: Wavelength dependence of oxidative DNA damage induced by UV and visible 
light. Carcinogenesis 18:811-816, 1997 
Meunier L, Bata Csorgo Z, and Cooper KD: In human dermis, ultraviolet radiation induces expansion of a CD36+ 
CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-
presenting cells are concomitantly depleted. J Invest Dermatol 105:782-788, 1995 
Rhodes LE, Durham BH, Fraser WD, and Friedmann PS: Dietary fish oil reduces basal and ultraviolet B-generated 
PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest 
Dermatol 105:532-535, 1995 
Rhodes LE, O'Farrell S, Jackson MJ, and Friedmann PS: Dietary fish-oil supplementation in humans reduces UVB-
erythemal sensitivity but increases epidermal lipid peroxidation. J Invest Dermatol 103:151-154, 1994 
Schwarz A, Beissert S, Grosse-Heitmeyer K et al: Evidence for functional relevance of CTLA-4 in ultraviolet-
radiation- induced tolerance.  J Immunol 165:1824-1831, 2000 
Simon JC, Cruz PD, Jr., Bergstresser PR, and Tigelaar RE: Low dose ultraviolet B-irradiated Langerhans cells 
preferentially activate CD4+ cells of the T helper 2 subset. J Immunol 145:2087-2091, 1990 
Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, and Cruz PD, Jr.: Ultraviolet B radiation converts 
Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal 
anergy in CD4+ T helper 1 cells. J Immunol 146:485-491, 1991 
Strickland I, Rhodes LE, Flanagan BF, and Friedmann PS: TNF-alpha and IL-8 are upregulated in the epidermis of 
normal human skin after UVB exposure: correlation with neutrophil accumulation and E- selectin 
expression.  J Invest Dermatol 108:763-768, 1997 
Teunissen MB, Piskin G, Nuzzo S et al: Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, 
which support the development of Th2 responses. J Immunol 168:3732-3739, 2002 
Torres-Alvarez B, Baranda L, Fuentes C et al: An immunohistochemical study of UV-induced skin lesions in actinic 
prurigo. Resistance of langerhans cells to UV light. Eur J Dermatol 8:24-28, 1998 
 
 145
  
 
 
 
Summary 
Summary 
 
 
Ultraviolet (UV) radiation, especially the short wavelengths in the UV-B (280-315 nm) range, 
has several effects on human health. UV radiation is involved in the formation of vitamin D and 
in pigmentation of the skin. UV radiation also has some adverse effects: it is involved in tumor 
initiation and growth and in worsening of infections. The latter two (undesirable) effects are 
predominantly caused by a UV-induced suppression of cellular immunity. This 
immunosuppression can, however, be regarded as a perfectly sound physiological reaction. It 
prevents the occurrence of a disruptive immune reaction against UV-modified organic 
molecules (neo-antigens; e.g. DNA, proteins) whenever the skin is exposed to UV-B radiation. 
An inadequate immunosuppression could therefore develop into a UV-triggered sun allergy 
e.g. polymorphous light eruption (PLE). 
PLE patients develop papules and/or vesicles on sun-exposed areas of the skin. Whether 
eczematous lesions belong to the diagnosis of PLE is still under debate.  Because of a delay  
(hours to days) between the actual exposure and the occurrence of PLE lesions, PLE is 
considered a delayed type (type IV) hypersensitivity reaction. PLE is independent of race, skin 
color or gender. However, women under the age of 50 years are more affected than men. 
PLE patients included in our experiments reacted pathologically to UV-B radiation (and often 
also to UV-A radiation), i.e. they developed papules and/or vesicles, but had a normal sunburn 
sensitivity (normal MED (minimal erythema dose)). In the experiments described in chapter 2 
we also included PLE patients with an extremely low MED and eczematous lesions. To study 
the initial reaction to UV radiation we exposed the skin of PLE patients to 6 MED UV-B and 
took skin biopsies from the (unaffected) UV-exposed skin 24h and 48h post irradiation and 
from unexposed skin as a control. The results from the experiments in PLE patients were 
compared to healthy controls who underwent the same regimen. In healthy individuals this 
regimen is known to cause a change in cell populations in the skin which is associated with 
UV-induced immunosuppression. 
To investigate our hypothesis that PLE is caused by a disturbance in UV-B-induced 
immunosuppression we first determined whether immunosuppressive CD11b+ cells were 
present in the UV-irradiated skin of PLE patients (chapter 2). CD11b+ cells were present in 
the UV-exposed skin of PLE patients, however, at the time we were not able to determine 
whether they indeed produced immunosuppressive interleukin (IL)-10. The CD11b+ cell 
population in the UV-exposed skin of PLE patients did not infiltrate the epidermis in contrast to 
the CD11b+ cells in healthy controls. Because CD11b is a broad-spectrum marker for myeloid 
cells we specified the cell population further by immunohistochemical staining with CD68 
(macrophages) and elastase (neutrophils). The CD11b+ cell population in the UV-exposed skin 
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of PLE patients consisted predominantly of macrophages while in healthy controls the majority 
of the CD11b+ cells were neutrophils.  
A more striking difference could be found in the behavior of the Langerhans cells. These cells 
disappeared from the skin of healthy individuals after UV-B exposure but persisted in the UV-
exposed epidermis of PLE patients.  
We first established in healthy controls whether apoptosis or migration of Langerhans cells 
was the main mechanism responsible for their disappearance (chapter 3). Although apoptotic 
(active caspase-3 or TUNEL positive) keratinocytes could be detected in the UV-exposed skin 
of healthy individuals, no apoptotic Langerhans cells could be found. To examine the migration 
of Langerhans cells we developed a novel method to trap migrating Langerhans cells in the 
blister fluid of suction blisters raised on the (un)exposed skin to an atmospheric pressure of 
 –200 mmHg using airtight cups. Migrating Langerhans cells with detectable levels of UV-
specific DNA damage (cyclobutane pyrimidine dimers (CPDs)) could be retrieved from the 
blister fluid of the UV-exposed and not the unexposed skin, showing that migration was the 
main mechanism responsible for UV-induced Langerhans cells depletion in healthy individuals. 
This novel method to detect migrating Langerhans cells in the blister fluid was subsequently 
used to determine whether UV-B-induced Langerhans cell migration was impaired in PLE 
patients (chapter 4). The isolated blister roofs confirmed that significantly less Langerhans 
cells disappeared from the skin of PLE patients in comparison with healthy individuals. Most 
importantly, significantly less migrating Langerhans cells could be detected in the blister fluid of 
the UV-exposed skin of PLE patients. This impaired Langerhans cell migration appeared to be 
attributable to a reduced number of IL-1-β and tumor necrosis factor (TNF)-α-producing cells in 
frozen sections from the UV-exposed skin of PLE patients in comparison with healthy controls 
(chapter 5). 
Only a minority (about 10-15%) of the migrating Langerhans cells in PLE patients and healthy 
volunteers had a detectable amount of CPDs, in contrast to 80-90% of the remaining 
Langerhans cells in the blister roofs. Therefore, we speculated that DNA repair was a 
prerequisite for UV-B-induced Langerhans cell migration. To investigate this hypothesis UV-
induced Langerhans cell depletion was studied in DNA repair-deficient mice with a defect in 
transcription-coupled repair (TCR) (CSB mice), global genome repair (GGR) (XPC mice) or in 
both TCR and GGR (XPA mice) (chapter 6).  Exquisitely UV sensitive mice with a defect in 
TCR (XPA and CSB) showed already a UV-induced Langerhans cell disappearance at a very 
low UV dose in contrast to their wildtype littermates.  In solely GGR-deficient mice (XPC) 
Langerhans cell disappearance appeared at a high UV dose comparable to their respective 
wildtype littermates. Together with a UV-induced Langerhans cell depletion, local 
immunosuppression could be observed at a low UV dose in TCR-deficient mice (XPA and 
CSB) and at a high UV-dose in solely GGR-deficient mice (XPC). TCR appeared to be 
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essential for a normal ‘wildtype’ response regarding Langerhans cell depletion and local 
immunosuppression. To summarize, these experiments showed that repair of UV-induced 
DNA damage is not a prerequisite for Langerhans cell disappearance in mice and that UV-
induced Langerhans cell depletion is associated with local (but not systemic) 
immunosuppression. The latter statement is in agreement with data from van de Pas et al. 
showing that PLE patients have an impaired immunosuppression after UV exposure together 
with our data on an impaired Langerhans cell migration in these patients. 
With regard to the persistent Langerhans cells in the UV-exposed skin of PLE patients the 
question rose whether these cells were activated, presenting antigen in the skin instead of the 
lymph nodes. Antigen presentation at an aberrant location might contribute to the 
pathogenesis of PLE. In contrast to what we expected, we could not find any activated (CD86, 
CD40, CD54) or matured (CD83) Langerhans cells in the UV-exposed epidermis of PLE 
patients (chapter 4). However, a significant higher number of activated Langerhans cells 
accumulated in the dermis of the UV-exposed skin of PLE patients in comparison with healthy 
controls. A simultaneous presence of activated, HLADR+ Langerhans cells together with 
(potentially type 1) T-cells in the dermis of PLE patients might lead to antigen presentation in 
the skin, thereby contributing to the pathogenesis of PLE. 
An exploration of the cytokine profiles in the UV-B exposed skin of PLE patients revealed that 
cells that expressed the Th2-skewing cytokine IL-4 were present in lesser numbers in the UV-
exposed skin of PLE patients in comparison with healthy individuals (chapter 5). This 
observation, together with an equal expression of the Th1-skewing and pro-inflammatory 
cytokines (IL-12 and interferon-γ) indicated a shift in the cytokine profile in the skin of PLE 
patients more towards a Th1 response in comparison with healthy individuals. Because both 
IL-4 and TNF-α were expressed by neutrophils, these cells appear to play a key role in the 
pathogenesis of PLE. 
Based on all data together, a hypothetical model can be constructed for the pathogenesis of 
PLE (chapter 7). A diminished expression of IL-1-β and TNF-α in the UV-exposed skin of PLE 
patient leads to an impaired Langerhans cell migration. This impaired and slow Langerhans 
cell migration results in an accumulation of activated Langerhans cells in the dermis. These 
Langerhans cells can activate dermal (potentially type 1) T-cells- if present. A reduced number 
of  IL-4 producing neutrophils without a difference in the expression of Th1-skewing cytokines 
leads to a shift towards a Th1 response in the skin of PLE patients. The normal, healthy 
immunosuppressive responses are reduced while the erythemal response is increased (slightly 
lower MED) in PLE patients. This shift in immune responses together with the possibility of an 
activation of Th1 cells in the dermis may underlie the pathogenesis of PLE.  
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In this thesis, the early events in the pathogenesis of PLE are described. Future research is 
necessary to further unravel the pathological mechanism underlying PLE and to develop highly 
specific and efficient therapies for this photodermatose. 
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Het spectrum van de zon kan opgesplitst worden in drie delen: het zichtbare licht, de infra-rode 
straling en aan de andere kant van het spectrum, bij golflengten van minder dan 400 nm, de 
ultraviolette straling. Het grootste gedeelte van de UV straling die het aardoppervlakte bereikt 
is UV-A straling (315-400 nm). Maar een klein gedeelte van de UV-B straling (280-315 nm) 
bereikt het aardoppervlakte, de rest wordt geabsorbeerd in de ozonlaag. Deze kleine 
hoeveelheid UV-B straling in het zonlicht heeft echter de meeste invloed op de huid.  
UV straling, met name UV-B straling, is zeer fotoreactief. Het kan fotochemische smog 
veroorzaken, maar kan ook plastic afbreken. Voorts kan UV straling geabsorbeerd worden 
door organische moleculen in de huid, zoals het genetisch materiaal (DNA) en eiwitten, en 
deze moleculen fotochemisch veranderen. Vanuit dit oogpunt bezien, kan men zich voorstellen 
dat UV straling een groot aantal verschillende effecten kan hebben op de huid. 
UV straling heeft een aantal positieve effecten op de huid: het is bijvoorbeeld betrokken bij de 
vorming van vitamine D (o.a. belangrijk voor de botopbouw) en bij de bruining van de huid 
(pigmentvorming). Aan de andere kant heeft UV straling een aantal schadelijke effecten: het is 
betrokken bij verbranding van de huid door de zon, het ontstaan en onverstoord doorgroeien 
van (huid)tumoren, huidveroudering en het verergeren van infecties. Een deel van deze 
schadelijke effecten, zoals de groei van tumoren en het verergeren van infecties, is toe te 
schrijven aan het feit dat UV straling het afweersysteem (immuunsysteem) onderdrukt. Een 
gedegen reactie van het immuunsyteem, dat betrokken is bij de afweer tegen geïnfecteerde of 
kwaadaardige cellen, is hierbij niet meer mogelijk.  
Vanuit dit laatste perspectief gezien, zou men kunnen concluderen dat deze onderdrukking 
van het immuunsysteem (immuunsuppressie) een slechte zaak is en voorkomen zou moeten 
worden. Elke gezonde persoon vertoont echter deze door UV straling veroorzaakte 
immuunsuppressie. Wanneer we er dan ook wat dieper over zouden nadenken, kunnen we 
beargumenteren dat we deze onderdrukking juist nodig hebben. Als deze onderdrukking 
namelijk niet plaatsvindt, zou dat betekenen dat iedere keer wanneer onze huid aan zonlicht 
blootgesteld wordt, een activatie van het immuunsysteem en dus een ontstekingsreactie zal 
plaatsvinden. 
Een verstoring van de UV-geïnduceerde onderdrukking van het immuunsysteem zou dus 
kunnen lijden tot een ontstekingsreactie zoals waarneembaar is bij mensen met zonneallergie 
oftewel chronische polymorfe lichtdermatose (CPLD). CPLD behoort tot de groep 
huidaandoeningen die we fotodermatosen noemen, omdat ze ontstaan en verergeren onder 
invloed van zonlicht. Ongeveer 10-20% van de van de bevolking in de gematigde klimaatzones 
heeft in meer of mindere mate last van zonneallergie. Deze CPLD patiënten krijgen jeukende 
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bultjes en blaasjes en soms eczeemachtige reacties op de zonbeschenen delen van hun huid. 
De huidreactie is meestal seizoensafhankelijk: de eerste reactie ontstaat vaak in de lente, 
neemt af gedurende de zomer en is meestal in de herfst en winter geheel afwezig. In zeer 
ernstige gevallen echter heeft de patiënt vaak het hele jaar door last van zijn aandoening en 
moet zijn/haar dag en nacht ritme omdraaien om een blootstelling aan zonlicht te vermijden. 
De huidreactie treedt op binnen enkele uren tot dagen na de eigenlijke blootstelling aan 
zonlicht en verdwijnt vaak na een dag tot enkele weken zonder littekenvorming.  Omdat de tijd 
tussen de eigenlijke blootstelling en het opkomen van de huidreactie vrij lang is (meerdere 
uren), wordt de reactie ook wel een vertraagd-type overgevoeligheidsreactie genoemd. In de 
meeste, minder ernstige gevallen is een eenmalige, kortdurende blootstelling aan zonlicht niet 
voldoende om de huidreactie op te wekken maar zijn daarvoor een aantal belichtingen nodig. 
CPLD is niet gerelateerd aan een bepaalde huidskleur of ras en kan in iedere levensfase 
ontstaan. De huidreactie komt meer voor bij (jonge) vrouwen dan bij mannen en meestal zijn 
UV-B straling en UV-A straling de veroorzakers van de reactie. 
Het meeste onderzoek op het gebied van CPLD is verricht naar de kenmerken van de 
huidaandoening op het moment dat de huidreactie aanwezig is. Er is echter nog maar weinig 
bekend over de fase die vooraf gaat aan het ontwikkelen van de huidreactie en die de 
eigenlijke aanleiding is tot het ontstaan van de symptomen. Het onderzoek beschreven in dit 
proefschrift richt zich nu juist op deze aanloopfase.  
In ons onderzoek hebben we gekeken naar de effecten van een eenmalige hoge dosis UV-B 
straling op de huid van CPLD patiënten en dat vergeleken met de reacties die optreden bij 
gezonde personen.  
De onderzoeksgroep van de Amerikaan Kevin Cooper heeft zich bezig gehouden met het 
effect van UV-B straling op de huid van gezonde personen. Daarbij hebben zij in het bijzonder 
gekeken naar bepaalde witte bloedcellen (CD11b+ cellen). Deze cellen komen in grote getale 
de huid in na een eenmalige hoge blootstelling aan UV-B straling. Ze spelen een belangrijke 
rol bij de onderdrukking van het immuunsysteem doordat ze interleukine 10 kunnen 
produceren, een stofje met een immuunsuppressieve werking. Gebruikmakend van deze 
kennis stelden wij de volgende hypothese op: immuunsuppressieve CD11b+ cellen zijn niet 
aanwezig in de huid van CPLD patiënten na blootstelling aan UV straling. CPLD patiënten 
werden daarom op een klein huidveldje blootgesteld aan een hoge dosis UV-B straling. Na 1 
dag en 2 dagen werd van de belichte huid en, ter controle, van de onbelichte huid onder lokale 
verdoving een klein stukje huid (biopsie) van 3 mm doorsnee afgenomen. Door middel van een 
biochemische kleurreactie hebben we kunnen aantonen dat deze CD11b+ cellen wel aanwezig 
zijn in de huid van CPLD patiënten, waarmee onze hypothese verworpen zou worden 
(hoofdstuk 2). Er waren echter duidelijke verschillen te zien in de huid van CPLD patiënten 
ten opzichte van gezonde controles: de CD11b+ cellen in de huid van CPLD patiënten 
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drongen niet door tot in de bovenste huidlaag (de opperhuid of epidermis) en het bleek ook om 
een ander type cellen te gaan (deze CD11b+ cellen waren voornamelijk macrofagen terwijl 
deze celpopulatie in gezonde personen voornamelijk uit neutrofielen bestond). 
Een ander, veel verrassender verschil konden we waarnemen bij de Langerhans cellen. Deze 
cellen zijn in staat om lichaamsvreemde stofjes (antigenen) op te nemen, te verteren en te 
presenteren op hun celoppervlakte. Deze cellen spelen een belangrijke rol in de activatie en 
suppressie van het immuunsysteem. De Langerhans cellen bevinden zich in de epidermis en 
verdwijnen bij gezonde personen na belichting van de huid met UV-B straling. In de huid van 
CPLD patiënten zagen we daarentegen, zelfs bij een belichting met een hoge UV dosis,  dat 
het merendeel van deze Langerhans cellen bleven zitten in de epidermis. Deze Langerhans 
cellen leken resistent te zijn voor UV-straling!  
In een volgende reeks van experimenten wilden we daarom uitzoeken waarom deze UV-
resistente Langerhans cellen niet verdwenen uit de huid van CPLD patiënten en of dat mede 
een oorzaak kon zijn voor het ontstaan van CPLD. Daartoe moesten we eerst achterhalen 
welk mechanisme een rol speelt bij het verdwijnen van de Langerhans cellen uit de huid van 
gezonde personen. Wanneer dat bekend is, kunnen we pas nagaan of dat mechanisme defect 
is bij CPLD patiënten. Daarom hebben we eerst in de UV-B-belichte huid van gezonde 
vrijwilligers gekeken. Twee mechanismen die ten grondslag zouden kunnen liggen aan de 
verdwijning van de Langerhans cellen zijn apoptose of migratie de huid uit (hoofdstuk 3). 
Wanneer een cel zoveel schade heeft dat hij die niet meer kan herstellen, zal hij een 
zelfmoordprogramma (apoptose) in werking zetten waardoor hij langzaam dood gaat en 
desintegreert zonder een ontstekingsreactie te veroorzaken. Apoptose is een 
beschermingsmechanisme waarbij het ontstaan van gemuteerde cellen, die later tot 
kankercellen kunnen uitgroeien, wordt voorkomen. Door middel van een biochemische 
kleurreactie in de afgenomen huidmonsters hebben we aangetoond dat de Langerhans cellen 
niet in apoptose gaan, maar veel van de omliggende opperhuidcellen (keratinocyten) wel.  
Het is moeilijk om een dynamisch proces als migratie aan te tonen in een biopsie die een 
statische momentopname laat zien. Daarom hebben we eerst een nieuwe methode ontwikkeld 
voor het meten van migratie. Door het trekken van een blaartje met behulp van onderdruk 
kunnen de epidermis en de onderste huidlaag (lederhuid of dermis) pijnloos van elkaar 
gescheiden worden. De holte die daardoor ontstaat, wordt gevuld met blaarvocht. De 
Langerhans cellen die zich in de epidermis bevinden ‘vallen’ als het ware, wanneer ze de huid 
uit migreren, in het blaarvocht. Wanneer we nu het blaarvocht met behulp van een klein 
naaldje uit de blaar halen, zouden we migrerende Langerhans cellen in dit blaarvocht moeten 
kunnen terugvinden. Dit bleek inderdaad ook het geval: in de UV-belichte huid, maar niet in de 
onbelichte huid, konden we migrerende Langerhans cellen terugvinden in het blaarvocht. Ter 
controle werd ook het blaardak (epidermis) van de blaar gehaald om aan te tonen dat de 
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Langerhans cellen inderdaad verdwenen waren. Het onderliggende mechanisme voor de 
verdwijning van Langerhans cellen bleek dus geen apoptose maar migratie te zijn. 
Met behulp van deze gegevens konden we nu nagaan of CPLD patiënten een defect hebben 
in de UV-geïnduceerde migratie van hun Langerhans cellen (hoofdstuk 4). Daartoe hebben 
we bij CPLD patiënten blaren getrokken op de belichte en onbelichte huid. Het bleek dat CPLD 
patiënten een sterk verminderde migratie hebben van hun Langerhans cellen. Een groot 
gedeelte van de cellen blijft gewoon zitten in de epidermis na UV-B belichting terwijl maar een 
heel klein gedeelte van de cellen terug te vinden is in het blaarvocht. 
Waardoor is deze Langerhans cel migratie nu verstoord in CPLD patiënten? Om dat te 
onderzoeken hebben we gekeken naar de aanwezigheid van allerlei wateroplosbare stofjes, 
cytokines, die migratie van deze Langerhans cellen kunnen induceren (hoofdstuk 5). De twee 
belangrijkste migratie-inducerende cytokines, die in gezonde personen geproduceerd worden 
na belichting van de huid met UV-B zijn interleukine (IL)-1-β en tumor necrosis factor-α (TNF-
α). Deze twee cytokines bleken door significant mindere cellen geproduceerd te worden in de 
belichte huid van CPLD patiënten. Deze verminderde productie vormt een plausibele 
verklaring voor de verminderde Langerhans cel migratie in CPLD patiënten. 
UV-B straling dringt niet dieper dan epidermis de huid in, waar het schade kan veroorzaken 
aan het DNA (thymidine dimeren). Migrerende Langerhans cellen uit de UV-B-belichte 
epidermis zijn dan ook herkenbaar aan hun UV-specifieke DNA schade. Het bleek echter dat 
maar 10-15% van alle migrerende Langerhans cellen UV-specifieke DNA schade had. 
Vermoedelijk wordt de schade eerst hersteld voordat de Langerhans cellen kunnen gaan 
migreren. Om dit te onderzoeken hebben we experimenten gedaan in (transgene) muizen die 
een defect hebben in het DNA herstelmechanisme waardoor ze niet of in beperkte mate de 
UV-geïnduceerde DNA schade kunnen herstellen (hoofdstuk 6). Deze muizen zijn zeer 
gevoelig voor UV-B straling en verbranden snel. Door deze muizen bloot te stellen aan lage 
doses UV-B straling konden we nagaan of een gebrek aan DNA herstel de migratie van de 
Langerhans cellen beïnvloedt. Het bleek echter dat deze muizen bij deze lage UV-B doses en 
geringe DNA schade al Langerhans cel migratie vertoonden. Herstel van het DNA is dus geen 
absolute voorwaarde voor Langerhans cel migratie in deze dieren. Met behulp van deze 
muizen konden we ook nagaan of er een verband bestond tussen de Langerhans cel migratie 
en de onderdrukking van het immuunsysteem. Met andere woorden, leidt een verminderde 
migratie tot een verminderde immuunsuppressie? De muizen die bij een lage dosis UV-B 
straling al Langerhans cel migratie vertoonden, lieten ook bij deze lage dosis al een 
onderdrukking van het immuunsysteem zien. Samenvattend kunnen we dus zeggen dat DNA 
herstel niet nodig is voor Langerhans cel migratie, in tegenstelling tot wat we vermoedden bij 
de mens, en dat Langerhans cel migratie gerelateerd is aan immuunsuppressie in de huid. Dit 
laatste lijkt ook het geval te zijn bij de mens want Chantalle van de Pas en anderen hebben 
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recent in Londen experimenteel aangetoond dat CPLD patiënten inderdaad, zoals wij 
vermoedden, na UV-B straling een verminderde onderdrukking hebben van het 
immuunsysteem en dat ze daarom waarschijnlijk ook, naar onze waarnemingen, minder 
migratie van Langerhans cellen uit de opperhuid vertonen. 
Terugkomend op de verstoorde Langerhans cel migratie in CPLD patiënten en het 
achterblijven van de Langerhans cellen in de epidermis kunnen we ons afvragen wat die 
achterblijvende Langerhans cellen in de epidermis doen. Kunnen ze daar het immuunsysteem 
activeren en zo de huidreactie veroorzaken? Om dit te onderzoeken hebben we gekeken naar 
de aanwezigheid van activatiemarkers op de Langerhans cellen (hoofdstuk 4). Wanneer de 
Langerhans cellen zowel hun ‘verteerde’ antigeen als deze activatie moleculen op hun 
celoppervlakte hebben, zijn ze in staat om cellen van het immuunsysteem, zoals de T-cellen, 
te activeren en hierdoor (eventueel) een ontstekingsreactie te veroorzaken. De Langerhans 
cellen die achterbleven in de epidermis van CPLD patiënten bleken, tegen onze verwachting 
in, niet geactiveerd te zijn (geen activatie moleculen op hun oppervlakte). Wat we wel konden 
waarnemen was een ophoping van geactiveerde Langerhans cellen in de onderste huidlaag 
(dermis). De gelijktijdige aanwezigheid in de dermis van geactiveerde Langerhans cellen 
samen met een bepaald type ontsteking-veroorzakende T-cellen zou mede verantwoordelijk 
kunnen zijn voor het ontstaan van CPLD. 
Diverse cytokines spelen een belangrijke rol bij het aansturen van het immuunsysteem. Zo 
bestaan er cytokines die een remmende werking op een vertraagde allergische reactie hebben 
(IL-10, IL-4) en cytokines die een stimulerende werking hebben (IL-12, interferon-γ). Deze 
cytokines kunnen op verschillende wijze worden beïnvloed door UV-B straling. De productie 
van remmende cytokines wordt verhoogd na belichting van de huid van gezonde personen 
terwijl de productie van stimulerende cytokines juist wordt verlaagd. Alles bij elkaar genomen 
leidt dit tot een onderdrukking van het immuunsysteem bij gezonde personen. In CPLD 
patiënten, bij wie de UV-geïnduceerde immuunsuppressie vermoedelijk verstoord is, is de 
balans tussen de productie van remmende en stimulerende cytokines hoogstwaarschijnlijk 
doorgeslagen richting stimulerende cytokines. Om deze hypothese te onderzoeken hebben we 
gekeken naar de productie van deze verschillende cytokines in de belichte huid van CPLD 
patiënten en die vergeleken met gezonde vrijwilligers (hoofdstuk 5). We konden bij de UV-
dosis die wij gebruikten voor de belichting geen verschil vinden in de productie van 
stimulerende cytokines in de huid van CPLD patiënten ten opzichte van gezonde vrijwilligers. 
Wel zagen we dat in de huid van CPLD patiënten, in vergelijking met gezonde personen, 
significant minder cellen aanwezig waren die IL-4 bevatten, een remmende cytokine. Deze 
kleinere hoeveelheid IL-4 draagt waarschijnlijk bij tot een verminderde onderdrukking van het 
immuunsysteem in CPLD patiënten. Deze verminderde productie van IL-4, maar ook van TNF-
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α, bleek vooral veroorzaakt te worden door een lager aantal cytokine-producerende 
neutrofielen in de huid van CPLD patiënten ten opzichte van gezonde personen. 
Wanneer we alle gegevens op een rijtje zetten kunnen we tot een hypothetisch model komen 
voor het ontstaan van CPLD (hoofdstuk 7). Doordat na UV-B belichting minder IL-1-β en TNF-
α wordt geproduceerd in de huid van CPLD patiënten migreren minder Langerhans cellen uit 
de epidermis. Door een verminderde en vertraagde Langerhans cel migratie hopen de 
Langerhans cellen zich op in de dermis. Deze Langerhans cellen, die geactiveerd zijn, kunnen 
daar hun antigenen presenteren aan specifieke T-cellen. Deze T-cellen kunnen vervolgens 
een ontstekingsreactie veroorzaken. Het lage aantal cellen dat het remmende cytokine IL-4 
produceert, speelt een belangrijke rol bij de verminderde onderdrukking van het 
immuunsysteem. Aangezien zowel TNF-α en IL-4 door (CD11b+) neutrofielen wordt 
geproduceerd, lijken deze cellen een prominente rol te spelen bij het ontstaan van CPLD.  
In dit proefschrift staan de eerste schreden beschreven op weg naar een opheldering van de 
mechanismen die ten grondslag liggen aan het ontstaan van CPLD.  Toekomstig onderzoek is 
nodig om het pathologisch mechanisme verder te ontrafelen en specifiekere en efficiëntere 
therapieën te ontwikkelen voor deze fotodermatose. 
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Hier ligt het dan. Mijn proefschrift. Vijf jaar werk verzamelt in een boekje. Mijn proefschrift zou niet 
compleet  zijn zonder dankwoord, want al die pagina’s heb ik niet alleen gevuld. Heel wat mensen 
hebben een steentje bijgedragen, een voetspoor achter gelaten. Al deze mensen zou ik willen bedanken 
voor hun bijdrage. 
Allereerst mijn copromotor en inspiratiebron, Frank de Gruijl. Frank, jij hebt me de weg gewezen in de 
wetenschap en me omgevormd tot de wetenschapper die ik nu ben en altijd heb willen zijn. Zonder jouw 
enthousiasme en hart voor het onderzoek had dit boekje er nu niet gelegen. Zelfs je onfortuinlijke 
verhuizing naar het LUMC heeft geen roet in het eten kunnen gooien, het heeft ons uiteindelijk alleen 
maar sterker gemaakt. Ik hoop dat ik voor anderen kan zijn wat jij voor mij bent geweest: een voorbeeld 
in de wetenschap. 
Prof. Van Vloten, Willem, mijn promotor. Van begin af aan heeft u mijn onderzoek in de gaten 
gehouden, maar ook buiten het onderzoek om heeft u altijd een oogje in het zeil gehouden. Een prettige 
gedachte. Ondanks uw minder goede gezondheid die helaas uiteindelijk leidde tot uw vertrek bij de 
afdeling, bent u iedere keer speciaal voor mij vanuit Wageningen naar Utrecht gereisd voor onze pow-
wows. Als uw laatste promovendus sluit niet alleen ik maar ook u een hoofdstuk af. Ik ben blij dat u mijn 
promotor hebt willen zijn. 
Verder wil ik, Edward Knol, mijn copromotor bedanken. Edward, bij jou kon ik altijd terecht voor 
immunologische vragen. Het is jammer dat het lichtonderzoek jou niet zo heeft kunnen raken, het is echt 
heel leuk!  
Prof. Carla Bruijnzeel-Koomen, mijn promotor, wil ik bedanken voor haar pittige bijdrage aan het 
onderzoek. Wat dat betreft, Carla, heb je een zware dobber aan me gehad, we zijn beiden erg 
eigenwijs. En je ziet, uiteindelijk kom ik toch nog bij 'T-cellen' uit. 
Voor aanlevering van patiënten was ik aangewezen op jou, Ina en op jou, Huib. Hoewel de aanvoer van 
nieuwe, geschikte patiënten af en toe erg mager was, hebben we het toch maar gered! Bedankt voor 
jullie hulp.  
Ilse en Kees, bedankt! Ilse, zonder jouw praktische hulp zou mijn boekje nog wel even op zich hebben 
laten wachten. Kees, meneer Binas, hoewel we niet al jouw inspirerende en innovatieve ideeën hebben 
kunnen uitvoeren, was het altijd zeer boeiend en motiverend om ze te bedenken. Ik zal ze 
missen…maar ik weet je te vinden! 
De (oude) lichtclub (pow-wowwers): Rob, Anne(marie), Heggert, Niek, Prof. Van de Leun, Marjan, Arne, 
Gerdine. Het was altijd heel gezellig samen! Marjan, ondanks je overgang naar een nieuwe baan heb je 
me nog op het laatst uit de brand kunnen helpen. Dank je wel! 
In het verlengde hiervan, Soe Janssens. We kennen elkaar nog niet zo heel lang, maar hopelijk is mijn 
proefschrift een inspiratiebron voor jouw onderzoek. Ik hoop dat we ook in de toekomst nog vaak 
contact zullen hebben. Succes! 
Alle studentes die hun steentje hebben bijgedragen aan de experimenten wil ik bij deze graag 
bedanken. Sarah, Mandy, Jet en Hilde (leuke foto’s!), bedankt! 
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Johan (Garssen), ondanks onze soms complexe communicatie en de geduld-op-de-proef-stellende 
kleuring van de muizenoortjes, hebben we het experiment toch tot een goed einde weten te brengen. 
Jon Laman en Marjan van Meurs, bedankt voor jullie gastvrijheid en hulp bij het opzetten van de 
cytokinekleuringen. 
Bert, Marjolein, Feiko en Ines, bedankt voor jullie hulp bij het afnemen van alle huidbiopten. 
Ook alle patiënten en vrijwilligers die deel hebben genomen aan de proefjes wil ik bij deze graag 
bedanken. Mijn boekje zou leeg zijn zonder jullie. 
Mijn kamergenoten door de jaren heen: Rob, Heggert, Lilian, Bert, Anoek, Annemarie, Arne, Gerdine, 
Ines, Rebecca, Feiko, Inge, Mayke en Chantal. Het is altijd een levendige, gezellige kamer geweest, 
waar buiten de boeiende wetenschappelijke discussies om, ook gelukkig tijd overbleef om te lachen! 
Adrie, Annebeth, Audrey, Coraline, Dirk-Jan, Els, Inge de V., Jantine, Joke-Afke, Machteld (Houdt vol!), 
Marja, Marjan H., Marjolein W., Marloes, Rogier en Suzanne B., bedankt voor de gezellige tijd samen. 
Verder wil ik alle arts-assistenten, stafmedewerkers en overige medewerkers van de afdeling 
Dermatologie bedanken voor hun interesse in mijn onderzoek. 
In het bijzonder wil ik jullie bedanken: Bert, Marjolein en Rebecca. Binnen één jaar tijd hebben we met 
z’n 3-en een promotieonderzoek afgerond en toch nog tijd gezien om elkaar onderling ermee te helpen. 
We kunnen een promotiebureautje beginnen! Rebecca, bedankt voor al je hulp, de inspirerende 
discussies en de ritjes naar Woerden. En die kamer delen, dat hadden we eerder moeten doen! 
Marjolein, ondanks de zeer drukke periode voor jou ben je altijd even attent en in voor een praatje, 
gezellig. Bert, mijn paranimf, je hebt altijd maar een half woord nodig om te begrijpen wat ik bedoel: 
beda…! En die gezellige etentjes laten we niet aan onze neus voorbijgaan! Wanneer gaan we weer? 
De NKT club van het Vrije Universiteit Medisch Centrum: Johan, Rik, Mary en Fons. Nu kan echt 100% 
van mijn hersenen zich aan de NKT cel gaan wijden. 
Last but not least mijn familie: 
Pap en mam, jullie hebben me altijd gestimuleerd in mijn hunker naar kennis en me het 
doorzettingsvermogen meegegeven dat nodig was om dit te bereiken. Bedankt! 
Jeroen, mijn broer(tje) en paranimf, bedankt voor al je computerhulp en het vervaardigen van de kaft en 
uitnodigingen. 
Cindy & Maarten, mijn schoonmoeder, Patrick & Brigitte (en Tom): jullie wil ik graag bedanken voor jullie 
onuitputtende interesse in mijn onderzoek. 
Erik, dank je voor je luisterend oor als ik weer thuis kwam met bergen verhalen die ik kwijt moest. Jouw 
nuchtere, rationele kijk op dingen heeft me iedere keer weer in balans gehouden. Je bent er voor me als 
ik je nodig heb, dank je wel! 
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Figure 1. CD1a staining of buttock skin, unexposed (- UV) and 48 hours after UV-B exposure 
(+ UV + 48h). Scale bar = 50 µm. (chapter 2) 
 
 
Figure 3. CD11b staining of buttock skin, unexposed (- UV) and 48 hours after UV-B exposure 
(+ UV + 48h). Scale bar = 50 µm. (chapter 2) 
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Figure 5. Double staining of CD11b (blue) and CD68 (red) of buttock skin, unexposed (- UV) 
and 48 hours after UV-B exposure (+ UV + 48h). The epidermis was demarcated manually. 
Scale bar = 50 µm. (chapter 2) 
 
 
 
Figure 1. Double staining of CD1a (blue) and active-caspase 3 (red) of buttock skin, 
unexposed (- UV), 24h (+ UV +24h) and 48h after UV-B exposure (+ UV +48h). Scale bar =50 
µm. (chapter 3) 
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Figure 3. Double staining of CD1a (blue) and H3 (red) of buttock skin, unexposed (- UV) and 
24h after UV-B exposure (+ UV) with an example of a doubled stained cell, migrating out of the 
epidermis (black arrow). Scale bar = 50 µm. (Chapter 3) 
 
 
Figure 4. Double staining of CD1a (blue) and H3 (red) in blister fluid of the UV-B-exposed skin. 
(Chapter 3) 
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Figure 1. IL-1-β expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE 
patient (c,d) and a healthy control (a,b), with an example of a rare cell expressing IL-1-β in the 
UV-exposed skin of a PLE patient (black arrow). Scale bar = 100 µm. (Chapter 5) 
 
 
Figure 2. TNF-α expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE 
patient (c,d) and a healthy control (a,b). Black arrows indicate examples of TNF-α-expressing 
cells. Scale bar = 100 µm. (Chapter 5) 
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Figure 3. IL-12 expression in unexposed skin (a,c) and 48h after UV exposure (b,d) of a PLE 
patient (c,d) and a healthy control (a,b). Black arrows indicate brightly IL-12-expressing cells. 
Scale bar = 100 µm. (Chapter 5) 
 
 
Figure 4. IL-4 expression in unexposed skin (a,c) and 24h after UV exposure (b,d) of a PLE 
patient (c,d) and a healthy control (a,b). Scale bar = 100 µm. (Chapter 5) 
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Figure 5. IL-10 expression in unexposed skin (a,d) and 24h (b,e) or 48h (c,f) after UV exposure 
of a PLE patient (d-f) and a healthy control (a-c). Black arrows indicate IL-10-expressing cells 
(a) or brightly IL-10-expressing cells (b,f). Scale bar = 100 µm. (Chapter 5) 
 
 
Figure 6. Co-expression for elastase (red) and IL-10 (a-c), TNF-α (d) or IL-4 (e) (blue) in the 
skin of a healthy control (a,b,d,e) or a PLE patient (c) 24h (a,c,d,e) or 48h (b) after UV 
exposure. Black arrows and magnifications indicate double positive cells. Gray arrows indicate 
single positive cells. Scale bar = 100 µm. (Chapter 5) 
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